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All protein-coding genes in the protozoan parasite Trypanosoma brucei are arranged in long 
clusters and are transcribed into polycistronic precursor RNAs. These pre-mRNAs require 
further processing by coupled trans splicing and polyadenylation to generate mature mRNAs. 
Although studies in the last decade have identified numerous spliceosomal components, we still 
know very little about the components, mechanisms, and dynamics of the 3´ end-processing 
machinery in trypanosomes. Moreover, most genes in trypanosomes contain one to three trans 
splice and even more dispersed polyadenylation sites, indicating that the regulation of both 
processes provides another, still not very well explored level of post-transcriptional gene 
regulation in trypanosomes: In terms of polyadenylation, factors regulating the polyadenylation 
efficiency of a primary transcript with a single poly(A) site directly affect protein expression, since 
unprocessed transcripts are degraded or not exported to the cytoplasm. In addition, multiple 
polyadenylation sites allow the generation of different transcript isoforms of a single gene by 
alternative polyadenylation.  
To characterize the catalytic core of the polyadenylation complex in T. brucei, we first identified 
the poly(A) polymerase [Tb927.7.3780] as the major functional, nuclear-localized enzyme in 
trypanosomes. In contrast, another poly(A) polymerase, encoded by an intron-containing gene 
[Tb927.3.3160], localizes mainly in the cytoplasm and appears not to be functional in general 3´ 
end processing of mRNAs. Based on tandem affinity purification with tagged CPSF160 and 
mass spectrometry, we identified ten associated components of the trypanosome 
polyadenylation complex, including homologues to all four CPSF subunits, Fip1, CstF50/64, and 
Symplekin, as well as two hypothetical proteins. RNAi-mediated knockdown revealed that most 
of these factors are essential for growth and required for both in vivo polyadenylation and trans 
splicing, arguing for a general coupling of these two mRNA-processing reactions. 
By combining genome-wide analysis of expression (RNA-seq) and in vivo RNA binding (iCLIP), 
we identified for the first time a trans-acting RNA-binding protein, the trypanosomatid 
polypyrimidine tract binding protein (PTB/hnRNP I) homolog DRBD4, as a regulator of 
polyadenylation. Based on SELEX-seq and iCLIP, we delineated purine-rich sequences 
containing AUGA elements as DRBD4 RNA-binding motif and mapped in vivo binding sites 
mainly in untranslated regions (UTRs). Integrating RNA-seq and iCLIP datasets revealed that 
DRBD4 binds upstream of poly(A) sites and modulates both their activation and repression, 
thereby affecting general transcript and isoform expression levels.  




Alle proteinkodierenden Gene des Parasiten Trypanosoma brucei, der zu den Protozoen zählt, 
sind in tandemartigen Clustern angeordnet und werden polycistronisch transkribiert. Die 
Prozessierung dieser Primärtranskripte in einzelne mRNAs erfordert eine gekoppelte trans- 
Spleiß- und Polyadenylierungsreaktion. Trotz der Identifizierung zahlreicher Faktoren des 
Spleißosomes in der letzten Dekade, ist nur wenig über die Faktoren, Mechanismen und 
Dynamik der Polyadenylierungsreaktion in Trypanosomen bekannt. Außerdem verfügen die 
meisten Gene über ein bis drei trans-Spleißstellen und stark degenerierte 
Polyadenylierungsstellen, wodurch sich eine weitere Ebene der posttranskriptionalen 
Genregulation ergibt, die jedoch weitgehend unerforscht ist: Eine Veränderung der 
Polyadenylierungseffizienz bei einem Transkript, das nur über eine Polyadenylierungsstelle 
verfügt, hat direkte Auswirkungen auf die Proteinexpression, da nicht prozessierte Transkripte 
degradiert oder nicht in das Cytoplasma exportiert werden. Außerdem ermöglichen mehrere 
Polyadenylierungsstellen die Herstellung von verschiedenen Transkriptisoformen eines 
einzelnen Genes durch alternative Polyadenylierung. 
Im Rahmen der Charakterisierung des T. brucei Polyadenylierungskomplexes haben wir 
zunächst die funktionelle, Zellkern-lokalisierte Poly(A) Polymerase [Tb927.7.3780] identifiziert. 
Die zweite Poly(A) Polymerase [Tb927.3.3160], die von einem Gen mit einem Intron kodiert 
wird, ist hingegen überwiegend cytoplasmatisch lokalisiert und nicht an der Polyadenylierung 
von mRNAs beteiligt. Mittels tandem affinity purification von Epitop-markiertem CPSF160 und 
einer anschließenden massenspektrometrischen Analyse konnten wir zehn Proteinfaktoren des 
Polyadenylierungskomplexes in T. brucei identifizieren: Homologe der vier CPSF 
Untereinheiten, Fip1, CstF50/64, Symplekin sowie zwei hypothetische Proteine. Des Weiteren 
konnten wir anhand eines RNAi-induzierten knockdowns der identifizierten Faktoren zeigen, 
dass die meisten sowohl für das Zellwachstum als auch für die in vivo Polyadenylierungs- und 
trans-Spleißreaktion essentiell sind.  
Durch die Kombination von genomweiten Genexpressions- (RNA-seq) und in vivo RNA-
Bindungsdaten (iCLIP) konnten wir das RNA-Bindeprotein DRBD4, ein Homolog des humanen 
polypyrimidine tract binding proteins (PTB/hnRNP I), als ersten trans-aktiven 
Polyadenylierungsregulator in Trypanosomen identifizieren. Mittels SELEX-seq wurden Purin-
reiche Sequenzen, die AUGA Tetramere enthalten, als Bindemotiv charakterisiert, und mittels 
iCLIP wurde die überwiegende Zahl der DRBD4 Bindungsstellen in untranslatierten Bereichen 
(UTR) von mRNAs lokalisiert. Anhand der kombinatorischen Auswertung der RNA-seq und 
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iCLIP Datensätze konnten wir zeigen, dass DRBD4 upstream von Polyadenylierungsstellen 
bindet und sowohl für die Aktivierung als auch die Repression essenziell ist, wodurch generelle 









  3. Introduction 
10 
 
3  Introduction 
3.1  Gene expression in eukaryotes 
The genetic information of eukaryotes is mostly stored as DNA in the nucleus. For the 
expression of genes, the DNA is first transcribed into RNA and in case of protein-coding genes, 
the mRNA is exported from the nucleus and translated into protein by the ribosome. Three major 
DNA-dependent RNA polymerases are involved in transcription of RNA: RNA polymerase I and 
III are responsible for the transcription of ribosomal RNAs (rRNA) and transfer RNAs (tRNA), 
whereas RNA polymerase II (Pol II) transcribes messenger RNAs (mRNA) of protein-coding 
genes. Moreover, Pol II transcribes non-coding RNAs and most small nuclear RNAs (snRNAs). 
The carboxy-terminal domain (CTD) of the largest PoI II subunit is involved in regulation of 
transcription by differential phosphorylation and couples transcription to important RNA 
processing reactions.  
The first transcription-coupled processing step is capping of the 5´ end of the nascent mRNA 
with 7-methylguanosine, forming the m7GpppN cap structure (Ghosh & Lima, 2010). This 
structure is required for mRNA stability, export, splicing and efficient translation initiation. After 
capping, the mRNA precursor undergoes cis splicing (see 3.2) since the genetic information of 
protein-coding genes is stored discontinuously in higher eukaryotes: The open reading frame 
(ORF) of a protein is encoded by exons (expressed regions), which are interspaced by non-
coding introns (intervening regions) that are removed during co-transcriptional cis splicing. The 
splicing reaction is catalyzed by a macromolecular complex, the spliceosome, which assembles 
while transcription still takes place. During complex assembly, conserved sequences of the 
exon/intron borders, the splice sites, are recognized by the spliceosome and the exons are 
joined together, while the intron is removed. Finally, Pol II reads through the polyadenylation 
signal required for 3´ end maturation of the transcription (see 3.3 and 3.4): The polyadenylation 
complex assembles on the nascent transcript, which is then cleaved by CPSF73 and 
polyadenylated by the poly(A) polymerase (PAP). The added poly(A) tail has an approximate 
length of 250 nucleotides (nts) and is essential for RNA stability, export and translation. 
Afterwards transcription is terminated via the degradation of the 3´ cleavage product by 
exonucleases Xrn2 (Kuehner et al., 2011). During all processing steps, a multitude of proteins 
bind to the RNA forming an mRNA-protein complex important for further downstream processes: 
RNA export (Kohler & Hurt, 2007), RNA surveillance and quality control (van Hoof & Wagner, 
2011, Schweingruber et al., 2013), translation into protein (Merrick, 2010), and degradation of 
the RNA (Houseley & Tollervey, 2009).  
  3. Introduction 
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3.2  Pre-mRNA splicing in eukaryotes 
The removal of intronic, non-coding sequences and the fusion of the coding exons is an 
essential step in pre-mRNA maturation (Sharp, 1994). Besides the above mentioned cis splicing 
(see 3.1), exons derived from two transcripts can be joined by trans splicing (Hastings, 2005). 
Trans splicing in trypanosomes (see 3.7) requires the spliced-leader (SL) donor RNA, from 
which a miniexon is transferred to the splice acceptor site (3´ splice site) of the pre-mRNA 
transcribed as a long polycistronic precursor.  
The chemical basis of both cis and trans splicing is a two-step transesterification reaction 
(Figure 3.1): In the first reaction, the 2´ hydroxyl group of the branch point adenosine carries out 
a nucleophilic attack on the 5´ splice site phosphate, forming the lariat intron (cis splicing) or the 
Y structure (trans splicing) both characterized by the 2´-5´ phosphodiester bond at the branch 
point. In the second step, the phosphate group at the 3´ splice site is nucleophilically attacked by 
the 3´ hydroxyl group of the released exon/miniexon, resulting in the ligation of the exons and 
the release of the intron. Finally, the intron lariat or Y structure is degraded by the debranching 
enzyme and exonucleases.  
 
Figure 3.1 Schematic models of cis and trans splicing. 
The model splice substrates consist of two exons (cis splicing; left) or one miniexon and a second exon 
(trans splicing; right) depicted as boxes. The introns are shown as solid lines. Both the 5´ and 3´ splice 
sites (5´ ss and 3´ ss) including the phosphate group (p), the branch point (BP) adenosine (A) and the 
polypyrimidine tract (PPT) are indicated. The splicing reaction is based on a two-step transesterification 
reaction: First, the 2´ hydroxyl group of the branch point adenosine carries out a nucleophilic attack on the 
5´ splice site phosphate, forming the lariat intron (cis splicing) or the Y structure (trans splicing) each 
characterized by the 2´-5´ bond at the branch point. In the second step, the phosphate group at the 3´ 
splice site is nucleophilically attacked by the 3´ hydroxyl group of the released exon/miniexon, resulting in 
the ligation of the exons and the release of the intron. 
  3. Introduction 
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For spliceosome assembly and efficient splicing conserved, cis-acting sequence motifs in the 
intron are required (Figure 3.2): The first two and the last two nucleotides in the intron at the 5´ 
donor (GT) and 3´ acceptor splice site (AG) define the exon/intron borders. The branch point 
adenosine carries out the nucleophilic attack on the 5´ splice site phosphate and the 
polypyrimidine tract serves as another essential sequence element (Patel & Steitz, 2003).  
 
Figure 3.2 Consensus sequences of mammalian introns. 
Consensus sequences of the 5´ and 3´ splice sites (5´ ss and 3´ss), the branch point (BP) adenosine (A) 
and the polypyrimidine tract (PPT). The letter heights at each position represent the frequency of 
occurrence of the corresponding nucleotides at that position. The positions that are involved in intron 
recognition are shown in black; other positions are shown in blue. Frequencies were derived from a set of 
mammalian introns. The exons 1 and 2 are shown as boxes and the intron as solid line. From Patel & 
Steitz, 2003; modified. 
 
The splicing reaction is catalyzed by the macromolecular spliceosome, which is composed of 
five (U1, U2, U4, U5 and U6) small nuclear ribonucleoprotein particles (snRNPs) as well as a 
large set of proteins (Will & Lührmann, 2011, Matera & Wang, 2014). Each snRNP consists of a 
specific small, U-rich RNA, each containing the conserved Sm site (5´ AUUUGUG 3´), which is 
bound by seven common Sm-proteins (B/B′, D3, D2, D1, E, F, and G) forming a heptameric ring. 
In contrast, the U6 snRNA is bound by seven related LSm-proteins (Lsm2-8) that assemble to 
an analogous heptameric ring. In addition, each snRNP carries several specific proteins. It was 
recently shown that the U2, U5 and U6 snRNPs form the catalytic center making the 
spliceosome indeed a ribozyme (Hang et al., 2015).  
Spliceosome assembly is a highly ordered process involving the five snRNPs, the pre-mRNA 
and numerous splicing factors (Will & Lührmann, 2011). Moreover, the spliceosome undergoes 
major rearrangements during the splicing reaction. 
Pre-mRNA splicing harbors an important regulatory potential, extending the complexity of the 
proteome by alternative cis splicing: 95% of all human genes undergo alternative cis splicing 
and approximately 100,000 of these events have been detected in major human tissues (Lee & 
Rio, 2015). Five variants of alternative cis splicing can be distinguished from constitutive 
splicing, when all exons of a single gene are included in the mature mRNA (Figure 3.3; page 13) 
  3. Introduction 
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(Hui & Bindereif, 2005): The selection of alternative 5´ or 3´ splice sites results in different exon 
lengths. Furthermore, a whole exon can be skipped or included (cassette exon). The inclusion of 
a cassette exon can also lead to skipping of the adjacent exon and vice versa, making them 
mutually exclusive exons. In case of intron retention, an intron is not removed from the 
transcript. Functional consequences of alternative cis splicing are altered localization, activity or 
function of a protein, since single exons often encode for functional protein domains (Sharp, 
1994).  
 
Figure 3.3 Alternative cis splicing patterns. 
In constitutive splicing, a single mRNA is generated from the pre-mRNA. In contrast, alternative splicing 
produces many splice variants from a single pre-mRNA, using the following principles: Alternative 5´ or 3´ 
splice sites, cassette exons, mutually exclusive exons and intron retention. Exons are depicted as boxes 
and introns as solid lines. Constitutive and alternative splicing is indicated by green and red lines, 
respectively. From Hui & Bindereif, 2005; modified. 
 
In general, alternative splicing is tissue-, development- and differentiation-specifically regulated, 
but it can be also activated by external stimuli like signal transduction cascades (Lee & Rio, 
2015). Regulators of alternative splicing are in most cases cis-acting proteins belonging to the 
SR-protein and hnRNP-protein families, which specifically bind to exonic or intronic splicing 
enhancers and silencers. SR-proteins (e.g. SRSF1) bind predominantly to splicing enhancer 
elements and activate splicing (Shepard & Hertel, 2009). They display a characteristic domain 
structure with a C-terminal domain containing arginine-serine dipeptides (SR-domain; protein-
protein interaction) and one or two N-terminal RNA recognition motifs (RRM) for RNA binding. In 
contrast, most hnRNP proteins (e.g. hnRNP I) bind splicing silencer elements and are involved 
in repression of splicing. Common domains of these proteins are RRMs that are often present in 
tandem (Han et al., 2010). Both SR- and hnRNP proteins often regulate splicing by affecting 
  3. Introduction 
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early spliceosome assembly but they can regulate splicing also by other mechanisms, e.g. 
looping out exons as described for hnRNP I (see 3.8).  
3.3 The human polyadenylation complex and its function 
Cleavage and polyadenylation of Pol II-transcribed nascent pre-mRNAs is an essential step in 3´ 
end maturation (Xiang et al., 2014). The only exceptions are the canonical histone (H1, H2A, 
H2B, H3 and H4) pre-mRNAs, which are only cleaved and end with a highly conserved stem-
loop (Marzluff et al., 2008). The nascent pre-mRNA is during 3´ end maturation in most cases 
cut at a CA dinucleotide, and a poly(A) tail of approximately 250 nts is added, first in a 
distributive, and after binding of PABPN1 (nuclear poly(A)-binding protein 1) in a processive 
manner by the poly(A) polymerase (PAP) (Brawerman, 1981, Wahle, 1991a, Bienroth et al., 
1993, Wahle, 1995a, Wahle, 1995b). For the correct procession of the 3´ end, several cis-acting 
elements of the RNA (Figure 3.4) are required (Proudfoot, 2011): First, the highly conserved 
AAUAAA hexanucleotide polyadenylation signal (PAS) typically located 15 to 30 nts upstream of 
the cleavage site (Sheets et al., 1990, Beaudoing et al., 2000, Hu et al., 2005). However, the 
PAS hexamer sequence can display microheterogeneity and an AUUAAA hexamer is common 
as well (Pauws et al., 2001). The second element is the GU- (YGUGUUYY; Y=pyrimidine) or U-
rich (UUUU) downstream sequence element (DSE) within 20 nts downstream of the cleavage 
site (Hart et al., 1985, McLauchlan et al., 1985, Gil & Proudfoot, 1987, MacDonald et al., 1994, 
Hu et al., 2005). Third, multiple UGUA upstream sequence elements (USE) are positioned 40 to 
100 nts upstream of the cleavage site (Hu et al., 2005). Mutations in these sequence elements, 
in particular the PAS, are associated with diseases like α- and β-thalassemia when the PAS is 
mutated to AAUAAG or AACAAA, respectively (Higgs et al., 1983, Orkin et al., 1985). 
 
Figure 3.4 Consensus sequence elements of the polyadenylation signal. 
The upstream sequence element (USE), the hexameric polyadenylation signal (PAS), the CA dinucleotide 
(cleavage site marked by a red arrow) and the downstream sequence element (DSE) are indicated. 
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Cleavage and polyadenylation is carried out by a large multiprotein complex composed of more 
than 85 associated proteins in humans (Shi et al., 2009). The core factors of the complex are the 
cleavage and polyadenylation specificity factor (CPSF), the cleavage stimulation factor (CstF), 
cleavage factor I (CFI), cleavage factor II (CFII), Symplekin, nuclear poly(A)-binding protein 1 
(PABPN1), the poly(A) polymerase and the CTD of Pol II (Figure 3.5). The above-mentioned 
cis-acting elements are essential for polyadenylation complex formation and directly bound by 
the CPSF (PAS binding), CstF (DSE binding) and CFI (USE binding).  
 
Figure 3.5 Simplified model of the human core cleavage and polyadenylation complex. 
The cleavage and polyadenylation specificity factor (CPSF160/100/73/30, Fip1 and WDR33; light blue) 
binds the hexameric AAUAAA polyadenylation signal (PAS). However, note that the PAS is directly bound 
to CPSF30 and WDR33, but not to CPSF160. The red arrow indicates cleavage of the RNA substrate 
mediated by the endonuclease CPSF73. The cleavage stimulation factor (CstF77/64/50; yellow) binds the 
downstream GU-or U-rich sequence element (DSE) via CstF64, and the UGUA upstream sequence 
element (USE) is bound to cleavage factor I (CFIm 25/68; pink). In addition, the scaffold protein Symplekin 
(purple), the poly(A) polymerase (PAP; red), cleavage factor II (CFII; composed of PcfI I and Clp I; green) 
and the RNA polymerase II (RNAP II) including the C-terminal domain (CTD) are indicated. From Xiang et 
al., 2014. 
 
The CPSF subcomplex consists of six different proteins CPSF160, 100, 73 and 30 (according to 
their molecular mass in kDa), Fip1 and WDR33, which are required for efficient cleavage and 
polyadenylation, since the PAS is directly bound to CPSF and CPSF73 is the processive 
endonuclease (Gilmartin & Nevins, 1989, Takagaki et al., 1989, Bienroth et al., 1991, Murthy & 
Manley, 1992, Benz et al., 2005, Mandel et al., 2006, Shi et al., 2009, Chan et al., 2014, 
Schönemann et al., 2014,). Moreover, the complex is recruited to the initiation complex and 
accompanies Pol II throughout transcription, coupling both transcription and 3´ end processing 
(Dantonel et al., 1997).  
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The largest protein, CPSF160, is composed of tandem WD40 repeats that cluster into three 
major β-propellers, which generally serve as protein scaffold but can also bind nucleic acids 
(Neuwald & Poleksic, 2000, Scrima et al., 2008, Stirnimann et al., 2010). This is consistent with 
CPSF160 RNA and protein interactions (CPSF100, Fip1, CstF77 and PAP) (Murthy & Manley, 
1992, Murthy & Manley, 1995).  
Both CPSF100 and 73 belong to the metallo-β-lactamase superfamily, whose members are 
mostly hydrolases depending on metal ions (Jenny et al., 1996, Callebaut et al., 2002). 
CPSF100 and CPSF73 have a ß-lactamase domain with a ß-caspase domain (ß-casp) inserted 
like a cassette with the active site of the protein at the interface of these two domains. However, 
only CPSF73 harbors the conserved residues (mainly histidine) that coordinate two zinc atoms 
involved in RNA cleavage making it the processive endonuclease (Mandel et al., 2006). Both 
proteins are tightly associated via their C-terminal domains, arguing for heterodimerization being 
required for cleavage, which is in line with homodimerization of other β-casp proteins (Dominski, 
2007, Michalski & Steiniger, 2015).  
CPSF30 consists of five C3H1 zinc fingers and a C-terminal C2HC zinc finger and binds in 
cooperation with WDR33 via zinc fingers two and three (minor contribution of the C-terminal zinc 
finger) directly to the PAS (Barabino et al., 1997, Chan et al., 2014, Schönemann et al., 2014, 
Shimberg et al., 2016). In addition, CPSF30 interacts with the Pol II body and likely participates 
in the association of CPSF and Pol II during transcription (Nag et al., 2007).  
Fip1 was discovered more than a decade later than the above mentioned proteins and interacts 
with the poly(A) polymerase, CPSF30, CPSF160 and CstF77 via the N-terminal region 
(Kaufmann et al., 2004). Moreover, the C-terminal arginine-rich domain can bind RNA, in 
particular U-rich sequences.  
The last CPSF subunit is WDR33 consisting of an N-terminal WD40 repeats, a middle collagen-
like domain and a C-terminal glycine-proline-arginine domain (Ito et al., 2001, Shi et al., 2009). 
WDR33 is essential for RNA binding of the polyadenylation complex since it recognizes in 
cooperation with CPSF30 the hexameric PAS (Chan et al., 2014, Schönemann et al., 2014, 
Shimberg et al., 2016). 
The second subcomplex of the polyadenylation machinery is termed CstF and composed of 
CstF77, 64 and 55 with two copies of each subunit (Takagaki et al., 1990, Gilmartin & Nevins, 
1991). The complex couples transcription and polyadenylation via the association with Pol II and 
directly binds the cis-acting DSE on the RNA transcript (MacDonald et al., 1994, McCracken et 
al., 1997).  
The largest factor, CstF77, harbors an N-terminal, half a TPR domain that is most likely involved 
in self-dimerization followed by a proline-rich segment, which binds the hinge domain of CstF64 
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and the WD40 repeats of CstF50 bridging them, since they do not make direct contact (Takagaki 
& Manley, 1994, Preker & Keller, 1998, Takagaki & Manley, 2000, Bai et al., 2007, Hockert et 
al., 2010). Additionally, the Pol II CTD is bound to CstF77 as well (McCracken et al., 1997).  
The second factor, CstF64, consists of an N-terminal RRM for DSE binding, a central hinge 
domain for CstF77 or Symplekin association, and a proline-glycine-rich region (Takagaki et al., 
1992, MacDonald et al., 1994, Takagaki & Manley, 1997, Takagaki & Manley, 2000, Perez 
Canadillas & Varani, 2003, Ruepp et al., 2011b). CstF64 as well as the isoform tauCstF64 are 
involved in the regulation of alternative polyadenylation (APA; see 3.4 and 3.5) and may have 
redundant functions (Wallace et al., 1999, Li et al., 2012, Shankarling & MacDonald, 2013, Yao 
et al., 2013).  
The last CstF subunit is CstF50 harboring an N-terminal self-dimerization domain and a C-
terminal WD40 repeat domain which functions as a binding platform for CstF77 (Takagaki & 
Manley, 1992, Takagaki & Manley, 2000). Moreover, CstF50 binds the Pol II CTD with high 
affinity and couples in cooperation with CstF77 (see above) transcription and 3´ end processing 
(McCracken et al., 1997).  
CFI is composed of two CFIm25 proteins and two proteins of the paralogous genes CFIm59, 
CFIm68 or CFIm72, of which the latter one is a larger isoform of CFIm68 (Rüegsegger et al., 
1996, Rüegsegger et al., 1998, Ruepp et al., 2011a). CFI associates early with the transcription 
elongation complex, recognizes the USE to stabilize the CPSF complex and is involved in 
mRNA export and regulation of APA (Rüegsegger et al., 1996, Venkataraman et al., 2005, 
Ruepp et al., 2009, Kim et al., 2010, Ruepp et al., 2011a, Gruber et al., 2012, Martin et al., 
2012). Knockdown of both CFIm25 and CFIm68 leads to an increased usage of proximal poly(A) 
sites, resulting in shorter 3´ untranslated regions (UTR), whereas in the wildtype situation the 
use of distal poly(A) sites (long 3´ UTRs) is preferred. 
The smallest protein of this complex, CFIm25, encompasses a central NUDIX domain without 
hydrolase activity serving as a binding platform for the USE (the CFIm25 dimer binds two USEs 
in an antiparallel fashion via CFIm68-mediated RNA looping), CFIm68, PABPN1 and the poly(A) 
polymerase (Dettwiler et al., 2004, Coseno et al., 2008, Tresaugues et al., 2008, Yang et al., 
2010, Li et al., 2011, Yang et al., 2011).  
In contrast to CFIm59 and 72, is CFIm68 the most common second subunit of the CFI complex. 
It is composed of an N-terminal RRM, a middle proline-rich region and a C-terminal RS domain 
resembling the domain organization of the previously mentioned SR proteins (see 3.2) 
(Rüegsegger et al., 1998). CFIm68 is involved in USE binding (see above) and interacts with the 
nuclear export machinery through the Thoc5 protein (TREX complex) and the export receptor 
NXF1/TAP (Gooding et al., 1998, Ruepp et al., 2009, Li et al., 2011, Yang et al., 2011).  
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CFII is the least-well characterized subcomplex of the polyadenylation machinery, since the 
factors with the exception of Clp I and PcfI I remain poorly defined and were mostly studied in 
yeast (de Vries et al., 2000). Knockdown of PcfI I impairs RNA cleavage and transcription 
termination, and Clp I was shown to interact with CPSF as well as CFI and likely tethers them to 
CFIIm (de Vries et al., 2000, West & Proudfoot, 2008). 
Symplekin is an essential scaffold protein of the polyadenylation complex and contains seven 
pairs of antiparallel α-helices (ARM repeat) at the N-terminus that are often involved in protein-
protein interactions (Takagaki & Manley, 2000, Andrade et al., 2001, Kennedy et al., 2009, 
Xiang et al., 2010). The central domain binds the hinge domain of CstF64 and, in addition, 
Symplekin associates with both CPSF73 and CPSF100 forming a stable complex required for 
RNA cleavage (Takagaki & Manley, 2000, Hofmann et al., 2002, Sullivan et al., 2009, Ruepp et 
al., 2011b).  
The canonical, nuclear localized poly(A) polymerase of the polyadenylation core complex, which 
adds the poly(A) tail to the pre-mRNA, is encoded by the human PAPOLA gene and belongs to 
the nucleotidyltransferase superfamily of DNA polymerase β (Edmonds, 1990, Raabe et al., 
1991, Wahle, 1991a, Wahle, 1991b, Colgan & Manley, 1997). At the N-terminus of the protein, 
the catalytic nucleotidyltransferase domain is inserted like a cassette in the PAP central domain 
(Raabe et al., 1994, Zhelkovsky et al., 1995, Martin & Keller, 1996, Martin et al., 1999, Martin et 
al., 2000). The catalytic domain contains the conserved aspartate triad that coordinates the 
magnesium ions that are essential for catalysis and ATP binding. Following the PAP central 
domain, a RNA-binding region and a C-terminal nuclear localization signal (NLS) are located. 
The general processivity of the poly(A) polymerase is regulated by the PABPN1 protein and the 
poly(A) tail is first synthesized in a distributive, and after binding of PABPN1 to the poly(A) tail, in 
a processive manner (Wahle, 1991a, Bienroth et al., 1993, Wahle, 1995b).  
As discussed above, PABPN1 stimulates the catalytic activity of the poly(A) polymerase to 
ensure a proper length of the poly(A) tail (see above) and may also regulate APA (see 3.4 and 
3.5) (Jenal et al., 2012). The middle coiled-coiled domain directly stimulates the poly(A) 
polymerase and the following RRM and C-terminal region are required for RNA binding, allowing 
PABPN1 to coat the newly synthesized poly(A) tail (Nemeth et al., 1995, Keller et al., 2000, 
Kerwitz et al., 2003). It was proposed that this structure restricts the CPSF complex to the PAS, 
to facilitate the interaction between CPSF and the poly(A) polymerase until the correct length of 
the poly(A) tail is reached (Kuhn et al., 2009).  
The last core subunit of the polyadenylation complex is the Pol II CTD that links both 
transcription and polyadenylation and is directly required for the latter one (McCracken et al., 
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1997, Hirose & Manley, 1998). However, the precise mechanism is not yet understood but a 
platform role was proposed, since several proteins (e.g. CstF77 and CstF50) bind to the CTD.  
Recent data from two studies suggested a new model for the previously introduced CPSF 
complex, dividing it into a RNA-binding module composed of CPSF160, CPSF30, Fip1 as well 
as WDR33 and a RNA-cleavage module built by CPSF100, CPSF73 and Symplekin (Chan et 
al., 2014, Schönemann et al., 2014, Shimberg et al., 2016). The hexameric PAS is directly 
bound to CPSF30 (zinc fingers two and three) and WDR33, whereas Fip1 binds U-rich 
sequences upstream and downstream of it. Moreover, CPSF160 binds RNA upstream of the 
cleavage site over a brought region (Figure 3.6). RNA cleavage is catalyzed by the 
endonuclease CPSF73 (see above) of the cleavage module, which is only essential for cleavage 
but not for PAS binding and polyadenylation.  
 
Figure 3.6 A new model for CPSF-RNA interaction. 
Multiple proteins mediate CPSF-RNA interactions: CPSF30 and Wdr33 directly interact with the hexameric 
AAUAAA polyadenylation signal (PAS), and CPSF30 binds to the AAUAAA motif via its zinc fingers two 
and three (shown as two fingers). Fip1 binds the U-rich auxiliary sequence upstream and downstream of 
the AAUAAA motif (shown only upstream of the AAUAAA). CPSF160 binds to RNA over a broad region 
upstream of the cleavage site. CPSF73, CPSF100 and Symplekin do not participate in AAUAAA binding, 
but function as the RNA cleavage module mediated by the endonuclease CPSF73. From Chan et al., 
2014. 
3.4 Alternative polyadenylation (APA) and its biological importance 
Recent discoveries showed that most human genes contain more than one polyadenylation site, 
suggesting that APA is a widespread phenomenon generating RNA transcripts with different 3´ 
ends (Millevoi & Vagner, 2010, Shi, 2012, Elkon et al., 2013). Four classes of APA events can 
be distinguished (Figure 3.7; page 20): Tandem 3´ UTR APA and alternative-terminal-exon APA 
are the most frequent, the less frequent intonic APA and the last frequent internal-exon APA 
type.  
In tandem 3´ UTR APA, alternative poly(A) sites are located in the last exon of the transcript, 
allowing the generation of mRNAs with different 3´ UTR lengths via the usage of proximal or 
distal poly(A) sites without any effect on the encoded protein. In contrast, the other three APA 
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types can directly affect the coding potential of the mRNA. Alternative splicing (see 3.2) can 
generate transcripts with alternative-terminal-exons causing the second APA type. An intronic, 
cryptic poly(A) site is activated during intronic APA resulting in the extension of an internal-exon 
making it the terminal one. Finally, in internal-exon APA, a poly(A) site in an internal exon is 
used for premature cleavage and polyadenylation in the coding region of the mRNA.  
 
Figure 3.7 The four different APA types.  
Tandem 3´ UTR APA involves alternative poly(A) sites within the same terminal-exon and hence 
generates multiple isoforms that differ in their 3´ UTR length, without affecting the protein encoded. The 
three other APA types potentially affect the coding sequence in addition to the 3´ UTR. In alternative-
terminal-exon APA, alternative splicing generates isoforms that differ in their last exon. Intronic APA 
involves cleavage at a cryptic, intronic poly(A) site extending an internal-exon making it the terminal one. 
Internal-exon APA involves premature cleavage and polyadenylation within an internal-exon of the coding 
region. Internal-exons are depicted as large boxes, 3´ UTRs as small red boxes and introns as solid black 
lines. Constitutive spliced (green lines) exons are shown in blue and alternatively spliced (orange lines) 
exons in green. From Elkon et al., 2013; modified. 
 
APA increases like alternative splicing (see 3.2) the complexity of the transcriptome by 
generating mRNA isoforms that differ either in their coding sequence or in their 3´ UTR, affecting 
protein function, mRNA stability or translation efficiency (Andreassi & Riccio, 2009, Fabian et al., 
2010). In particular, the 3´ UTR is very important since it functions as a binding platform for 
miRNAs that mainly regulate translation efficiency and for trans-acting proteins that influence 
mRNA stability.  
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Diverse biological processes are linked to APA: Many tissue-specific polyadenylation events and 
global trends in poly(A) site selection (brain and nervous system: distal poly(A) site; placenta, 
ovaries and blood: proximal poly(A) site) argue for a general role in development and cellular 
differentiation (Zhang et al., 2005). Perhaps the most profound association of APA was found 
with cellular proliferation (Sandberg et al., 2008, Elkon et al., 2012): The activation of T cell 
proliferation is linked to a usage of proximal poly(A) sites, and a general shortening of 3´ UTRs 
was also observed in cancer cells (Mayr & Bartel, 2009, Lin et al., 2012, Morris et al., 2012). 
This can most likely be explained by binding sites for miRNAs or trans-acting proteins in the 3´ 
UTR that can negatively affect mRNA stability or translation efficiency. In addition, APA is 
involved in neuronal activation upon external stimuli (Timmusk et al., 1993, An et al., 2008, Lau 
et al., 2010). The brain-derived neurotrophic factor gene contains two poly(A) sites, allowing the 
generation of two isoforms with either a short 3´ UTR, which is translated into protein at basal 
levels, or a long 3´ UTR only translated after external stimulation. Such a regulation is most likely 
mediated by a trans-acting factor like an RNA-binding protein or a miRNA, but remains elusive.  
3.5 Regulation of polyadenylation 
The above described APA (see 3.4) requires precise regulation, since it is involved in diverse 
biological processes, and dysregulation can result in non-functional proteins and is generally 
associated with cancer (Millevoi & Vagner, 2010, Shi, 2012, Elkon et al., 2013). Differential 
regulation of the polyadenylation efficiency of a transcript containing a single poly(A) site directly 
affects protein expression, since unprocessed transcripts are degraded or not exported to the 
cytoplasm (Millevoi & Vagner, 2010). Three simplified models for the regulation of 
polyadenylation have been proposed: “First come, first serve”, “Survival of the fittest” and 
“Agonist/Antagonist” (Davis & Shi, 2014).  
The “First come, first serve” model describes the predominant usage of the proximal poly(A) site 
since it is transcribed earlier, reflecting a direct linkage to transcription. This has been observed 
for both slow Pol II mutants in Drosophila melanogaster and drugs that reduce the transcription 
elongation rate (Pinto et al., 2011, Yu & Volkert, 2013). Further studies also suggested a direct 
influence of the chromatin structure because it often influences the elongation rate under 
physiological conditions (Brown et al., 2012). The promoter of the retrogene Mcts2 is located 
within an intron of the mouse H13 gene, which is due to CpG methylation imprinted and only 
expressed from the paternal allele (Wood et al., 2008, Cowley et al., 2012). Depending on the 
Mcts2 expression status, either the proximal (Mcts2 expressed) or the distal (Mcts2 not 
expressed) H13 poly(A) site is used, indicating that the expression of the retrogene reduces the 
transcription rate favoring the usage of the proximal H13 poly(A) site.  
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The “Survival of the fittest model” is based on the observation that distal poly(A) sites are often 
stronger than proximal ones because their PAS and DSE better resemble the conserved 
canonical sequences (Martin et al., 2012, Smibert et al., 2012, Tian & Graber, 2012, Yao et al., 
2012, Lackford et al., 2014). However, poly(A) sites are regulated by additional factors including 
the concentration of various core polyadenylation complex constituents (Takagaki et al., 1996, 
Takagaki & Manley, 1998). For example, Immunglobulin M (IgM) is subjected to intronic APA 
that produces an mRNA encoding a secreted protein, whereas polyadenylation at the distal site 
generates a membrane-bound IgM. This process is directly controlled by the up-regulation of 
CstF64 levels during B cell activation: In contrast to low CstF64 levels, where the strong, distal 
poly(A) site is used, high CstF64 levels favor the weak proximal poly(A) site. This is in line with 
an increased usage of distal poly(A) sites upon co-depletion of CstF64 and tauCstF64, indicating 
that both factors are essential for proximal poly(A) site activation (Yao et al., 2012). Depletion of 
CFIm25 or CFIm68 has the opposite effect, the activation of proximal poly(A) sites, suggesting 
the requirement of both factors for the maintenance of long 3´ UTRs (Gruber et al., 2012, Martin 
et al., 2012).  
The last model “Agonist/Antagonist” is based on individual positive or negative effects on poly(A) 
site choice by trans-acting factors such as RNA-binding proteins (Shi, 2012). The polypyrimidine 
tract binding protein (PTB/hnRNP I) represses poly(A) sites via competing with CstF64 for the 
downstream GU/U-rich sequence element, resulting in an inhibition of mRNA 3´ end cleavage 
and an accumulation of unprocessed pre-mRNAs (Castelo-Branco et al., 2004). In addition, PTB 
can activate polyadenylation by, first, promoting RNA binding of hnRNP H close to the 
polyadenylation site, which in turn facilitates the recruitment of CstF or the poly(A) polymerase, 
and, second, by increasing the processivity of the poly(A) polymerase (Millevoi et al. 2009). 
Finally, general splicing factors can also participate in the regulation of polyadenylation. The U1 
snRNP is essential for cis splicing and binds to nascent pre-mRNAs repressing cryptic poly(A) 
sites, often located in introns preventing premature cleavage and polyadenylation (Kaida et al., 
2010, Berg et al., 2012).  
3.6 The African trypanosomes: Trypanosoma brucei  
Trypanosoma brucei is a protozoan parasite belonging to the order of Kinetoplastida and the 
name of the order is derived from the kinetoplast, the DNA-containing compartment in their 
single mitochondrion (Achcar et al., 2014). The parasite undergoes a complex life-cycle in an 
insect vector, the tsetse fly (Glossina spp.) and a vertebrate host. Trypanosoma brucei can be 
divided in three subspecies causing different forms of trypanosomiasis, a lethal tropical disease 
common in Africa (Malvy & Chappuis, 2011, Migchelsen et al., 2011, Lejon et al., 2013): T. 
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brucei gambiense is most prevalent in central and western Africa and causes chronic human 
trypanosomiasis, leading to death of the untreated patient within three years. In contrast, T. 
brucei rhodesiense causes acute human trypanosomiasis, which is deadly within six months and 
is most common in southern and eastern Africa. The last subspecies is T. brucei brucei that is 
non-infective for humans but causes the Nagana cattle disease (also caused by several other 
Trypanosoma species). About 10,000 people get infected every year by human 
trypanosomiasis, which in over 96% is caused by T. brucei gambiense, and 70 million people in 
Africa live in the risk of being infected. Moreover, Trypanosoma brucei became due to some 
special biochemical and cellular characteristics an important model organism: The expression of 
variant surface glycoproteins allowing the evasion of the hosts immune response, and RNA 
editing of mitochondrial mRNAs (deletion or insertion of uridine nucleotides) by guide RNAs and 
the editosome. The special characteristics in gene expression, namely spliced-leader trans 
splicing and the polycistronic organization of protein-coding genes, which will be discussed in 
the following (see 3.7).  
3.7 Expression of protein-coding genes in trypanosomes 
In trypanosomes all protein-coding genes are arranged in long, polycistronic transcription units 
(PTU) with up to 100 functionally unrelated genes, which are transcribed by Pol II (Figure 3.8; 
page 24) (Johnson et al., 1987, Berriman et al., 2005). Genes within a PTU are transcribed from 
the same strand, whereas neighboring PTUs are transcribed from the opposite strand separated 
by a strand switch region (SSR). Transcription of neighboring PTUs is either divergent or 
convergent and the SSR functions as transcription start site (TSS) or transcription termination 
site (TTS), respectively (Martinez-Calvillo et al., 2003, El-Sayed et al., 2005). Surprisingly, no 
Pol II promoter sequence has been identified in trypanosomes with the exception of the SL RNA 
gene (see below and 3.2), suggesting that transcription of protein-coding genes is not regulated 
and proceeds roughly at the same rate (Luo et al., 1999, Ruan et al., 2004, Das et al., 2005, 
Schimanski et al., 2005a, Palenchar & Bellofatto, 2006, Schimanski et al., 2006, Lee et al., 
2007, Lee et al., 2009). An enrichment of specific histone modifications and variants at both TSS 
and TTS argues for an epigenetic mechanism of transcription initiation and termination: The 
histone modifications H4K10ac and H3K4me3, histone variants H2A.Z and H2B.Z and the 
bromodomain factor 3 protein (Bdf3), which binds acetylated lysine, are enriched at convergent 
SSRs functioning as transcription start sites (Hassan et al., 2002, Siegel et al., 2009, Wright et 
al., 2010). Nucleosomes containing H2A.Z are less stable, suggesting less condensed 
chromatin-favoring transcription (Jin & Felsenfeld, 2007, Siegel et al., 2009). In contrast, 
transcription terminates at convergent SSRs, which display an enrichment of H3K76m1/2, H3.V, 
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H4.V and base J, suggesting that they serve as marks for transcription termination, and two 
recent studies showed indeed that H3.V and base J are required for transcription termination 
(Siegel et al., 2009, Gassen et al., 2012, van Luenen et al., 2012, Reynolds et al., 2016, Schulz 
et al., 2016). Moreover, Pol I transcribed tRNA genes are often located at TTS and may 
contribute to termination of Pol II transcription (Hull et al., 1994).  
 
Figure 3.8 Organization of polycistronic transcription units in trypanosomes. 
Transcription of polycistronic transcription units (PTU; indicated as colored bold arrow) starts at 
(transcription start site, TSS) divergent (div.) strand switch regions (SSR) and terminates (transcription 
termination site, TTS) at convergent (conv.) SSRs. Genes within a PTU are transcribed from the same 
strand, whereas neighboring PTUs are transcribed from opposing strands separated by a SSR. At TSS 
H4K10ac and H3K4me
3
, H2A.Z, H2B.Z and bromodomain factor 3 protein (Bdf3) are enriched, whereas at 
TTS H3K76m
1/2
, H3.V, H4.V, base J and tRNA genes are enriched. From Siegel et al., 2011; modified. 
 
After transcription of polycistronic transcription units, single mRNAs need to be processed by 
two coupled mechanisms, namely trans splicing and polyadenylation (Figure 3.9; page 25) 
(Boothroyd & Cross, 1982, Agabian, 1990, Huang & van der Ploeg, 1991a, Huang & Van der 
Ploeg, 1991b, LeBowitz et al., 1993, Ullu et al., 1993, Matthews et al., 1994, Benz et al., 2005, 
Günzl, 2010, Preußer et al., 2012, Preußer et al., 2012). Both processes are regulated by the 
polypyrimidine tract upstream of a trans splice site, which affects polyadenylation of the 
upstream gene and trans splicing of the downstream gene. During trans splicing a 39 nts long 
miniexon derived from the SL RNA, which already contains a highly modified m7G cap structure 
termed cap4, is added to the 5´ end of all mRNAs (Bangs et al., 1992). The trans splicing 
reaction is catalyzed by the spliceosome (see 3.2) and it is assumed that the SL RNP replaces 
the U1 snRNP. However, two genes, the putative poly(A) polymerase Tb927.3.3160 and an 
ATP-dependent DEAD box helicase Tb927.8.1510, contain an intron with a conserved sequence 
and require additional U1 snRNP-dependent cis splicing (see 3.2) (Tschudi & Ullu, 1990, Mair et 
al., 2000, Liang et al., 2003, Berriman et al., 2005, Kolev et al., 2010, Siegel et al., 2010, Tkacz 
et al., 2010).  






Figure 3.9 mRNA processing in trypanosomatids. 
Schematic representation of the major mRNA processing steps in trypanosomatids. After transcription of 
polycistronic transcription units (colored boxes), which are separated by strand switch regions (SSR), the 
pre-mRNAs undergo trans splicing and polyadenylation [(A)n]. Each of the protein-coding genes (shown in 
different colors) is processed through trans splicing, whereby the SL RNA with its cap 4 structure provides 
the 5´ exon (miniexon, in magenta); in addition, very few genes require cis splicing of an internal intron 
(see green boxes). Both cis and trans splicing proceed through two transesterification steps and require 
the U2, U4/U6, and U5 small nuclear ribonucleoproteins (snRNPs) as well as many additional protein 
factors. Moreover, cis splicing requires the U1 snRNP, trans splicing the SL RNP as specific factors. From 
Preußer et al., 2012. 
 
The 3´ end of each mRNA is processed by cleavage and polyadenylation (see 3.3 and 3.4), 
which is catalyzed in other eukaryotes by the polyadenylation complex. However, in 
trypanosomes most constituents of the polyadenylation machinery remain still elusive. So far 
only three subunits of the CPSF complex -CPSF30, CPSF73, and Fip1- have been identified as 
orthologues of their mammalian counterparts (see 3.3) and were biochemically characterized to 
some extent. T. brucei CPSF30 has a conserved domain structure similar to its human 
counterpart, harboring five C3H1 zinc fingers and a C-terminal C2HC zinc finger. CPSF30 is 
essential for cell viability and processing of polycistronic pre-mRNAs, since its depletion results 
in an accumulation of dicistonic α/β-tubulin pre-mRNA (Hendriks et al., 2003). Fip1 is mainly 
localized in the nucleus, essential for cell viability and contains the conserved Fip1 domain, 
which is required for interaction with CPSF30 (zinc fingers four and five) in trypanosomes 
(Bercovich et al., 2009). Moreover, the protein harbors an C3H1 zinc finger and a histidine- (H-
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rich) and a proline-rich (P-rich) region. CPSF73 was recently co-purified with the spliceosomal 
U1 snRNP protein U1A, arguing for a coupling of both pre-mRNA processing reactions (Tkacz et 
al., 2010). However, even for the poly(A) polymerase, in other eukaryotes probably the best 
delineated component, a definitive identification and biochemical characterization have not been 
accomplished in trypanosomes. At least two genes code for putative poly(A) polymerases 
[Tb927.3.3160 and Tb927.7.3780], the first of which is peculiar in that it represents one of the 
two genes in trypanosomes that require cis splicing (see above). In addition, the polyadenylation 
signal itself is poorly defined, since the two canonical cis-acting elements, the AAUAAA motif 
(PAS) and the GU/U-rich sequence (DSE), are not conserved in trypanosomes. The only known 
cis-acting element required for polyadenylation is the above mentioned polypyrimidine tract. 
Genome-wide data showed that most genes contain one to three trans splice- and even more 
dispersed polyadenylation sites, allowing both alternative trans splicing and polyadenylation 
(Kolev et al., 2010, Nilsson et al., 2010, Siegel et al., 2010, Veitch et al., 2010, Siegel et al., 
2011). For alternative trans splicing four biological roles have been discussed (Figure 3.10 A; 
page 28) (Preußer et al., 2012): (1) Skipping of the canonical AUG start codon; (2) in- or 
exclusion of targeting signals; (3) in- or exclusion of regulatory elements (e.g. upstream open 
reading frames); (4) usage of an alternative ORF. However, only for the in- or exclusion of 
targeting signals a specific example has been described so far (Rettig et al., 2012). Alternative 
trans splicing creates a long and a short isoform of the isoleucyl-tRNA synthetase mRNA. The 
long isoform encodes for a protein, which is due to an additional N-terminal signal sequence 
imported into the mitochondrion, whereas the second protein isoform, encoded by the short 
mRNA, remains in the cytoplasm. This indicates an important role of alternative trans splicing in 
post-transcriptional gene regulation in trypanosomes. However, trans-acting factors, which 
contribute to the regulation of alternative splicing still remain elusive. So far only a few splicing 
repressors, such as the trypanosomatid orthologue of hnRNP F/H, and splicing activators, like 
the T. brucei PTB homologs DRBD3/4 (see 3.8), have been identified (Stern et al., 2009, Gupta 
et al., 2013). With to alternative polyadenylation, which may affect mature transcript levels by 
altering the length of the 3´ UTR and also 5´ UTR of the downstream gene, so far neither any 
regulatory elements nor trans-acting factors have been identified (Figure 3.10 B; page 28). 
Variations in the length of the 3´ UTR and 5´ UTR possibly alter the inclusion of important 
regulatory elements in the mature mRNA. These RNA elements, located mainly in the 3´ UTR, 
are of special interest in trypanosomes, since gene expression is regulated mostly on the post-
transcriptional level with effects on either mRNA stability or translation efficiency (Clayton & 
Shapira, 2007, Haile & Papadopoulou, 2007, Kramer & Carrington, 2011, Kramer, 2012, 
Clayton, 2013, Clayton, 2014, Kolev et al., 2014). Key players in the regulation of mRNA stability 
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are trans-acting RNA-binding proteins: As an example, the RRM-containing proteins DRBD3 and 
DRBD4 are involved in positive and negative regulation of mRNA stability, and in case of 
DRBD3 it was shown that the regulatory sequence elements are located in the mRNA 3´ UTR 
(Estevez, 2008, Stern et al., 2009). The best understood example is the stabilization of 
chaperone mRNAs during heat shock of bloodstream form trypanosomes by the ZC3H11 zinc 
finger protein (Delhi et al., 2011, Droll et al., 2013, Singh et al., 2014). The N-terminal zinc finger 
binds to UAU repeats in the mRNA 3´ UTR, while the C-terminal domain is required for 
stabilization. ZC3H11 interacts with MKT1 and PBP1, which in turn interacts with PABP that is 
known to increase mRNA stability when recruited to the 3´ UTR. RNA degradation in 
trypanosomes is in general similar to other eukaryotes. First, the RNA is deadenylated by the 
CAF1-NOT complex (CAF1 is the processive deadenylase) and afterwards decapped at the 5´ 
end by an enzyme still not identified (Milone et al., 2002, Schwede et al., 2008, Schwede et al., 
2009, Farber et al., 2013, Erben et al., 2014). Finally, the mRNA is either degraded from the 5´ 
end by the exonuclease Xrna or from the 3´ end by the exosome (Clayton & Estevez, 2011, 
Manful et al., 2011).  




Figure 3.10 Biological functions of alternative trans splicing and polyadenylation.  
Alternative trans splicing (A) and polyadenylation (B) patterns of pre-mRNAs and the different resulting 
mature mRNAs are schematically shown. (A) Protein-coding exons (green or yellow) and the SL RNA-
derived miniexon (SL) are represented as large boxes, targeting signals and regulatory elements as small 
boxes (red or blue) and intergenic regions as black lines. Four potential biological roles of alternative trans 
splicing have been reported in trypanosomes, including skipping of the AUG start codon, in- or exclusion 
of targeting signals, in- or exclusion of regulatory elements, and the usage of an alternative open reading 
frame (orange box). (B) Protein-coding genes (green or gray) and the SL RNA-derived miniexon (SL) are 
represented as large boxes. The intergenic region forming alternative 5´ and 3´ UTRs between two genes 
is indicated by small colored boxes (blue, purple and yellow). Alternative polyadenylation affects the 3´ 
UTR (tandem 3´ UTR APA) and can, due to the polycistronic gene organization, also affect the 5´ UTR of 
the downstream gene by altering trans splice site choice (APA affecting the 5´ UTR). From Preußer et al., 
(2012); modified. 
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3.8 The trypanosomatid PTB/hnRNP I homologs DRBD3 and DRBD4 
The Trypanosoma brucei homologs of vertebrate PTB are DRBD3 and DRBD4 (De Gaudenzi et 
al., 2005, Stern et al., 2009). Vertebrate PTB belongs to the hnRNP protein family (see 3.2) and 
is a classical repressor of alternative splicing (Romanelli et al., 2013). PTB is a shuttling protein 
mainly localized in the nucleus that binds via its four RRMs 15-25 nts long polypyrimidine tracts 
containing UCUUC and CUCUCU elements (Perez et al., 1997, Oberstrass et al., 2005, Ray et 
al., 2009, Reid et al., 2009, Lamichhane et al., 2010, Maynard & Hall, 2010). The RRMs one and 
two are connected by a flexible linker allowing independent RNA binding, whereas the RRMs 
three and four interact, resulting in an antiparallel orientation of their bound RNA. Moreover, the 
polypyrimidine motifs bound to the RRMs three and four are separated by a minimum of 15 nts, 
allowing RNA looping. The expression of PTB and the neuronal-specific paralog nPTB is auto- 
and cross-regulated by alternative splicing (Markovtsov et al., 2000, Rahman et al., 2002, 
Wollerton et al., 2004). PTB represses splicing of its own exon 11, causing nonsense-mediated 
decay (NMD) and promotes skipping of nPTB exon 10, causing NMD as well. However, in 
neuronal cells nPTB autoregulates exon 10 inclusion, resulting in higher nPTB protein levels (Ni 
et al., 2007).  
Several PTB-mediated mechanisms for repression of exon inclusion during cis splicing have 
been characterized: PTB binding sites within the polypyrimidine tract overlap with U2AF and U2 
snRNP binding sites, arguing for a competition of these factors for their respective binding sites 
resulting in regulation of splicing. Based on the RNA-binding properties of PTB (see above) it 
can also loop out the branch point adenosine or a whole exon leading to exon skipping (Liu et 
al., 2002, Oberstrass et al., 2005, Spellman et al., 2005, Auweter & Allain, 2008, Lamichhane et 
al., 2010, Maynard & Hall, 2010).  
Additionally, PTB can also promote exon inclusion and two different models have been 
proposed. First, via PTB binding to a polypyrimidine stretch positioned exclusively downstream 
of the respective regulated exon (Izquierdo et al., 2005). Second, by binding near the splice sites 
of the exon antagonizing the action of different splicing repressors (Xue et al., 2009).  
In addition to splicing, PTB also increases the stability of various mRNAs e.g. pre-proinsulin, 
prohormone convertase 1/3 and 2 (Knoch et al., 2004, Fred & Welsh, 2009).  
Moreover, PTB can both stimulate and repress polyadenylation: PTB activates polyadenylation  
by, first, promoting RNA binding of hnRNP H close to the polyadenylation site, which in turn 
facilitates the recruitment of CstF or the poly(A) polymerase, and, second, by increasing the 
processivity of the poly(A) polymerase (Millevoi et al. 2009). In contrast, PTB represses 
polyadenylation by competing with CstF64 for the downstream GU/U-rich sequence element, 
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resulting in an inhibition of 3´ end cleavage and an accumulation of unprocessed pre-mRNAs 
(Castelo-Branco et al., 2004). 
The trypanosomatid homologs DRBD3 and DRBD4 are required for cell viability and contain two 
and four RRM domains, respectively (De Gaudenzi et al., 2005, Stern et al., 2009). In contrast to 
DRDB4, which is predominantly nuclear, DRBD3 can be detected in both cytoplasm and nucleus 
(Stern et al., 2009, Fernandez-Moya et al., 2012). Both proteins are no general splicing factors 
but are required for efficient trans splicing of genes having a C-rich polypyrimidine tract and 
moreover, DRBD3 is needed for cis splicing. In addition, DRBD3 and 4 regulate the stability of 
different subsets of mRNAs either in a positive or negative manner (Estevez, 2008, Stern et al., 
2009). DRBD3 was shown to have a polypyrimidine-rich binding motif and to bind mRNAs 
preferentially in their 3´ UTR (Das et al., 2015). Moreover, DRBD3 is involved in the intracellular 
trafficking of bound mRNAs in form of ribonucleoprotein complexes, in response to stress 
conditions such as heat shock and starvation (Fernandez-Moya et al., 2012).  
3.9 Aims of this work 
The expression of polycistronic protein-coding genes in the protozoan parasite Trypanosoma 
brucei requires coupling of the two major mRNA processing steps, trans splicing and 
polyadenylation, to produce mature mRNAs (see 3.7). The protein components, the mechanisms 
and dynamics of both processes and in particular their mechanistic linkage are still not well 
characterized. Although studies in the last decade have identified numerous spliceosomal 
components, we still know very little about the composition and functioning of the 
polyadenylation machinery in trypanosomes: Only CPSF73, CPSF30 and Fip1 had previously 
been identified and to some extent functionally described. 
The first aim of this work was the initial characterization of the polyadenylation complex in T. 
brucei, including the identification of both the functional poly(A) polymerase and the other 
constituents of the polyadenylation machinery. Afterwards the proteins should be further 
investigated with regard to their role in trans splicing and polyadenylation, since these processes 
are coupled in vivo. 
The second aim was to analyze the regulation of polyadenylation in trypanosomes. This was 
based on the exemplary DRBD4 protein, which is a homolog of human PTB that is known to 
regulate both splicing and polyadenylation in vivo. As a starting point for our functional analysis, 
we planned to determine both the DRBD4 RNA-binding motif and genome-wide binding sites. 
Afterwards DRBD4-dependent poly(A) sites should be identified and analyzed for DRBD4 
binding, with the aim to characterize poly(A) sites directly regulated by DRBD4 in vivo. 
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4 Material and Methods 
4.1 Material 
4.1.1 Chemicals and reagents  
2 (β)-mercaptoethanol     Roth  
4´,6-diamidino-2-phenylindole (DAPI)   Roth  
Acetic acid       Roth  
Agarose ultra pure      Roth  
Amberlite® MB-1 hydrogen and hydroxide form Sigma-Aldrich 
Ammonium persulfate (APS)     Bio-Rad  
Ampicillin       Roth  
Antibiotic-antimycotic (100×)    ThermoFischer Scientific 
Anti-protein C affinity matrix    Roche Applied Science 
Blasticidin      Sigma-Aldrich 
Boric acid       Roth  
Bovine serum albumin (20 mg/ml) (BSA)  Roche Applied Science 
Bromphenol blue      Merck  
Calcium chloride (CaCl2)     Merck  
Cellfectin® II reagent     ThermoFischer Scientific 
Chloroform       Roth  
Ciprofloxacin      AppliChem 
Cold-water fish gelatin     Sigma-Aldrich  
Dimethyl pyrocarbonate (DMPC)    Sigma-Aldrich  
Dimethyl sulfoxide (DMSO)    Sigma-Aldrich 
Dipotassium phosphate (K2HPO4)   Roth 
Disodium hydrogen phosphate (Na2HPO4×2H2O) Roth 
Dithiothreitol (DTT)      Roth 
DNAzol®      ThermoFischer Scientific 
Doxycyclin (Dox)     Sigma-Aldrich 
Ethanol (≥ 99,8%)      Roth  
Ethidium bromide     Roth  
Ethylenediaminetetraacetic acid (EDTA)   Roth  
Ethyleneglycoltetraacetic acid (EGTA)  Sigma-Aldrich 
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Fetal bovine serum (FBS)    ThermoFischer Scientific 
Ficoll® PM 400     Sigma-Aldrich 
Formamide       Roth  
Geniticin       ThermoFischer Scientific 
Glucose       Sigma-Aldrich  
Glutamin       Sigma-Aldrich  
Glutathione sepharose 4B beads   GE Healthcare 
Glycerol       Roth  
Glycine       Roth  
GlycoBlue (15 mg/ml)     ThermoFischer Scientific 
Glycogen (20 mg/ml)      PeqLab  
Glyoxal solution ~40% in H2O (~8.8 M)  Sigma-Aldrich 
Hemin       Sigma-Aldrich 
Heparin sodium salt     Sigma-Aldrich 
Hygromycin      ThermoFischer Scientific 
Hypoxanthine      Sigma-Aldrich 
IgG sepharoseTM 6 fast flow    GE Healthcare 
Immu-Mount™      ThermoFischer Scientific  
InstantBlue-protein stain    Expedeon 
Isopropanol       Roth  
Isopropyl-β-D-thiogalactopyranosid (IPTG)  Roth 
LB-agar (Luria/Miller)      Roth  
LDS loading-buffer (4×)     ThermoFischer Scientific  
L-proline      Sigma-Aldrich 
L-threonine      Sigma-Aldrich 
Magnesium chloride (MgCl2)     Merck  
Mangan chloride (MnCl2)    Merck 
Methanol       Roth  
Milk-powder (fat-free)     Roth  
Monopotassium phosphate (KH2PO4)  Roth 
N-2-hydroxyethylpiperazine (HEPES)  Roth 
N,N,N´,N´-tetramethylenediamine (TEMED)  Bio-Rad  
Nonidet P-40 (NP-40)     Sigma-Aldrich  
PageBlueTM protein staining solution    ThermoFischer Scientific 
Penicillin G      Serva 
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Phleomycin      Sigma-Aldrich 
Phosphate-buffered saline (PBS; 10×)  ThermoFischer Scientific 
Polyoxyethylene (20) sorbitan monolaurate  Sigma-Aldrich  
(Tween 20) 
Polyvinyl alcohol (PVA)    Sigma-Aldrich 
Polyvinylpyrrolidone     Sigma-Aldrich 
Potassium chloride (KCl)     Roth  
Potassium phosphate  (KH2PO4)   Roth 
Puromycin      Sigma-Aldrich 
Reducing agent (10×)     ThermoFischer Scientific 
Roti-phenol      Roth 
(Phenol/Chloroform/Isoamylalcohol 25:24:1)   
Rotiphorese gel 30      Roth 
(30% Acrylamide/bisacrylamide 37.5:1)    
Rotiphorese gel 40     Roth 
(40% Acrylamide/bisacrylamide 19:1)  
SDM-79 CGGGPPTA     PAA 
Sf-900™ II SFM     ThermoFischer Scientific  
Sodium acetate      Merck  
Sodium azide (NaN3)     Merck 
Sodium chloride (NaCl)     Roth  
Sodium citrate      Roth  
Sodium dodecyl sulfate (SDS)    Roth  
Sodium pyrophosphate tetrabasic (Na4P2O7) Sigma-Aldrich 
Sodium pyruvate     Sigma-Aldrich 
StrataClean resin     Agilent Technologies 
Tris-hydroxymethylaminomethane (Tris)   Roth  
Triton X-100       Merck  
TRIzol® reagent      ThermoFischer Scientific 
tRNA from yeast      Roche Applied Science 
Trypton      Roth 
Urea        Roth  
Xylene cyanole      Fluka  
Yeast extract      Roth 
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4.1.2 Commercial Kits 
Bac-to-Bac® baculovirus expression system ThermoFischer Scientific 
Bio-Rad silver stain     Bio-Rad 
High sensitivity DNA analysis kit   Agilent Technologies 
HiScribe™ T7 high yield RNA synthesis kit  New England Biolabs 
LabChip XT DNA 750 assay kit   PerkinElmer 
Lumi-Light western blotting substrate  Roche Applied Science 
PerfeCTa® SYBR® green FastMix®   Quanta Biosciences 
Prime-It® RmT random primer labeling kit  Agilent Technologies 
Qiagen® plasmid plus maxi kit    QIAGEN 
QIAprep spin miniprep kit     QIAGEN 
QIAquick gel extraction kit     QIAGEN 
QIAquick PCR purification kit    QIAGEN 
qScript™ cDNA synthesis kit    Quanta Biosciences 
qScript™ flex cDNA kit    Quanta Biosciences 
Qubit® dsDNA HS assay kit    ThermoFischer Scientific 
RNeasy mini kit      QIAGEN  
4.1.3 Enzymes and enzyme inhibitors 
Accuprime supermix 1     ThermoFischer Scientific 
AcTEV protease (10 U/µl)    ThermoFischer Scientific 
Circligase II (100 U/μl)     Epicentre 
cOmplete™ EDTA-free protease inhibitor   Roche Applied Science 
Fast digest BamHI      ThermoFischer Scientific 
Phusion® high-fidelity DNA polymerase  New England Biolabs 
Proteinase K (PK; 20 mg/ml)     Roth 
Restriction endonucleases     New England Biolabs 
RNase I (100 U/μl)      ThermoFischer Scientific 
RNase A/T1 Mix (2 mg/ml; 5000 U/ml)  ThermoFischer Scientific 
RNaseOUT RNase inhibitor (40 U/μl)   ThermoFischer Scientific 
RQ1-DNase (1 U/μl)      Promega 
Shrimp alkaline phosphatase (SAP; 1 U/μl)   ThermoFischer Scientific 
Superscript III reverse transcriptase (200 U/μl) ThermoFischer Scientific  
T4 DNA ligase (400 U/μl)     New England Biolabs 
T4 polynucleotide kinase (PNK; 10 U/μl)   New England Biolabs 
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T4 RNA ligase (10 U/μl)     ThermoFischer Scientific  
T7 RNA polymerase (20 U/μl)    ThermoFischer Scientific 
Taq DNA polymerase     expressed and purified by Silke Schreiner 
TURBO DNase (2 U/μl)     ThermoFischer Scientific 
USB® sequenase™ version 2.0 DNA polymerase Affymetrix 
4.1.4 Nucleotides 
Deoxynucleoside triphosphate mix    Peqlab 
(dNTPs, 100 mM) 
Ribonucleoside triphosphates (100 mM)   Roche Applied Science 
[α-32P]-ATP (3000 Ci/mmol; SCP-207)   Hartmann Analytic 
[α-32P]-CTP (3000 Ci/mmol; SCP-209)   Hartmann Analytic 
[α-32P]-dCTP (3000 Ci/mmol; SCP-205)   Hartmann Analytic 
[γ-32P]-ATP (800 Ci/mmol; SCP-801)   Hartmann Analytic 
4.1.5 Markers 
DIG-labeled DNA molecular weight marker VII  Roche Applied Science 
Gene ruler DNA ladder mix     ThermoFischer Scientific 
Gene ruler low range DNA ladder mix   ThermoFischer Scientific 
pBR322 (Bolivar et al., 1977); HpaII digested kindly provided by Michael R. Green  
  (University of Massachusetts Medical  
  School, Worcester, USA) 
pcDNA3.1(+); HpaII digested  ThermoFischer Scientific 
peqGOLD protein-marker IV     Peqlab 
4.1.6 Antibodies 
Anti-GFP antibody      Roche Applied Science 
Anti-protein A antibody produced in rabbit   Sigma-Aldrich 
Anti-protein C antibody ab18591 (rabbit)  Abcam 
Anti-rabbit IgG; peroxidase antibody (goat)  Sigma-Aldrich 
Goat anti-rabbit IgG; secondary antibody;   ThermoFischer Scientific 
Alexa fluor® 488 conjugate   
Goat anti-rabbit IgG; secondary antibody;  ThermoFischer Scientific 
Alexa fluor® 594 conjugate  
 




pBR322 (Bolivar et al., 1977)    kindly provided by Michael R. Green  
       (University of Massachusetts Medical  
       School, Worcester, USA)  
pcDNA3.1(+)  ThermoFischer Scientific 
pC-PTP-NEO (Schimanski et al., 2005b)  kindly provided by Arthur Günzl (University  
       of Connecticut Health Center, Connecticut,  
       USA) 
pFastBacTMHT B     ThermoFischer Scientific 
pGEX-6P-2       GE Healthcare 
pLEW100 (Shi et al., 2000)    kindly provided by Arthur Günzl (University  
       of Connecticut Health Center, Connecticut,  
       USA) 
pJM326 (Schrader et al., 1998)   kindly provided by Arthur Günzl (University  
       of Connecticut Health Center, Connecticut,  
       USA) 
4.1.8 Bacterial and eukaryotic cells 
DRBD4-PTP/YFP     all DRBD4 cell lines were kindly provided by 
DRBD4-RNAi (Tb427/pSPR2/p3217/p4379)  Mark Carrington (University of Cambridge, 
DRBD4-RNAi (Tb427/p4106/p3217/p4379)  Department of Biochemistry, Cambridge,  
         UK) 
MAX efficiency® DH10Bac™ competent cells ThermoFischer Scientific 
One shot® BL21 Star™ (DE3) chemically   ThermoFischer Scientific 
competent E. coli   
Sf9 insect cells in Sf-900™ II SFM   ThermoFischer Scientific 
Single step (KRX) competent cells    Promega 
Tb427 29.13 (Wirtz et al., 1999)   kindly provided by Ulrich Göringer 
        (TU Darmstadt, Molecular Genetics,  
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4.1.9 T. brucei SDM-79 medium  
Ciprofloxacin      1.5 mg/l 
Fetal bovine serum (FBS)    10% 
Glucose      1 g/l 
Hemin (2.5 mg/ml in 0.05 M NaOH)   5 mg/l 
L-proline      600 mg/l 
L-threonine      350 mg/l 
Penicillin G      60 mg/l 
SDM-79 CGGGPPTA     One pack for 5 l medium 
Sodium pyruvate     100 mg/l 
The pH is adjusted with NaOH to 7.4 and the medium is filter sterilized with a Sartolab-P20 plus 
0.20 µm filter (Sartorius). 
4.1.10 Laboratory equipment  
ÄKTA purifier 10     GE Healthcare 
Agilent 2100 Bioanalyzer    Agilent Technologies 
Axioskop 20 fluorescence microscope   Zeiss  
BioPhotometer      Eppendorf  
BLX-254 UV-Crosslinker     Bio-Link  
Cooling-Thermomixer MKR 13    HLC  
Curix60      AGFA 
Electro cell manipulator 600    BTX 
Foto/PrepI      Fotodyne 
G:BOX gel documentation system    Syngene  
GeneAmp PCR system 9700    Applied Biosystems  
LabChip XT/XTe     PerkinElmer 
Mastercycler ep realplex² S     Eppendorf  
Mini-PROTEAN tetra electrophoresis system  Bio-Rad  
NanoDrop 1000 spectrophotometer    ThermoFischer Scientific  
NuPAGE electrophoresis and blotting system  ThermoFischer Scientific  
PerfectBlue gelsystem mini M   Peqlab 
Qubit® 2.0 fluorometer    ThermoFischer Scientific 
Safety stand 630 A     BTX 
Slab gel dryer SE1160    Hoefer Scientific Instruments 
SpeedVac® plus SC100A    Savant 
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Sub-Cell GT agarose gel system    Bio-Rad  
SureCycler 8000     Agilent Technologies 
Trans-Blot® turbo™ transfer system   Bio-Rad 
Tri-Carb 1600TR     PACKARD 
Typhoon™ FLA 9500     GE Healthcare 
Veriti thermal cycler      Applied Biosystems 
Wide mini sub cell 41E/1261    Bio-Rad 
4.1.11 DNA and RNA oligonucleotides (in 5´ to 3´direction) 
Cloning of T. brucei pC-PTP-NEO constructs (Sigma-Aldrich) 
PAP-PTP Tb927.3.3160 fw. ATAAGGGCCCGGTTTGTCAGGTGCTTCCAT 
PAP-PTP Tb927.3.3160 rv.  ATAAGCGGCCGCGCCTTCAGGTCTTGTAACAGGTG 
PAP-PTP Tb927.7.3780 fw.  GATTA GGGCCCCGTACCAAGGCTACGTGGAT 
PAP-PTP Tb927.7.3780 rv.  GATTAGCGGCCGCGCAAAACCGAGTCCCAGCGCTT 
CPSF160-PTP fw.  GATTAGGGCCCCGAAGCGGTCTGAAATTTGT 
CPSF160-PTP rv.   GATTAGCGGCCGCGC CTGCCTTCCCGTTGCATCAC 
CPSF30-PTP fw.  GATTAGGGGCCCCGAAGCGGTCTGAAATTTGT 
CPSF30-PTP rv.  GATTAGCGGCCGCGCCTGCCTTCCCGTTGCATCAC 
 
Cloning of T. brucei pLEW100 RNAi constructs (Sigma-Aldrich) 
PAP Tb927.3.3160 RNAi fw. GCATAAAGCTTACGCGTTCAGGTGCTTCCATCTTCTC 
PAP Tb927.3.3160 RNAi rv.  GCATATCTAGA GCCACATAGGAACTCCACAC 
PAP Tb927.7.3780 RNAi fw.  CATAAAGCTTACGCGTGGTTGACCTTGCTCCCAGTA 
PAP Tb927.7.3780 RNAi rv.  GCATATCTAGATGGCCAGTTGAATTATCACG 
CPSF160 RNAi fw.  CATAAAGCTTACGCGTGCGGGTACCTTTGACAGAAA 
CPSF160 RNAi rv.  CATATCTAGA AACCTCGTTGCGTACATTCC 
CPSF100 RNAi fw.  ATATAAGCTTACGCGTAGCCCTCGTACGCACTTAAT 
CPSF100 RNAi rv.  ATATTCTAGATTGGTCCCGCTACACTCATT 
CPSF73 RNAi fw.  ATATAAGCTTACGCGTCTTCGCGCAGAGTCAAATGT 
CPSF73 RNAi rv.  ATATTCTAGAATCCTCTAACTCCACGGTGC 
CPSF30 RNAi fw.  ATATAAGCTTACGCGTGCCTTTTATCAGCGTCTCGG 
CPSF30 RNAi rv.  ATATTCTAGAGACCTCATGCCCCTCTTCTC 
Fip1 RNAi fw.   ATATAAGCTTACGCGTCGGTTTCAACGAGAGCAGTT 
Fip1 RNAi rv.   ATATTCTAGATGCTGGTGTATTCGGATCCA 
CstF50 RNAi fw.  ATATAAGCTTACGCGTGGACTGGCACCCTTATCACT 
CstF50 RNAi rv.  ATATTCTAGAAATGGCATTGATCGGGTTGG 
CstF64 RNAi fw.  ATATAAGCTTACGCGTTACTTCGAAGAGGAAGAGAATAATG 
CstF64 RNAi rv.  ATATTCTAGATACCCAACTGCTATACCCCGT 
Symplekin RNAi fw.  ATATAAGCTTACGCGTCACGTGGCATTCTCAGTTCC 
Symplekin RNAi rv.  ATATTCTAGAGATGAGGACCTGATCTGGCA 
CFIm25 RNAi fw.  ATATAAGCTTACGCGTTACCTGCGACGAACACAAAC 
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CFIm25 RNAi rv.  ATATTCTAGAGAGATCGAACAATGGAGCGG 
CFIIm RNAi fw.  ATATAAGCTTACGCGTGGTAACTGACATGGGGCTTG 
CFIIm RNAi rv.  ATATTCTAGACCGGGGAGAGAAACGAAAAG 
Tb927.11.13860 RNAi fw. ATATAAGCTTACGCGTCCAACATACTTGCCGTGGTC 
Tb927.11.13860 RNAi rv. ATATTCTAGACAACGATGACCAGCAACACA 
Tb927.8.4480 RNAi fw. ATATAAGCTTACGCGTACTTCTGCTAGCTGGGGAAG 
Tb927.8.4480 RNAi rv. ATATTCTAGATAATCCATGCCTCTTCGCCA 
 
Cloning of baculovirus pFastBacTMHT B expression constructs (Sigma-Aldrich) 
PAP Tb927.3.3160 fw.  CATAGGATCCGAGTGGATGTATGGCCCAAC 
PAP Tb927.3.3160 rv.  CATATCTAGATTACTTCAGGTCTTGTAACAGGT 
PAP Tb927.7.3780 fw.  CATAGGATCCTCACGAACAGACAAGTCGTTC 
PAP Tb927.7.3780 rv. CATATCTAGATCAAAAACCGAGTCCCAGCGC 
 
Cloning of bacterial pGEX-6P-2 expression constructs (Sigma-Aldrich) 
GST-CPSF30 fw.   CCTGGGATCCTTTACTGACAACGCTGCCCACA 
GST-CPSF30 rv.   CCGGGAATTCTTACTGCCTTCCCGTTGCATC 
GST-DRBD4 fw.   ATATGTCGACTCAAACCTGTCTTTTGAGTAACATTC 
GST-DRBD4 rv.   ATATGCGGCCGCTCACTCATTCTGTTCGTCCTGTG 
 
Sequencing primer (Sigma-Aldrich) 
pc-PTP-NEO seq rv.  AATTCTCGCTAGCAGTAGTTGG 
pGEX-6P-2 seq fw.   AAGCCACGTTTGGTGGTG 
pGEX-6P-2 seq rv.  CCGGGAGCTGCATGTGTCAGAGG 
pFastBacTMHT B seq.  AAATGATAACCATCTCGC 
 
mRNA detection primer (Sigma-Aldrich) 
mRNA CPSF160 fw.  AAGTCCTCGAGTCGGTTCTC 
mRNA CPSF160 rv.  AAACATGCGTGGTGTCAGTC 
mRNA CPSF100 fw.  GTTGGTTGGGTGGAAGGTTC 
mRNA CPSF100 rv.  CACGCAACTTATGGAGGTCG 
mRNA CPSF73 fw.  GAGCACGAGATCTCAGACGA 
mRNA CPSF73 rv.  ATCCTCTAACTCCACGGTGC 
mRNA CPSF30 fw.  CCCACCGTGTGTCTTTTACC 
mRNA CPSF30 rv.  CACTTTGCATACCCGGACAG 
mRNA Fip1 fw.  CTGTCAGCGTTTCTTGGAGG 
mRNA Fip1 rv.  GTTGTTGTTGTGGTGGTGGT 
mRNA CstF50 fw.  GGACTGGCACCCTTATCACT 
mRNA CstF50 rv.  CTCCACTCGTTCCACTGACT 
mRNA CstF64 fw.  AACACCACCAGCCGATGTAT 
mRNA CstF64 rv.  TTCAGGAAGGGGCACAATCT 
mRNA Symplekin fw.  CCGGATATGCAGAGTTCGCT 
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mRNA Symplekin rv.  TCGAGAAGCAACACTGGCAT 
mRNA CFIm25 fw.  GAAGTGGTGGTTGATGTCGG 
mRNA CFIm25 rv.  GAGATCGAACAATGGAGCGG 
mRNA CFIIm fw.  CGTTCACTTCATCCACGCTT 
mRNA CFIIm rv.  AAGGTGGCACTTTATCCCGT 
mRNA Tb927.11.13860 fw. ACAACTTAGTGGGCTCGTCA 
mRNA Tb927.11.13860 rv. CAACGATGACCAGCAACACA 
mRNA Tb927.8.4480 fw. CTGCAGATGTGGCCAGTTTT 
mRNA Tb927.8.4480 rv. TAATCCATGCCTCTTCGCCA 
 
Polyadenylation assay (Sigma-Aldrich) 
Poly(T) with G   CGGGGGTTTTTTTTTTTTTTTTTTTT 
 
Trans splicing assay (Sigma-Aldrich) 
PPIase exon rv.   CGTTGCGACCACTTCTGCA 
PRP8 exon rv.   GATGACCACTTCTCAGTGAC 
SL RNA 6-28 fw.  ACGCTATTATTAGAACAGTTTCT 
SL RNA rv.   CAGGAACCAACAGCACAATG 
 
PCR primer for loading controls (Sigma-Aldrich) 
7SL RNA fw.   GTTGCGTTGACTTGGTGTTC 
7SL RNA rv.   TCGGTGTGCTTCTGCAAC 
U3 RNA fw.   CCGTACTCTGAACAGAATCGTTTT 
U3 RNA rv.   CCGTTCATCGAACAGCTCTC' 
 
SELEX annealing oligonucleotides (Sigma-Aldrich); N: random nucleotide 
SLX-N20    GCGTCTCGAGCGTAGTTANNNNNNNNNNNNNNNNNNNNAG 
TCGGCATCTTGGTACCCTATAGTGAGTCGTATTA 
T7 fw.    TAATACGACTCACTATAGGG 
 
SELEX RT-PCR primer (Sigma-Aldrich) 
SLX-RT   GCGTCTCGAGCGTAGTTA 
SLX-T7 fw.   TAATACGACTCACTATAGGGTACCAAGATGCCGACT 
 
SELEX RT barcoding primer (Sigma-Aldrich); N: random nucleotide; experimental barcode 
SLX_R1   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NCCAANNNGCGTCTCGAGCGTAGTTA 
SLX_R2   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NCACCNNNGCGTCTCGAGCGTAGTTA 
SLX_R3   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NGTTCNNNGCGTCTCGAGCGTAGTTA 
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SLX_R4    CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NGGCTNNNGCGTCTCGAGCGTAGTTA 
SLX_R5   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NTGCANNNGCGTCTCGAGCGTAGTTA 
SLX_R6   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NAGCTNNNGCGTCTCGAGCGTAGTTA 
SLX_R7   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NCGTCNNNGCGTCTCGAGCGTAGTTA 
SLX_R8   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NATACNNNGCGTCTCGAGCGTAGTTA 
SLX_R9   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NCTTGNNNGCGTCTCGAGCGTAGTTA 
SLX_R10   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NTAACNNNGCGTCTCGAGCGTAGTTA 
SLX_R11   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NTTCTNNNGCGTCTCGAGCGTAGTTA 
SLX_R12   CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGN 
     NACTCNNNGCGTCTCGAGCGTAGTTA 
 
SELEX library amplification primer (Sigma-Aldrich); N: random nucleotide 
SLX-Sol-5×N fw.  AATGATACGGCGACGTCCGAGATCTACACTCTTTCCCTACAC 
     GACGCTCTTCCGATCTNNNNNGGGTACCAAGATGCCGACT 
SLX_Sol rv.   CAAGCAGAAGACGGCATACG 
 
Oligonucleotides for T7 in vitro transcription (Sigma-Aldrich) 
DRBD4 motif_1_s (T7 fw.) TAATACGACTCACTATAGGG 
DRBD4 motif_1_as  TTGGGTTCATTGGGTTGGGTTCATTGGGTTCCCTATAGTGAG 
     TCGTATTA 
DRBD4 motif_2_s  TAATACGACTCACTATAGGGAAATGAATGACGTCGAG 
DRBD4 motif_2_as  CTCGACGTCATTCATTTCCCTATAGTGAGTCGTATTA 
DRBD4 motif_3_s  TAATACGACTCACTATAGGGAAGAAATGAACGTCGAG 
DRBD4 motif_3_as  CTCGACGTTCATTTCTTCCCTATAGTGAGTCGTATTA 
DRBD4 motif_4_s  TAATACGACTCACTATAGGGAAATGAATGAATGA CGTCGAG 
DRBD4 motif_4_as  CTCGACGTCATTCATTCATTTCCCTATAGTGAGTCGTATTA 
DRBD4 motif_5_s  TAATACGACTCACTATAGGGAAAAGAATGAAGAACGTCGAG 
DRBD4 motif_5_as  CTCGACGTTCTTCATTCTTTTCCCTATAGTGAGTCGTATTA 
DRBD4 motif_6_s  TAATACGACTCACTATAGGGAAATGAAAATGACGTCGAG 
DRBD4 motif_6_as  CTCGACGTCATTTTCATTTCCCTATAGTGAGTCGTATTA 
DRBD4 motif_7_s  TAATACGACTCACTATAGGGAAATGAAAAAATGACGTCGAG 
DRBD4 motif_7_as  CTCGACGTCATTTTTTCATTTCCCTATAGTGAGTCGTATTA 
DRBD4 motif_8_s  TAATACGACTCACTATAGGGAAATGAAAAAAAAAATGACGTCG 
     AG 
DRBD4 motif_8_as  CTCGACGTCATTTTTTTTTTCATTTCCCTATAGTGAGTCGTATT 
     A 
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DRBD4 motif_9_s  TAATACGACTCACTATAGGGAAAAAAAAAAAAAACGTCGAG 
DRBD4 motif_9_as  CTCGACGTTTTTTTTTTTTTTCCCTATAGTGAGTCGTATTA 
DRBD4 motif_10_s  TAATACGACTCACTATAGGGAAATTAATTAATTA CGTCGAG 




     TCCTTTCTT 
Tb927.11.3630_PPT_as_1 AAGAAAGGAAAGAAAAGGAGAAAGAGAAGGAAACCCTATAG 
     TGAGTCGTATTA 
Tb927.11.3630_PPT_s_2 TAATACGACTCACTATAGGGCTTCCCTCCTTTCTCTTTCTTTTT 
Tb927.11.3630_PPT_as_2 AAAAAGAAAGAGAAAGGAGGGAAGCCCTATAGTGAGTCGTAT 
     TA 
Tb927.6.510_PPT_s (T7 fw.) TAATACGACTCACTATAGGG 
Tb927.6.510_PPT_as GAAAAAAATGGGGAAAAGGAAAAAAAAGCCCTATAGTGAGTC 
     GTATTA 
 
iCLIP RNA oligonucleotide (Dharmacon); P: phosphate 
3´-linker    P-UGAGAUCGGAAGAGCGGUUCAG-Puromycin 
 
iCLIP RT-primer (Sigma-Aldrich); P: phosphate; N: random nucleotide; experimental barcode 
iCLIP-RT4   P- NNAGGTNNNAGATCGGAAGAGCGTCGTGGATCCTGAACC 
     GC 
iCLIP-RT8   P-NNCATTNNNAGATCGGAAGAGCGTCGTGGATCCTGAACC 
     GC 
iCLIP-RT9   P-NNGCCANNNAGATCGGAAGAGCGTCGTGGATCCTGAACC 
     GC 
iCLIP-RT10   P-NNGACCNNNAGATCGGAAGAGCGTCGTGGATCCTGAACC 
     GC 
 
iCLIP oligonucleotide for linearization of circular ssDNA (MWG Eurofins) 
Cut_oligo   GTTCAGGATCCACGACGCTCTTCAAAA 
 
iCLIP PCR-primer compatible with high-throughput sequencing (MWG Eurofins) 
Solexa P5    AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC 
     GACGCTCTTCCGATCT 
Solexa P3    CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGC 
     TGAACCGCTCTTCCGATCT 
 
PCR-primer for Northern blot probes (Sigma-Aldrich) 
Probe Tb927.8.760 fw.  CCGAAGATACCCGAAGACCA 
Probe Tb927.8.760 rv. AACATCCGAACATGAGGGGA 
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Probe Tb927.8.770 fw. GATAACGTGTCGCTGACCAC 
Probe Tb927.8.770 rv. TGCCTCCTCGTCAAAGTGAT 
Probe Tb927.11.5440 fw. TGTTTCAAAGGTGGGGCTTG 
Probe Tb927.11.5440 rv. CGTGAGAAGTTTGGCTACCG 
Probe Tb927.6.1470 fw. CAAGGTGGAGTGAGGAAGGA 
Probe Tb927.6.1470 rv. TGCGCCTTTTGTCTACCATG 
Probe Tb927.2.6000 fw. CCAGTTCTCCCCGTGTTTTG 
Probe Tb927.2.6000 rv. CCAAATCACGCGTCATGAGT 
Probe 18S rRNA fw.  CAGCGGATCACGCGCTTACA 
Probe 18S rRNA rv.  CTGTGCAATTATACATGCA 
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4.2 General techniques 
4.2.1 Guideline  
All methods were adapted from laboratory protocols or the cited literature. Enzymes, reagents 
and kits were, if not otherwise stated, used according to the manufactures instructions. If not 
otherwise mentioned, all reactions and incubation steps were performed at room temperature. 
4.2.2 Working with RNA 
All steps were performed with certified RNase-free material and all buffers were prepared with 
RNase-free water. This was prepared by addition of 1:1,000 volumes of dimethyl pyrocarbonate 
(DMPC) to deionized water, stirring for 1 h and two times autoclaving (120°C, 20 min, 2 bar). In 
the following, RNase-free water is termed “DMPC-water”. If not otherwise mentioned, samples 
where always kept on ice.  
4.2.3 Isolation of nucleic acids from T. brucei cells 
For the isolation of genomic DNA or total RNA from procyclic T. brucei cells, the DNAzol® or 
TRIzol® reagent (both ThermoFischer Scientific) was used, respectively. If high-quality RNA 
was required, e.g. for RT-PCR, the RNA precipitation step was skipped, the RNA solution was 
mixed 1:1 with 70% ethanol and further purified using RNeasy columns (QIAGEN).  
4.2.4 Purification of nucleic acids 
Phenol/chlorofrom extraction was used to purify nucleic acids form enzymatic reactions. The 
nucleic acid/protein solution was dissolved with DMPC-water >300 µl and an equal volume of 
RNA-grade phenol/chloroform/isoamylacohol (25:24:1) was added. The mixture was vigorously 
mixed for 30 sec and centrifuged (4°C, 5 min, 25,000 × g) for phase separation. The upper, 
aqueous phase was transferred in a new reaction tube and nucleic acids were precipitated (see 
4.2.5). If the yield was critical, PhaseLock heavy gel tubes (5 Prime) were used.  
4.2.5 Precipitation of nucleic acids 
To concentrate or desalt nucleic acids, ethanol or isopropanol precipitation was used. The 
nucleic acid solution was mixed with 1:10 volumes of 3M sodium-acetate (pH 5.2) and 10-20 µg 
glycogen (PeqLab) or 7.5-15 µg GlycoBlue (ThermoFischer Scientific). To precipitate nucleic 
acids, 2.5 volumes of 100% ethanol or 0.7-0.8 volumes of isopropanol were added, followed by 
incubation (4°C, -20°C or -80°C for 30 min to 16h) and centrifugation (4°C, 30 min, 25,000 × g). 
The pellet was washed with 70% ethanol and centrifuged for 5 min using the same conditions. 
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Precipitated nucleic acids were dissolved in deionized water or in case of RNA in DMPC-water. 
RNA-pellets were for subsequent denaturing polyacrylamide/urea gel electrophoresis directly 
dissolved in 1× formamide loading buffer (0.5× TBE, 45% formamide, 0.025% bromphenol blue, 
0.025% xylene cyanol).  
4.2.6 Photometric determination of nucleic acid concentration 
To determine the nucleic acid concentration, the NanoDrop 1000 spectrophotometer 
(ThermoFischer Scientific) or BioPhotometer (Eppendorf) was used. In case of iCLIP and 
SELEX-seq libraries, the nucleic acid concentration was measured using the Qubit® 2.0 
fluorometer (ThermoFischer Scientific) and the Qubit® dsDNA HS assay kit (ThermoFischer 
Scientific). 
4.2.7 Databases, web-based bioinformatics and programs 
As a general database for T. brucei specific genome-data “TriTrypDB” was used (Aslett et al., 
2010). Pairwise nucleotide and protein sequence alignments were performed by the “EMBOSS 
Needle” and multiple sequence alignments by the “Clustal Omega” program. Pattern and profile 
search were done by “InterProScan” (Jones et al., 2014). Protein structure prediction was 
carried out via the “GeneSilico metaserver” (Kurowski & Bujnicki, 2003). PCR primer were 
designed using “Primer3” (Rozen & Skaletsky, 2000) and melting temperatures were calculated 
by “Oligo Calc” (Kibbe, 2007). In addition, useful tools like “Reverse complement” from “The 
sequence manipulation suite” (Stothard, 2000), “NEBcutter V2.0” as well as “Double digest 
finder” provided by New England Biolabs, "LIGATION CALCULATOR” and “BLAST®” (Altschul 
et al., 1990) were used. For planning of molecular cloning strategies “Vector NTI 10.3.1” 
(ThermoFischer Scientific) and for analysis of genome-wide data the “Integrative genomics 
viewer” were utilized (Robinson et al., 2011, Thorvaldsdottir et al., 2013). Mass spectrometry 
data were evaluated with “Scaffold version 4.0.4” (Proteome Software) and relative band 
intensities were measured using “ImageJ” (Schneider et al., 2012). Literature search was 
performed using “PubMed”.  
 
BLAST®    http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Clustal Omega   http://www.ebi.ac.uk/Tools/msa/clustalo/ 
Double digest finder   https://www.neb.com/tools-and-resources/interactive- 
      tools/double-digest-finder 
EMBOSS Needle   http://www.ebi.ac.uk/Tools/psa/emboss_needle/ 
GeneSilico metaserver   https://www.genesilico.pl/meta2/ 
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InterProScan    http://www.ebi.ac.uk/interpro/search/sequence-search 
LIGATION CALCULATOR  http://www.insilico.uni-duesseldorf.de/Lig_Input.html 
NEBcutter V2.0   http://nc2.neb.com/NEBcutter2/ 
Oligo Calc    http://biotools.nubic.northwestern.edu/OligoCalc.html 
Primer3    http://primer3.ut.ee/ 
PubMed    http://www.ncbi.nlm.nih.gov/pubmed 
Reverse complement   http://www.bioinformatics.org/sms/rev_comp.html 
The sequence manipulation suite http://www.bioinformatics.org/sms/index.html 
TriTrypDB    http://tritrypdb.org/tritrypdb/ 
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4.3 Cell culture of procyclic T. brucei 
4.3.1 Cultivation of procyclic T. brucei cells 
Cell culture of eukaryotic cells was carried out under sterile conditions, using a clean bench in a 
designated cell culture laboratory. Commercially available flasks and pipettes were used. 
Procyclic T. brucei cells were grown for two to three days at 28°C in SDM-79 medium (see 
4.1.9) after dilution to 2×106 cells/ml. Glycerol stocks were prepared in SDM-79 (containing 10% 
glycerol) and stored at -80°C or in liquid nitrogen. According to the type of cell line antibiotics 
were added to the media (Table 4.1). 
 
Table 4.1 Antibiotics for T. brucei cell culture. 
 
Cell line Antibiotic 
PTP/YFP-tag Geniticin [40 µg/ml] 
Tb427 29.13  
Geniticin [15 µg/ml] 
Hygromycin [50 µg/ml] 
Tb427 29.13 + 
pLEW100 
Geniticin [15 µg/ml] 
Hygromycin [50 µg/ml] 
 Phleomycin [2.5 µg/ml] 
DRBD4-RNAi            
(pSPR2/p3217/p4379) 
Blasticidin [10 µg/ml] 
Geniticin [15 µg/ml] 
Puromycin [1 µg/ml] 
DRBD4-RNAi            
(p4106/p3217/p4379) 
Blasticidin [10 µg/ml] 
Geniticin [15 µg/ml] 
Puromycin [1 µg/ml] 
4.3.2 Transfection of procyclic T. brucei cells 
Procyclic T. brucei cells (see 4.3.1) were transfected with 10 µg linearized plasmid (in 20 µl 
sterile water) by electroporation. The cells (8×107 to 1×108) were suspended in 380 µl Cytomix 
pH 7.6 (120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4 pH 7.6, 25 mM HEPES pH 7.6, 5 
mM MgCl2, 2 mM EGTA pH 7.6, 0.5% glucose, 100 µg/ml BSA, 1 mM hypoxanthine), mixed with 
the plasmid, transferred in a Gene pulser®/MicroPulser™ electroporation cuvette 0.2 cm (Bio-
Rad) and electroporated (1500 V, 25 µF, 24 Ω) using a Electro cell manipulator 600 (BTX). 
Afterwards 10 ml fresh SDM-79 medium was added and the cells were grown for 8 h before the 
selective antibiotic was added (see 4.3.1). Finally, the cells were spread (200 µl each) in 96-well 
plates for growing to obtain clonal cell lines.  
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4.3.3 Generation of clonal cell lines 
To generate a stable RNAi cell line, the linearized pLEW100 construct (see 4.9.1) was 
transfected into Tb427 29.13 cells and integrated into an rDNA spacer. The plasmid (10 µg) was 
linearized using SacII (see 4.6.2), isopropanol precipitated (see 4.2.5, no addition of glycogen or 
sodium-acetate) and transfected (see 4.3.2). To generate a C-terminal PTP-tagged cell line, the 
pC-PTP-NEO construct (see 4.9.2) was transfected (see 4.3.2) in T. brucei 427 (WT) cells and 
integrated in the endogenous locus. The constructs were linearized in the insert using XhoI 
(Tb927.7.3780, Tb927.3.3160, CPSF160) or BsmI (CPSF30), precipitated and transfected as 
described above.  
4.3.4 Reverse knockdown using procyclic T. brucei RNAi cell lines 
For a specific, RNAi-mediated knockdown of a single gene (see 4.3.3), 2×106 cells/ml were 
treated for 24 h with 1 mg/ml doxycyclin (Sigma-Aldrich, in 70% ethanol). Afterwards the cells 
were counted, diluted to 2×106 cells/ml and treated again with doxycyclin. As control 70% 
ethanol was used. The cells were harvested for a large, preparative knockdown after day one, 
two and three after RNAi induction. The knockdown was extended for up to five days for growth 
curve experiments. RNAi for RNA-seq was induced in the cell line Tb427/pSPR2/p3217/p4379 
by the addition of 0.2 mg/ml doxycycline and cells were diluted every day to 2×104 cell/ml. For 
Northern blotting (cell line: Tb427/p4106/p3217/p4379) RNAi was induced by the addition of 0.2 
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4.4 Reverse transcription (RT) and polymerase chain reaction (PCR) 
4.4.1 Reverse transcription (RT) 
RNA was reverse transcribed for PCR-based analysis using the qScript™cDNA synthesis kit 
(Quanta Biosciences) containing oligo(dT) and random hexamer primer. For specific RT the 
Superscript III reverse transcriptase (ThermoFischer Scientific) or the qScript™ flex cDNA kit 
(Quanta Biosciences) was used. Total RNA was isolated as described in 4.2.3. 
4.4.2 Polymerase chain reaction (PCR) 
Taq polymerase and a 10× Taq PCR buffer (100 mM Tris-Cl pH 9.0, 500 mM NaCl, 15 mM 
MgCl2, 1% Triton X-100) were used for standard PCR. Preparative PCR for cloning of protein-
coding genes was performed using Phusion® high-fidelity DNA polymerase (New England 
Biolabs). As template either cDNA (see 4.4.1) or genomic DNA (see 4.2.3) was used. 
 
Standard 25 µl PCR and temperature profile 
 
Volume Component Concentration 
  2.5 μl 10× Taq PCR buffer 1× (1.5 mM MgCl2) 
  0.5 μl  Taq DNA polymerase - 
  1.0 μl MgCl2 (25 mM) 1.0 mM 
  1.0 μl dNTPs (10 mM each) 0.4 mM 
  1.0 μl  forward primer (10 μM) 0.4 μM 
  1.0 μl  reverse primer (10 μM) 0.4 μM 
  1.0 μl  DNA template - 
17.0 μl deionized water 
 25.0 μl   
   
initial denaturation 94°C 2 min   
denaturation 94°C 10 sec 
25-35 
cycles 
annealing 52-62°C 20 sec 
elongation 72°C 30-120 sec 
final elongation 72°C 7 min 
 
storage 4°C hold 
 
 
If required, the PCR reaction was scaled up to 2× (50 μl) or 4× (100 μl) and the magnesium 
chloride concentration was altered for optimization. The annealing temperature of each primer 
pair was empirically determined or by using “Oligo Calc” (see 4.2.7). For primer design “Primer3” 
(see 4.2.7) was used (with the exception of open reading frame primer for protein expression 
constructs). The elongation time was set depending on the length of the PCR product by 
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assuming an average elongation of 1 kb per min. The cycle number was determined empirically. 
PCR reactions were analyzed by gel electrophoresis and ethidium bromide staining (see 4.5.1). 
Preparative PCR products were gel purified (see 4.5.2). Primer sequences are summarized in 
4.1.11.  
4.4.3 Quantitative RT-PCR (RT-qPCR) 
Since PCR described in 4.4.2 allows only semiquantitative measurements, quantitative RT-PCR 
(RT-qPCR) was used to determine RNA levels precisely. Total RNA was isolated (see 4.2.3) and 
converted into cDNA according to 4.4.1. All experiments were performed as biological replicates 
and technical triplicates. The Quanta PerfeCTa® SYBR® green FastMix® (Quanta Biosciences) 
and Mastercycler ep realplex² S (Eppendorf) were used. qPCR data was analyzed using the 
provided software and quantified according to an established strategy (Pfaffl, 2001). Primer 
amplification efficiencies were determined by a dilution series of cDNA (see 4.4.1) from T. brucei 
427 (WT) cells. CT values were plotted against the logarithm of the dilution factor to obtain the 
slope. Finally, the amplification efficiency was calculated according to the formula: E = 10(-1/slope). 
Relative expression levels were calculated using the following formula:  








E is the amplification efficiency and ΔCT is the difference between the control and knockdown 
sample. 
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4.5 Gel electrophoresis-based analysis and detection methods 
 
For gel electrophoresis of nucleic acids the Tris-Borate-EDTA (TBE) buffer system was used. 
The 10× TBE buffer stock solution (890 mM Tris-Cl pH 8.0, 890 mM boric acid, 20 mM EDTA) 
was diluted as indicated.  
4.5.1 Gel electrophoresis of DNA 
Agarose gel electrophoresis was used as standard method for the analysis of DNA. The agarose 
concentration was chosen depending on the fragment length to obtain optimal resolution (Table 
4.2).  
 
Table 4.2 Agarose concentration in DNA gels. 
DNA fragment-dependent agarose concentration used for gel electrophoresis including running behavior 





Bromphenol blue Xylen cyanol 
0.5-7 kb 1.0   300 bp 3.0 kb 
0.4-6 kb 1.2   200 bp 1.5 kb 
0.2-3 kb 1.5   120 bp 1.0 kb 
0.1-2 kb 2.0 <100 bp 0.8 kb 
 
Agarose was dissolved in 0.5× TBE by boiling in a microwave, supplemented with ethidium 
bromide (final concentration 0.5 µg/ml) and stored at 50°C. Gels were poured and run in 
horizontal gel systems (PerfectBlue gelsystem mini M [Peqlab] or Sub-Cell GT [Bio-Rad]). DNA 
samples were diluted 1:6 with a 6× DNA loading dye (1× TBE, 20% glycerol, 0,025% xylen 
cyanol, 0,025% bromphenol blue) and run for 30-60 min at 120 V in 0.5× TBE. Gels were 
analyzed and documented under UV-irradiation using the G:BOX gel documentation system 
(Syngene). Gene ruler DNA ladder mix or Gene ruler low range DNA ladder mix (both 
ThermoFischer Scientific) was used as marker.  
Polyacrylamide gel electrophoresis (Mini-PROTEAN tetra electrophoresis system [Bio-Rad]) was 
used for high resolution analysis of very short DNA fragments (<200 bp, e.g. iCLIP library 
preparation PCR). A 6% solution of acrylamide/bisacrylamide (19:1) was prepared in 1× TBE, 
and polymerization was initiated by adding 1:125 volumes of 10% APS and 1:1,250 volumes of 
TEMED. Gels were run for 25 min at 200 V (1× TBE), stained for 10 min with ethidium bromide 
(5 μg/ml in 1× TBE) and destained for 2 min in deionized water. Analysis was carried out as 
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described above. As marker, Gene ruler low range DNA ladder (ThermoFischer Scientific) was 
used.  
4.5.2 Extraction of DNA from agarose gels 
Gel purification was used for the isolation of a single DNA species from a complex mixture. 
Agarose gel electrophoresis was performed with an agarose concentration <2% according to 
4.5.1, followed by purification using the QIAquick gel extraction kit (QIAGEN). 
4.5.3 Denaturing polyacrylamide/urea gel electrophoresis of RNA 
For the analysis of RNA, the samples were diluted 1:2 in 2× formamide loading buffer (1× TBE, 
90% formamide, 0.05% bromphenol blue, 0.05% xylene cyanol) or as pellets directly dissolved 
in 1× formamide loading buffer after precipitation (see 4.2.5). RNA was denatured for 5 min at 
95°C and put on ice for additional 3 min. The samples were loaded onto denaturing TBE 
polyacrylamide/urea gels for electrophoresis, using either the Mini-PROTEAN tetra 
electrophoresis system (Bio-Rad) or a custom gel system (21 cm × 18 cm × 0.5 mm). The gel 
was prepared using a 10 to 15% solution of acrylamide/bisacrylamide (19:1) in 1× TBE 
containing 50% urea. Polymerization was initiated by the addition of 1:125 volumes of 10% APS 
and 1:1,250 volumes of TEMED. The gels were run for 20 min at 23 W prior loading of the 
sample. Samples were loaded and separated for 40 to 110 min at 23W (0.5× TBE). For 
unspecific detection of RNA Bio-Rad silver stain (Bio-Rad) was used. As a marker, DIG-labeled 
DNA molecular weight marker VII (Roche Applied Science) was used.  
Radioactive labeled samples were detected by autoradiography (see 4.5.4). As marker, 
pcDNA3.1(+) or pBR322 were HpaII digested, fragments were SAP (ThermoFischer Scientific) 
treated and radioactive labeled at their 5´ end using T4 PNK (New England Biolabs) and [γ-32P]-
ATP (800 Ci/mmol; SCP-801 [Hartmann Analytic]).  
4.5.4 Autoradiography 
After separation of radioactively labeled RNA samples by gel electrophoresis (see 4.5.3), 
autoradiography was performed for detection. One glass plate was removed and the gel was 
covered with plastic wrap. An X-ray film (-80°C) or phosphorimaging screen (room temperature) 
was exposed in a film cassette for up to several days depending on the signal strength. 
Phosphorimaging screens were scanned using a Typhoon FLA 9500 (GE Healthcare) and 
quantified using the provided “ImageQuant TL” program.  
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4.5.5 Glyoxal RNA gel and Northern blotting 
Five µg of total RNA form T. brucei (see 4.2.3) was denatured for 40 min at 50°C (in 50% 
DMSO, 4% glyoxal, 10 mM sodium phosphate, pH 6.9) and separated on a 1.2 % agarose gel 
(10 mM sodium phosphate, pH 6.9). In the following, RNA was capillary blotted overnight on an 
Amersham Hybond-N membrane (GE Healthcare) using 20× SSC (150 mM NaCl, 15 mM 
sodium citrate), crosslinked at 254 nM (120 mJ/cm2), incubated at 80°C for 60 min and pre-
hybridized (5× SSC, 5× Denhardt’s solution, 10% SDS, 0.1% Na4P2O7, 0.1 % heparin sodium 
salt) for 1 h at 65°C. Following overnight (65°C) hybridization with 32P-dCTP-labeled PCR 
probes (3000 Ci/mmol; SCP-205 [Hartmann Analytic]) complementary to the ORF of the target 
gene (Prime-It® RmT random primer labeling kit [Agilent Technologies]), the membrane was 
wash twice (0.1× SSC, 0.1% SDS) for 30 min at 60°C and quantified by autoradiography using 
the Typhoon FLA 9500 (GE Healthcare) imaging system and X-ray films (see 4.5.4). 
4.5.6 Denaturing polyacrylamide/SDS gel electrophoresis of proteins 
For gel electrophoresis of proteins, the discontinuous Laemmli gel/buffer system and Mini-
PROTEAN tetra electrophoresis system (Bio-Rad) were used (Laemmli, 1970). A 10-15% 
acrylamide/bisacrylamide (37.5:1) solution was prepared in separating gel buffer (375 mM Tris-
Cl pH 8.8, 0.1% SDS) depending on the protein to be analyzed. Polymerization was initiated by 
adding 1:125 volumes of 10% APS and 1:1,250 volumes of TEMED. Stacking gels were poured 
after polymerization of the separating gel, using a 5% acrylamide/bisacrylamide (37.5:1) solution 
in stacking gel buffer (62.5 mM Tris-Cl pH 6.8, 0.05% SDS). Polymerization was initiated by 
adding the same ratios of TEMED and APS. Protein samples were mixed 1:1 with 2× SDS 
sample buffer (125 mM Tris-Cl pH 6.8, 20% glycerol, 4% SDS, 5% ß-mercaptoethanol, 0.025 
mg/ml bromphenol blue) and boiled for 10 min in a water bath. Electrophoresis was performed 
for 45-90 min in SDS running buffer (25 mM Tris-Cl, 192 mM glycine, 0.1% SDS) with a current 
limit of 15 mA in stacking- and 35 mA in separating gels. For unspecific detection of proteins, the 
PageBlueTM protein staining solution (ThermoFischer Scientific) or InstantBlue-protein stain 
(Expedeon) was used. After destaining with water, the gels were dried on a Slab gel dryer 
SE1160 (Hoefer Scientific Instruments). As marker, peqGOLD protein marker IV (Peqlab) was 
used.  
4.5.7 Western blotting 
Western blotting was performed for specific detection of proteins in cellular lysates. After gel 
electrophoresis, (see 4.5.6) the gel, the PVDF western blotting membrane (Roche Applied 
Science) and the blotting paper (Bio-Rad) were soaked in blotting buffer (25 mM Tris, 190 mM 
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glycine, 0.025% SDS). The blotting sandwich was assembled from the bottom as following: 
blotting paper, PVDF membrane, gel, blotting paper. Transfer was performed using the Trans-
Blot® turbo™ transfer system (Bio-Rad) and the standard SD (semi-dry) program. The 
membrane was blocked (5% milk powder in 1× PBS, 0.1% Tween 20) for 1 h or overnight at 
4°C. The primary antibody (Table 4.3) was added for 1 h in blocking buffer and after binding, the 
membrane was washed (1× PBS, 0.1% Tween 20) three times for 10 min. The secondary 
antibody (Table 4.3) was bound for 1 h in blocking buffer and the membrane was washed as 
described above. Finally, the membrane was dried and Lumi-Light western blotting substrate 
(Roche Applied Science) was added for detection using X-ray films (GE Healthcare).  
 
Table 4.3 Primary and secondary antibodies used for Western blotting. 
 
Antibody Dilution  
Anti-protein A antibody produced in rabbit  1:5,000 
Anti-protein C antibody ab18591 (rabbit) 1:400 
Anti-rabbit IgG; peroxidase antibody (goat) 1:10,000 
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4.6 Cloning of DNA fragments in E. coli 
4.6.1  Cultivation of E. coli 
Bacterial cells were cultured under sterile conditions. All used consumables were certified sterile, 
autoclaved (120°C, 20 min, 2 bar) or heated (180°C, 2 h). LB-medium (10 g/l NaCl, 10 g/ml 
trypton, 5 g/ml yeast extract) or LB-agar (Roth) for cultivation was dissolved in deionized water, 
autoclaved and handled using a Bunsen burner. For selective growing according to the 
resistance of the transformed plasmid, the following antibiotics were added to the media: 
Ampicillin [100 µg/ml], Gentamicin [7 µg/ml], Kanamycin [50 µg/ml] and Tetracyclin [10 µg/ml]. 
4.6.2 Digestion of DNA fragments 
PCR products were amplified (see 4.4.2) using primer with 5´ overhangs containing restriction 
sites. Plasmid DNA and PCR products were digested with New England Biolabs restriction 
enzymes. For simultaneous double digestion, the optimal buffer conditions were selected using 
the “Double digest finder” on the New England Biolabs webpage (see 4.2.7).  
4.6.3 Ligation of DNA fragments 
For cloning of DNA fragments, both the plasmid and insert were digested according to 4.6.2. 
Linearized plasmid and insert were gel purified (see 4.5.2) and molar ratios were determined by 
agarose gel electrophoresis (see 4.5.1). A five to seven fold molar excess of the insert was 
mixed with the plasmid (calculated using the “LIGATION CALCULATOR“; see 4.2.7) and 
incubated for 1 h or overnight at 16°C for ligation, using the T4 DNA ligase (New England 
Biolabs). 
4.6.4 Transformation of E. coli cells 
One vial of Single step (KRX) competent cells (Promega) was thawed on ice, mixed with 5 µl 
ligation reaction or 20 ng plasmid and incubated for 5 min on ice. For One shot® BL21 (DE3) 
chemically competent E. coli cells (ThermoFischer Scientific), the incubation time was prolonged 
to 20-30 min. Cells were incubated for 2 min on ice after head shock (42°C, 30 sec), mixed with 
450 µl LB medium and shacked for 1 h at 37°C. Cells were plated on LB-agar plates, 
supplemented with antibiotics according to 4.6.1 and grown overnight at 37°C.  
4.6.5 Identification and analysis of bacterial clones 
Colony PCR was used for screening of bacterial clones. A single colony was picked using a 
pipet tip and stirred in a 1× PCR reaction (see 4.4.2) with insert specific primer. To ensure 
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efficient cell lysis, the initial denaturation step in the temperature profile was extended to 5 min. 
LB-medium (5 ml) containing antibiotics (see 4.6.1) was inoculated with selected clones and 
incubated overnight at 37°C while shaking. Plasmid DNA was isolated using the QIAprep spin 
miniprep kit (QIAGEN). Plasmids were analyzed by restriction digestion (see 4.6.2) and gel 
electrophoresis (see 4.5.1). Plasmids containing an insert with the expected length were 
sequenced by SeqLab (Sequence Laboratories Göttingen). For large scale-preparation of 
plasmid DNA, the Qiagen® plasmid plus maxi kit (QIAGEN) was used. 
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4.7 Protein expression and purification 
4.7.1 Expression of GST-fusion proteins in E. coli 
For the expression of N-terminal GST-fusion proteins in E. coli, the recombinant (see 4.9.3) 
pGEX-6-P2 vector (GE Healthcare) was transformed in One shot® BL21 (DE3) chemically 
competent E. coli cells (ThermoFischer Scientific) according to 4.6.4. The expression culture 
was inoculated 1:1000 and overexpression (16 °C, shaking, overnight) was induced with 0.1 mM 
IPTG when OD600 0.4-0.6 was reached. The cells were harvested by centrifugation (4°C, 5 min, 
5,000 × g) and stored at -80°C after washing with 1× PBS. 
4.7.2 Purification of GST-fusion proteins from E. coli 
The cell pellet (see 4.7.1) was thawed on ice and resuspended in GST-lysis buffer (10 mM Tris-
Cl pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 0.1 mM DTT, cOmplete™ EDTA-free protease inhibitor 
[Roche Applied Science]) and incubated for 30 min at 4°C on wheel. Afterwards, the cells were 
sonicated (3×10) on ice and the lysate was supplemented with 0.01% NP-40. Cell debris was 
removed by two times centrifugation (4°C, 20 min, 20,000 × g) and the cell lysate was finally 
cleared using a syringe with a 0.45 µm filter (Rotilabo® syringe filter CME [Roth]). Prior addition 
of cell lysate and protein binding for 30 min on wheel, 80 µl (packed bead volume) pre-blocked 
(1× PBS, 0.2 mg/ml glycogen, 0.1 mg/ml BSA, 10 mM DTT, 0.05% Tween 20) glutathione 
sepharose 4B beads (GE Healthcare) were washed 3× with GST-binding buffer (10 mM Tris-Cl 
pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 0.1 mM DTT, 0.01% NP-40). Beads were washed with 5 ml 
GST-binding buffer, twice with 5 ml GST-binding buffer 600 (10 mM Tris-Cl pH 7.5, 600 mM KCl, 
2.5 mM MgCl2, 0.1 mM DTT, 0.01% NP-40), transferred in a 1.5 ml tube and washed again (3× 
GST-binding 600 and twice GST-binding buffer). Proteins bound to beads were stored in GST-
lysis buffer at 4°C for up to 4 weeks. An aliquot of the slurry was analyzed by SDS-PAGE (see 
4.5.6), including a BSA standard to determine the protein concentration and purity of the sample.  
4.7.3 Cultivation of Sf9 insect cells 
Cell culture of Sf9 insect cells (ThermoFischer Scientific) was carried out under sterile conditions 
using a clean bench in a designated cell culture laboratory. Commercially available flasks and 
pipettes were used. The adherent growing Sf9 insect cells were cultured at 28°C in Sf-900™ II 
SFM medium (supplemented with 10% FBS and 0.5× Antibiotic-antimycotic, all ThermoFischer 
Scientific). The cells were resuspended in fresh medium and split in a 1:5 or 1:10 dilution after 
three to four days, when a high confluency was reached. 
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4.7.4 Expression of recombinant proteins in Sf9 insect cells 
Recombinant pFastBacTMHT B (ThermoFischer Scientific) vector was cloned according to 4.9.3 
and baculovirus for protein expression in Sf9 insect cells was obtained, using the Bac-to-Bac® 
baculovirus expression system (ThermoFischer Scientific). 
4.7.5 Purification of baculovirus-expressed proteins 
Sf9 insect cells (see 4.7.4) were harvested by centrifugation (4°C, 5 min, 1,000 × g), washed 
with 1× PBS and resuspended in a fourfold packed cell volume of lysis buffer (50 mM NaH2PO4, 
300 mM NaCl, 10 mM imidazole, 1% NP-40, cOmplete™ EDTA-free protease inhibitor [Roche 
Applied Science], pH 8.0 using NaOH). The cells were lysed for 10 min on ice and cell debris 
was removed by centrifugation (4°C, 20 min, 20,000 × g). Recombinant proteins were affinity-
purified, using an ÄKTA purifier 10 and 1ml HisTrap FF Crude columns (both GE Healthcare). 
The column was washed (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0 using 
NaOH) with a tenfold column volume, using a flow rate of 1 ml/min and a maximal pressure of 
0,5 MPa. The protein was eluted (50 mM NaH2PO4, 300 mM NaCl, 100 mM imidazole, pH 8.0 
using NaOH) and further gel-purified on an ÄKTA purifier 10 and a Superdex 200 16/60 column 
(both GE Healthcare) using storage buffer (20 mM Tris-Cl, pH 8.0, 200 mM NaCl, 10% glycerol, 
5 mM β‐mercaptoethanol) and a flow rate of 1 ml/min and a maximal pressure of 0,3 MPa. For 
storage of purified protein, the samples were frozen in liquid nitrogen.  
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4.8 Special techniques 
4.8.1 Indirect Immunofluorescence 
T. brucei cells (2×107 to 4×107) expressing PTP-tagged proteins were harvested, washed with 
1× PBS and resuspended in 1× PBS. 20 µl of the cell suspension were fixed for 30 min at 4°C 
with 4% paraformaldehyde in 1× PBS on a coverslip. The cells were washed (1× PBS), 
permeabilized for 5 min (1% TritonX-100 in 1× PBS), washed again (1× PBS) and blocked (1× 
PBS, 0.05% Tween 20, 0.02% NaN3, 1% cold-water fish gelatin [Sigma Aldirch]). Afterwards the 
cells were incubated for 1 h with a 1:40,000 dilution of anti-protein A antibody (Sigma-Aldrich) in 
blocking solution. After washing (1× PBS, 0.05% Tween 20), goat anti-rabbit Alexa fluor® 
488/594 secondary antibodies (1:400 dilution [ThermoFischer Scientific]) were added for 1 h in 
blocking solution (including 1 μg/ml DAPI). Finally, cells were washed (1× PBS, 0.05% Tween 
20) and coverslips were mounted in Immu-Mount™ (ThermoFischer Scientific). For imaging, an 
Axioskop 20 fluorescence microscope (Zeiss) and the provided Axio Vision software were used. 
4.8.2 DNA oligonucleotide annealing 
400 pmol of complementary DNA oligonucleotides (see 4.1.11) were annealed in 25 µl 
annealing buffer (10 mM Tris-Cl pH 7.5, 50 mM NaCl, 1 mM EDTA) as follows:  
 
94°C 
1°C in 45 sec 
  4°C 
  4°C hold 
4.8.3 In vitro transcription 
In vitro transcription was performed from annealed DNA oligonucleotides (see 4.8.1) or a 
linearized plasmid that contained the 3´ UTR of the T. brucei α-Tubulin gene (provided by 
Christian Preußer), using T7 RNA polymerase (ThermoFischer Scientific). The reaction was 
incubated for 3 h at 37°C and set up as follows: 
 
Volume Component 
  5.00 µl 5× transcription buffer 
  2.50 µl DTT (100 mM) 
  6.75 µl DMPC-H2O 
  2.50 µl ATP or CTP (2mM; depending on labeling) 
  1.25 µl UTP (10 mM) 
  1.25 µl GTP (10 mM) 
  1.25 µl ATP or CTP (10 mM; depending on labeling) 
  4. Material and Methods 
60 
 
  1.00 µl DNA template (0.1-0.2 µg oligonucleotide or 1 µg plasmid) 
  0.50 µl RNaseOUT 
  1.00 µl T7 RNA polymerase 




The DNA template was digested by the addition of 3 μl RQ1 DNase (1 U/μl) and incubation for 
30 min at 37°C. Prior RNA purification using Mini quick spin RNA columns (Roche Applied 
Science), a 1 µl aliquot was taken for scintillation (Tri-Carb 1600TR [PACKARD]). Afterwards the 
transcripts were ethanol precipitated (see 4.2.5), separated on a 15% denaturing 
polyacrylamide/urea gel (see 4.5.3), detected by autoradiography (see 4.5.4) and excised from 
the gel. To isolate RNA, the gel piece was crushed and rotated overnight in 400 µl 1× PK buffer 
(100 mM Tris-Cl pH 8.0, 12.5 mM EDTA, 150 mM NaCl, 1% SDS). The liquid portion was 
transferred, the RNA was ethanol precipitated (see 4.2.5), subjected to scintillation (Tri-Carb 
1600TR [PACKARD]) and resuspended in DMPC-H2O after calculating the yield according to the 
following formula: 




4.8.4 In vitro polyadenylation assay 
For standard in vitro polyadenylation assays, 4 nM in vitro transcribed 32P-labeled RNA (see 
4.8.3), derived from the 3´ end of T. brucei α-tubulin mRNA, was assembled with poly(A) buffer 
(25 mM Tris-Cl pH 7.4, 50 mM KCl, 1.5 mM MgCl2, 1.5 mM MnCl2, 0.05 mM EDTA, 0.5 mM 
DTT, 10% glycerol, 2.6% polyvinyl alcohol [PVA]). 32 nM recombinant purified poly(A) 
polymerase (see 4.7.5) was added on ice. The reaction was started by the addition of 1 mM ATP 
and incubation at 37°C. RNAs were ethanol precipitated (see 4.2.5) and analyzed by denaturing 
polyacrylamide/urea gel electrophoresis (see 4.5.3) in combination with autoradiography (see 
4.5.4). 
4.8.5 Tandem affinity purification (TAP) and mass spectrometry 
Tandem affinity purification of PTP-tagged proteins was done as described by Schimanski et al., 
2005, with minor modifications: Briefly, T. brucei cells were collected from 3-liter cultures 
(corresponding to ~4 ml packed cell volume) and lysed in 7 ml extraction buffer (150 mM KCl, 20 
mM Tris-Cl pH 7.7, 3 mM MgCl2, 0.5 mM DTT, cOmplete™ EDTA-free protease inhibitor [Roche 
Applied Science]). For IgG affinity chromatography, 300 μl of IgG sepharose 6 fast flow beads 
(packed bead volume [GE Healthcare]) were incubated with extract for two hours at 4°C. Beads 
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were washed extensively with PA-150 buffer (150 mM KCl, 20 mM Tris-Cl pH 7.7, 3 mM MgCl2, 
0.5 mM DTT, 0.1% Tween 20), followed by TEV protease buffer (150 mM KCl, 20 mM Tris-Cl pH 
7.7, 3 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 0.1% Tween 20). Tagged proteins were eluted in 
2 ml of TEV protease buffer containing 250 units of AcTEV protease (ThermoFischer Scientific). 
For anti-protein C affinity purification, CaCl2 was added to the eluate to a final concentration of 2 
mM. The eluate was incubated for 2 hours at 4°C with 300 μl of anti-protein C affinity matrix 
(packed bead volume [Roche Applied Science]). The beads were washed with PC-150 buffer 
(150 mM KCl, 20 mM Tris-Cl pH 7.7, 3 mM MgCl2,1 mM CaCl2, 0.1% Tween 20), and the protein 
C-tagged proteins were eluted with 0.5 ml EGTA elution buffer (5 mM Tris-Cl pH 7.7, 10 mM 
EGTA, 5 mM EDTA). Eluted proteins were concentrated, using a SpeedVac® plus SC100A 
(Savant) vacuum concentrator and StrataClean resins (Stratagene), analyzed on 4-12% 
NuPAGE gels (ThermoFischer Scientific), and stained with InstantBlue-protein stain (Expedeon) 
(see 4.5.6) Proteins were in-gel digested with endoproteinase trypsin and analyzed by LC-
MS/MS under standard conditions. Data were searched against a T. brucei protein sequence 
database (NCBInr v.11.09.2013, 38,057 entries). Data were evaluated with “Scaffold version 
4.0.4” (Proteome Software), and proteins were ranked by their unique peptide counts in LC-
MS/MS analysis, using a peptide and protein threshold of 95.0% and a minimum of three 
peptides. 
4.8.6 In vivo polyadenylation assay 
To determine the general polyadenylation status of mRNAs, we measured the length of the 
poly(A) tails by splint labeling according to Tkacz et al., 2010. Briefly: Two to five µg of total RNA 
(see 4.2.3) was mixed with 200 pmol oligo(dG)-oligo(dT) primer in 1× sequinase buffer, heated 
to 85°C and quenched on ice for 30 min. Prior heating, 1 µl of the reaction was analyzed by RT-
PCR (see 4.4.1 and 4.4.2) using U3 or 7SL RNA specific primer, serving as loading control for 
normalization. Afterwards 0.1 nmol DTT, 4.8 U USB® sequenase™ version 2.0 DNA 
polymerase (Affymetrix) and 10 pmol dCTP including 2.5 µCi [α-32P]-dCTP (3000 Ci/mmol; SCP-
205 [Hartmann Analytic]) were added. The reaction was incubated for 30 min, ethanol 
precipitated (see 4.2.5) and resuspended in 50 µl RNase A/T1 mix (2 µg RNase A / 5U RNase 
T1 mix [ThermoFischer Scientific], 20 µg yeast tRNA [Roche Applied Science], 300 mM NaCl, 
10 mM Tris-Cl pH 7.5, 5 mM EDTA) to digest (37°C, 30 min) the RNA leaving intact only the 
radioactively labeled poly(A) tails. The poly(A) tails were purified by phenol/chloroform extraction 
(see 4.2.4) and ethanol precipitation (see 4.2.5), separated on a denaturing 15% 
polyacrylamide/urea gel (see 4.5.3) and detected by autoradiography (see 4.5.4). Quantitation 
was performed by measuring the relative intensities of 32P-labeled product bands, using 
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“ImageJ”. Fold changes were obtained by calculating the middle “Riemann sum”, which can be 
understood as a weighted average of the polyadenylation efficiency: 










in which S is the “Riemann sum” of the function f(x) over the total measured intensities (n) 
divided into separate sections (i). 
4.8.7 Individual-nucleotide resolution UV cross-linking and immunoprecipitation (iCLIP) 
Three biological replicates of iCLIP experiments using a stable PTP-tagged DRBD4 cell line and 
wildtype T. brucei 427 (WT) cells as negative control were performed according to an 
established strategy with minimal changes (Preußer et al., 2014). In brief: After UV-C cross-
linking, cell lysates were prepared in 1.2 ml extraction buffer (150 mM KCl, 20 mM Tris-Cl pH 
7.7, 3 mM MgCl2, 0.5 mM DTT, cOmplete™ EDTA-free protease inhibitor [Roche Applied 
Science]) using a Dounce homogenizer (25 strokes with a type B pestle) followed by sonication. 
The RNP-complexes were purified after DNase (Promega) and limited RNase I (final 
concentration 1 U/ml [ThermosFischer Scientific]) treatment by applying the first step of tandem 
affinity purification (IgG sepharose 6 fast flow beads [GE Healthcare]). After SAP 
(ThermoFischer Scientific) treatment, 3´ RNA-linker ligation (T4 RNA ligase [ThermoFischer 
Scientific]), AcTEV protease (ThermoFischer Scientific) cleavage, the second affinity step (anti-
protein C affinity matrix [Roche Applied Science]) and 5´ terminal 32P-labeling (T4 PNK [New 
England Biolabs]) the RNP-complexes were gel separated under denaturing conditions 
(NuPAGE electrophoresis and blotting system; NuPAGE™ Novex™ 4-12% Bis-Tris protein gels 
1.0 mm 12-wells [both ThermoFischer Scientific]. Afterwards the complexes were electroblotted 
onto a nitrocellulose membrane (0.45 µm [Bio-Rad]) and bound RNA was recovered by PK 
(Roth) treatment and precipitation (see 4.2.5). RNA was reverse transcribed (Superscript III 
reverse transcriptase [ThermoFischer Scientific]), using oligonucleotides which introduce a 5´ 
barcode as well as a BamHI restriction site. The cDNAs were size-fractionated by denaturing 
polyacrylamide gel electrophoresis (Novex® TBE-Urea gels 6% 10-wells [ThermoFischer 
Scientific]), circularized (Circligase II [Epicentre]) and after annealing of a complementary 
oligonucleotide, linearized between the two adapter regions by BamHI (ThermoFischer 
Scientific) digestion. The cDNA was PCR amplified (30-32 cycles; Accuprime supermix 1 
[ThermoFischer Scientific]) and the library was purified using QIAquick PCR purification kit 
(QIAGEN) and Caliper (XT DNA 750 assay kit [Perkin-Elmer]). After quality control using an 
Agilent 2100 Bioanalyzer and High sensitivity DNA analysis kit (both Agilent Technologies), the 
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library was subjected to high-throughput sequencing on an Illumina MiSeq instrument (single-
read; 100 bp for DRBD4_1/2 and WT; 75 bp for DRBD4_3).  
The YFP-based iCLIP protocol was adapted from the protocol described above with minimal 
changes, including skipping of AcTEV protease cleavage and the second affinity step: 2 µg anti-
GFP antibody (Roche Applied Science) in TBS-T (50 mM Tris-Cl pH 7.5, 150 mM NaCl, 0.05% 
Tween20) was bound for 2 h (4°C) to Dynabeads protein G (ThermoFischer Scientific). The 
beads were washed with TBS-T and cell lysate was applied for 2 h at 4°C after DNase and 
RNase (final concentration 10 U/ml) treatment. Afterwards the beads were extensively washed 
using TBS-T1000 (50 mM Tris-Cl pH 7.4, 1 M NaCl, 0.05% Tween 20), followed by SAP 
treatment. The library was PCR amplified (27 cycles), purified and subjected to high-throughput 
sequencing on an Illumina MiSeq instrument (single-read; 75 bp).  
Sequence reads were aligned to T. brucei 927 genome assembly (TriTrypDB; http://tritrypdb.org; 
release 6: TriTrypDB-6.0_TbruceiTREU927) to determine the crosslink sites and their 
corresponding crosslink-tag counts. For details of sequencing data analysis, see Preußer et al., 
2014 and references therein. The T. brucei 927 genome was used for mapping because of its 
more comprehensive genome assembly and gene annotation in comparison with T. brucei 427. 
4.8.8 Systematic evolution of ligands by exponential enrichment-sequencing (SELEX-
seq) 
An RNA pool with a degenerated sequence of 20 nts was prepared by T7 in vitro transcription 
(HiScribe™ T7 high yield RNA synthesis kit [New England Biolabs]), using a DNA 
oligonucleotide containing the random sequence annealed to a T7 promoter complementary 
DNA oligonucleotide. Selection was performed in a total volume of 200 µl (10 mM Tris-HCl pH 
7.5, 100 mM KCl, 2.5 mM MgCl2, 0.1% Triton X-100) with 40 pmol GST-DRBD4/GST-CPSF30 
or GST (as negative control) bound (see 4.7.2) to pre-blocked glutathione sepharose 4B beads 
(GE Healthcare) and 4 nmol transcript. After a 20 min incubation at room temperature, the 
samples were washed three times with 1 ml of washing buffer (10 mM Tris-HCl pH 7.5, 
100/300/600 mM KCl, 2.5 mM MgCl2, 0.1% Triton X-100), treated with PK (Roth), 
phenol/chloroform extracted (see 4.2.4), and ethanol precipitated (see 4.2.5). The stringency of 
washing steps was increased for each round of selection. Selected RNAs were reverse-
transcribed (qScript™ flex cDNA kit [Quanta Biosciences]) and PCR amplified (see 4.4.1 and 
4.4.2). Transcripts for the next round of selection were generated by in vitro transcription as 
described above. After five rounds of selection, RNA aliquots from each round and from the fifth 
round of GST selection were used for barcoding (barcodes 1-5: GST-DRBD4 and 6: GST or 
barcodes 7-11: GST-CPSF30 and 12: GST) by reverse transcription (qScript™ flex cDNA kit 
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[Quanta Biosciences]). cDNA libraries were amplified by PCR (see 4.4.2), pooled in equal 
amounts and purified by QIAquick PCR purification kit (Qiagen) and Caliper (XT DNA 750 assay 
kit [Perkin-Elmer]). After quality control using an Agilent 2100 Bioanalyzer and High sensitivity 
DNA analysis kit (both Agilent Technologies), the library was subjected to high-throughput 
sequencing on a MiSeq instrument (single-read 100 bp [Illumina]). Sequence reads were first 
sample-barcode sorted, trimmed by PCR primer sequences on both ends, and further random-
barcode filtered to obtain 20 nts sequence tags of the enriched RNA pools. The numbers of 
filtered sequence tags (from each SELEX round) containing either one of the 256 or 4,096 
possible tetramer or hexamer motifs, respectively, was summarized, and the z-score values 
were calculated for enrichment of each motif. Moreover, the top eight tetramers from the final 
selection round were combined, allowing up to two nucleotides spacing between them, and 
ranked according to their frequency in the SELEX-sequence tags  
4.8.9 GST pulldown assay 
For assaying protein-RNA interactions, 10 pmol of GST-DRBD4 (or GST as negative control) 
was immobilized (see 4.7.2) on glutathione sepharose 4B beads (GE Healthcare) and incubated 
with 500 fmol denatured, in vitro transcribed, 32P-labeled RNAs (see 4.8.3) in a final volume of 
200 µl binding buffer (10 mM Tris-Cl pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 0.1 mM DTT, 0.01% 
NP-40). After binding at room temperature for 30 min, beads were washed four times with 1 ml 
binding buffer. Bound RNA was recovered by the addition of 400 µl PK buffer (100 mM Tris-Cl 
pH 7.5, 12.5 mM EDTA, 150 mM NaCl, 1% SDS) and 10 min incubation at 80°C. Afterwards the 
RNA was extracted with phenol/chloroform (see 4.2.4), ethanol precipitated (see 4.2.5), 
analyzed on a 15% denaturing polyacrylamide/urea gel (see 4.5.3) and detected by 
autoradiography (see 4.5.4). For quantification of pulldown efficiencies the Typhoon FLA 9500 
(Ge Healthcare) imaging system was used (see 4.5.4). 
4.8.10 RNA-seq and identification of polyadenylation sites 
RNA-seq libraries for the determination of polyadenylation sites were made and sequenced at 
the Beijing Genomics Institute (Shenzhen, China). Poly(A)+ RNA was purified from total RNA, 
converted to cDNA using a 5´-T15VN-3´ oligonucleotide (V=A, G or C; N=T, A, G or C), sheared, 
and size-selected for fragments ~200 bp in length, using the Illumina TruSeq RNA sample 
preparation kit v2 (Illumnia). Sequencing was performed on an Illumina Hiseq 2000 (Illumina) 
platform yielding 90 bp paired-end reads. Polyadenylation sites were identified by the SLaP 
mapper tool (Fiebig et al., 2014), using the T. brucei 927 genome assembly. 
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4.8.11 Correlation between DRBD4 iCLIP binding and polyadenylation site choice 
The poly(A) sites identified in uninduced control cells by RNA-Seq were clustered with a 
maximal spacing of 20 nucleotides. The poly(A) site reads from the control and the DRBD4-
knockdown cells in each of the 8,962 clusters were summarized. The Bioconductor package 
DESeq (Anders & Huber, 2010) was applied to determine the differential expression of poly(A) 
site clusters. As a result, 234 down- and 248 up-regulated clusters with a minimum of 10 poly(A) 
site reads in control cells (14 in knockdown cells) were selected for further analysis, using as a 
criterion an absolute fold change greater than 0.75 in log2 value. Poly(A) site clusters with p-
values greater than 0.75 (expression not affected by DRBD4 knockdown) were selected for 
background group selection. For each regulated cluster, four clusters with similar expression 
levels (in the range of 0.9 to 1.1) were randomly picked as background clusters. The position 0 
of the poly(A) site cluster was defined as the nucleotide with the highest poly(A) read count 
within the cluster. The iCLIP crosslink-tag counts in the region between -200 nts and +200 nts of 
the regulated and background clusters were summarized. For the distribution of iCLIP crosslink 
tags, fitted values with 21-nts windows were used for smooth-line presentation, with iCLIP tag 
counts plotted on the Y-axis and positions relative to the defined position 0 on the X-axis. 
4.8.12 Flow cytometry 
Mid-log phase density cells (5×106 cells/ml) were analyzed with and without doxycycline 
induction, using a BD FACScan (BD Biosciences).  
 
  




4.9.1 Generation of pLew100 RNAi constructs 
For a specific RNAi-mediated knockdown of a single gene (Table 4.4), 300-500 bp of the 3´ UTR 
were cloned (see 4.6) as a stem loop construct in the pLEW100 vector, allowing the expression 
of a double stranded RNA (Wang et al., 2000). The target gene insert was amplified by PCR 
(see 4.4.2) using a forward primer containing a HindIII and MluI restriction site and a reverse 
primer containing a XbaI restriction site. The “sense insert” was first cloned in pJM325, using 
HindIII and XbaI restriction sites. The “antisense insert” was directly cloned into pLew100, using 
MluI and XbaI restriction sites. Afterwards the “sense insert” and a ~530 bp long stuffer derived 
from pJM325 were cloned into pLEW100, using HindIII and XbaI restriction sites.  
 






of the gene  
PAP Tb927.7.3780 1527-1997 
PAP Tb927. 3.3160 944-1440 
CPSF160 Tb927.11.14650 3243-3720 
CPSF100 Tb927.11.230 584-997 
CPSF73 Tb927.4.1340 1683-2106 
CPSF30 Tb927.11.12750 271-759 
Fip1 Tb927.5.4320 285-765 
Symplekin Tb927.8.7490 3754-4235 
CstF64 Tb927.8.8210 4-396 
CstF50 Tb927.6.1830 744-1191 
CFIm25 Tb927.7.1620 392-819 
CFIIm Tb927.6.3690 729-1183 
hyp. Protein Tb927.11.13860 234-710 
hyp. Protein Tb927.8.4480 264-724 
 
4.9.2 Generation of PTP-tag fusion protein constructs 
For the expression of C-terminal PTP-tagged proteins from the endogenous locus, the pC-PTP-
NEO vector was used (Schimanski et al., 2005b).  
The ORFs of Tb927.3.3160 (nts 672-1461), Tb927.7.3780 (nts 1172-2061), CPSF160 (nts 3601-
4356) and CPSF30 (nts 74-831), were PCR-amplified (see 4.4.2) and inserted in-frame (see 4.6) 
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into the pC-PTP-NEO vector upstream of the PTP tag sequence, using the ApaI and NotI 
restriction sites.  
4.9.3 Generation of protein overexpression constructs 
For overexpression of recombinant proteins in Sf9 insect or One shot® BL21 (DE3) chemically 
competent E. coli cells, the pFastBacTMHT B (ThermoFischer Scientific) and pGEX-6P-2 (GE 
Healthcare) vectors were used, respectively. The ORFs of PAP Tb927.3.3160 (nts 3-1464) and 
PAP Tb927.7.3780 (nts 3-2064) were PCR amplified (see 4.4.2) and cloned (see 4.6) into the 
pFastBacTMHT B vector, using the BamHI and EcoRI restriction sites. The ORFs of 
Tb927.11.12750 (nts 3-834; CPSF30) and Tb927.11.14100 (nts 3-1518; DRBD4) were PCR 
amplified (see 4.4.2) and cloned (see 4.6) into the pGEX-6P-2 vector, using the BamHI and 
EcoRI or SalI and NotI restriction sites, respectively.  




5.1 The trypanosomatid polyadenylation complex 
5.1.1 The trypanosomatid poly(A) polymerases  
To identify the major functional poly(A) polymerase in T. brucei, we focus here on two putative 
poly(A) polymerases [Tb927.3.3160 and Tb927.7.3780] and initially compared the sequences 
with their human homolog, PAPOLA (Figure 5.1 and Supplementary Figure 8.1; page 128-
129). Based on the Needleman-Wunsch alignment algorithm, the human PAPOLA protein 
shows 17.4% and 24% identity with the trypanosomatid Tb927.3.3160 and Tb927.7.3780 
proteins from T. brucei, respectively. Although there are regions of low sequence similarity, 
structure predictions of these two T. brucei poly(A) polymerases suggest a strong structure 
conservation of the two proteins. Moreover, by domain structure prediction of these two T. brucei 
poly(A) polymerases, the highly conserved domains of the poly(A) polymerase described in 
higher eukaryotes, such as the central domain harboring the nucleotidyltransferase activity 
including the three catalytic aspartic acid residues, are present in both trypanosomatid proteins 
(Zhelkovsky et al., 1995, Martin & Keller, 1996, Martin et al., 1999). Following the central 
domain, an RNA-binding domain was predicted for all three proteins. However, both 
trypanosomatid proteins lack a recognizable, classical nuclear localization signal at their C-
terminus.  
 
Figure 5.1 Domain structure of trypanosomatid poly(A) polymerases. 
Domain organization of the PAPs, comparing the human poly(A) polymerase alpha (hPAPOLA) and two 
putative trypanosomatid PAPs [Tb927.7.3780 and Tb927.3.3160]. The PAP central domain, harboring the 
nucleotidyltransferase domain and the conserved catalytic aspartic acid residues (in blue), the RNA-
binding domain (in green), and the known nuclear localization signals (NLS; in magenta) are illustrated. 
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To compare the two putative enzymes, we next generated two clonal procyclic cell lines, which 
stably express either Tb927.3.3160 or Tb927.7.3780, each with a C-terminal PTP-tag (protein C 
epitope / TEV cleavage site / 2× protein A epitope). Expression of both proteins was monitored 
by Western blot analysis (Figure 5.2 A) and in addition, the subcellular distribution of both 
proteins was visualized by indirect immunofluorescence (Figure 5.2 C and D). Interestingly, the 
PTP-tagged version of the Tb927.7.3780 predominantly localizes to the nucleus, whereas the 
putative poly(A) polymerase Tb927.3.3160 clearly localizes mainly in distinct cytoplasmic spots, 
suggesting differential functions. However, one has to consider that the large C-terminal tag may 
influence the localization within the cell. 
 
Figure 5.2 Expression and cellular localization of two poly(A) polymerases in T. brucei. 
(A) The expression of PTP-tagged putative poly(A) polymerase [Tb927.7.3780] and [Tb927.3.3160] in T. 
brucei cells was detected by Western blotting, using polyclonal anti-protein A antibodies (lane PTP). As 
control, T. brucei 427 wildtype (lane WT) cells were included. Protein size markers in kDa.  
(B and C) Cell lines stably expressing PTP-tagged versions of the two poly(A) polymerases were fixed 
and stained with DAPI. The localization of tagged proteins was assessed by indirect immunofluorescence, 
using anti-protein A antibodies followed by Alexa-594 and Alexa-488-coupled secondary antibodies for 
Tb927.7.3780 and Tb927.3.3160, respectively. Superimpositions of DAPI and PTP-tagged proteins 
(merge) as well as with brightfield are shown (merge with brightfield). 
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5.1.2 Only the putative poly(A) polymerase Tb927.7.3780 shows in vitro activity 
To assess and compare the enzymatic activity of both proteins, we expressed His-tagged 
versions of the two poly(A) polymerases in Sf9 insect cells, using the Bac-to-Bac® baculovirus 
expression system followed by HPLC purification (Figure 5.3).  
 
Figure 5.3 Recombinant expression of trypanosomatid poly(A) polymerases in Sf9 cells. 
Recombinant proteins were expressed in baculovirus-infected Sf9 cells, HPLC-purified, and analyzed by 
SDS-PAGE and Coomassie staining. BSA standards (100-500 ng) were used for quantification. Protein 
size markers (M) in kDa. 
 
The purified recombinant proteins were assayed for unspecific polyadenylation activity, using an 
RNA substrate derived from the 3´ end of the T. brucei α-tubulin mRNA. Interestingly, only the 
Tb927.7.3780 protein showed in vitro activity under these conditions, in contrast to the 
Tb927.3.3160 protein (Figure 5.4; page 71). The RNA substrate was efficiently elongated by 
Tb927.7.3780 (approximately 150 nts within 10 min), suggesting a high processivity of the 
enzyme. As previously shown for the human poly(A) polymerase, non-specific activity is very 
inefficient in the absence of specificity factors, such as CPSF or CFI; however, if Mg2+ is 
replaced by Mn2+, the unspecific activity is strongly enhanced (Christofori & Keller, 1988, Wahle 
et al., 1991). This is also the case for the poly(A) polymerase Tb927.7.3780 in trypanosomes 
(Figure 5.4; page 71).  




Figure 5.4 Recombinant putative poly(A) polymerase Tb927.7.3780 polyadenylates in vitro. 
Only the putative poly(A) polymerase Tb927.7.3780 shows in vitro activity and requires manganese as a 
cofactor for unspecific polyadenylation. In vitro transcribed 
32
P-labeled RNA (derived from the T. brucei α-
tubulin 3´ UTR) was incubated at 37°C with baculovirus-expressed and purified putative poly(A) 
polymerase [Tb927.3.3160 or Tb927.7.3780]. Reactions were performed in the presence of MnCl2 or 
MgCl2 or a mixture of both (1.5 mM), and either in presence (+) or absence (-) of ATP. Reactions were 
analyzed after 30 minutes on a denaturing 12.5% polyacrylamide/urea gel. Marker sizes in nucleotides. 
5.1.3 In vivo activity of the putative poly(A) polymerases 
To compare the activities of the two trypanosomatid poly(A) polymerases in vivo, we silenced 
them individually in procyclic T. brucei by doxycycline-inducible RNAi. The knockdown efficiency 
was confirmed by RT-qPCR, using primer detecting the respective Tb927.3.3160 and 
Tb927.7.3780 mRNAs (Figure 5.5 A; left side; page 72). After three days of RNAi induction, we 
observed a knockdown efficiency of approximately 80% and 70%, respectively. In addition, we 
performed semiquantitative RT-PCR using the same primer pairs, confirming the knockdown 
(Figure 5.5 A; right side; page 72). When we monitored the cell viability upon knockdown, only 
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after silencing Tb927.7.3780 expression, cell growth was rapidly affected; in contrast, 
knockdown of Tb927.3.3160 did not result in a phenotypic growth defect (Figure 5.5 B). 
 
Figure 5.5 Only the putative poly(A) polymerase Tb927.7.3780 is required for cell viability. 
(A) The mRNA levels were analyzed by real-time RT-PCR (left) or semiquantitative RT-PCR (right) from 
uninduced cells (t0) and after 1, 2, and 3 days of RNAi induction (t24-t72, as indicated). U3 RNA served 
for normalization and as control. M, markers (100, 200, 300, 400, and 500 bp).  
(B) Growth curves of representative cell lines, in which RNAi was induced by doxycycline, (+ Dox, lines 
with asterisks) and respective uninduced controls (-Dox, lines with triangles). 
 
To investigate whether individual knockdown of the two poly(A) polymerases affects the global 
mRNA polyadenylation status in vivo, total RNA was analyzed after three days, and the poly(A) 
tail length was examined according to Tkcaz et al., 2010. In brief, poly(A) tails were labeled at 
their 3´ end by splint ligation, using an oligo(dG)-oligo(dT) primer to allow subsequent fill-in with 
32P-dCTP. Total RNA was then treated with RNase A and T1, leaving intact poly(A) tails, which 
were analyzed by gel electrophoresis. The relative band intensities of the poly(A) tails were 
measured by ImageJ and normalized against signals of U3 RNA (Figure 5.6; page 73). The 
results clearly indicate that Tb927.7.3780 depletion severely reduced relative amounts and 
lengths of the poly(A) tails, unlike Tb927.3.3160 depletion, where an opposite effect of a slight 
increase in activity was observed. Taken together, our results indicate that the poly(A) 
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polymerase Tb927.7.3780 (annotated as putative) represents the major functional nuclear 
poly(A) polymerase in trypanosomes. In contrast, the poly(A) polymerase from the intron-
containing gene Tb927.3.3160 localizes mainly in the cytoplasm and appears not to be 
functional in general 3´ polyadenylation. 
 
Figure 5.6 Only the putative poly(A) polymerase Tb927.7.3780 is active in polyadenylation in vivo. 
Depletion of poly(A) polymerase Tb927.7.3780, but not of Tb927.3.3160, impairs polyadenylation in vivo. 
RNA from uninduced (- Dox) and induced (+ Dox) cells was splint-labeled, digested with RNases A/T1, 
followed by separation of the labeled tails on a denaturing 15% polyacrylamide/urea gel. U3 RNA detected 
by RT-PCR served as loading control. Marker sizes are indicated in nucleotides. The relative intensities of 
both signals were measured with ImageJ and plotted. The black and grey lines represent the tail length 
distributions in uninduced and induced cells, respectively. 
5.1.4 Identification of the constituents of the polyadenylation complex 
To systematically investigate the composition of the trypanosomatid polyadenylation machinery, 
we used tandem affinity purification (TAP), based on the largest subunit of the CPSF complex, 
the putative CPSF160 [Tb927.11.14560]. We generated a clonal procyclic cell line, which stably 
expresses CPSF160 with a C terminal PTP tag (for Western blot analysis, see Figure 5.7 A; for 
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its cellular distribution, Figure 5.7 B). As expected, CPSF160-PTP predominantly localizes to 
the nucleus, with only minor staining of the cytoplasm. 
 
Figure 5.7 Expression and cellular localization of T. brucei CPSF160-PTP.  
(A) Expression of PTP-tagged CPSF160 homolog [Tb927.11.14560; lane PTP] in T. brucei cells was 
detected by Western blotting, using polyclonal anti-protein A antibodies. As a control, T. brucei 427 
wildtype (lane WT) cells were analyzed. Protein size marker in kDa. 
(B) Nuclear localization of CPSF160-PTP. Cell lines stably expressing PTP-tagged T. brucei CPSF160 
were fixed and stained with DAPI. The localization of tagged protein was assessed by indirect 
immunofluorescence, using anti-protein A antibodies (CPSF160-PTP). In addition, superimpositions of 
DAPI and PTP-tagged protein (merge) as well as with brightfield are shown (merge with brightfield). 
 
Based on CPSF160-PTP, two independent tandem affinity purifications (TAP) were performed 
(prot C exp. 1 and 2); as control, wildtype T. brucei 427 cells (WT) were used (Figure 5.8; page 
75). Factors co-purifying with CPSF160 were analyzed by mass spectrometry and are listed in 
Figure 5.8 (page 75; for raw data, see Supplementary Table 8.1; page 131-133): Eight proteins 
were identified by homology search as putative factors of the polyadenylation complex in 
trypanosomes, including five CPSF subunits (CPSF160; CPSF100; CPSF73; CPSF30; Fip1), 
two constituents of CstF (CstF64 hinge domain [see below]; CstF50), and the scaffold protein 
Symplekin. Two additional proteins were found [Tb927.11.13860; Tb927.8.4480], which are 
likely associated with the polyadenylation complex, since they are clearly above the peptide 
counts of the background control (WT). However, neither the poly(A) polymerase Tb927.7.3780 
nor Tb927.3.3160 was co-purified with CPSF160-PTP. In addition, we did homology-based 
databank searches for trypanosomatid homologs of other eukaryotic polyadenylation factors, 
which had not appeared in our mass spectrometry analysis. As a result, we identified potential 
homologs of the 25 kDa subunit of cleavage factor I (CFIm25) [Tb927.7.1620] and cleavage 
factor II (CFIIm) [Tb927.6.3690] (Figure 5.8; page 75). 




Figure 5.8 Identification of components of the polyadenylation complex, based on TAP-tag 
purification of the nuclear localized trypanosomatid CPSF160 homolog. 
CPSF160-associated proteins were identified by mass spectrometry. Extracts were prepared from T. 
brucei cell lines that stably express tagged CPSF160 (in two biological replicates; exp. 1/2), followed by 
TAP-tag affinity purification. Proteins after the second purification step (protein C elution) were analyzed 
by SDS-PAGE and Coomassie staining (lanes prot C experiment 1/2). As control, T. brucei 427 wildtype 
cells were used (lane WT). Protein size markers in kDa (M). Putative protein constituents of the T. brucei 
polyadenylation complex were identified by mass spectrometry. Each protein is described by name 
(factor), the TriTrypDB annotation number (http://tritrypdb.org/tritrypdb/), its molecular mass (in kDa), the 
number of exclusive unique peptide counts obtained by mass spectrometry, and, if applicable, by literature 
reference. Below, the three proteins identified only by database search (PAP, CFI25m, and CFII) are 
listed by name, TriTrypDB annotation number, and molecular mass.  
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In addition to MS-based homology search, we further confirmed our data by comparative 
InterProScan protein domain identification of the individual trypanosomatid factors and their 
respective human counterparts (Figure 5.9; page 78).  
All CPSFs (see above) identified in our mass spectrometry analysis have a domain organization 
that is similar to their respective human homologs: For both CPSF160 subunits (sequence 
identity: 20.9%) the C-terminal CPSF A domain, whose function is unknown, could be identified.  
Both the human as well as the trypanosomatid CPSF100 (sequence identity 22.0%) and 
CPSF73 (sequence identity 39.3%) have a ß-lactamase domain with a ß-caspase domain (ß-
casp) inserted like a cassette with the active site of the protein at the interface of these two 
domains (Mandel et al., 2006). In higher eukaryotes CPSF73 is the endonuclease in 3´ end 
processing, and the residues (mainly histidines) coordinating the two zinc atoms that are 
required for RNA cleavage are conserved in trypanosomes as well. In contrast, CPSF100 lacks 
the zinc-binding residues and cannot bind zinc, arguing against nuclease activity of the protein. 
In addition both CPSF 100 and CPSF73 have an RMMBL domain (RNA metabolizing metallo 
beta lactamase) and characteristic C-terminal domains, required for in vivo core cleavage 
complex formation composed of CPSF100, CPSF73 and Symplekin (Michalski & Steiniger, 
2015).  
The domain structure of T. brucei CPSF30 is compared to the human protein conserved 
(sequence identity 31.0%), harboring five C3H1 zinc fingers and a C-terminal C2HC zinc finger. 
The human protein was shown to bind (in cooperation with WDR33) the canonical AAUAAA 
hexamer polyadenylation signal via zinc fingers two and three, with a minor contribution of the C-
terminal zinc finger (Chan et al., 2014, Schönemann et al., 2014, Shimberg et al., 2016). 
Although, the AAUAAA polyadenylation signal was not found in trypanosomes, the conserved 
CPSF30 domain structure argues for a possible role in RNA binding.  
Fip1 (sequence identity 12.7%), the fifth CPSF identified in our mass spectrometry analysis, 
contains the Fip1 domain (Fip1) present in the human homolog, which is required for the 
interaction with CPSF30 (zinc fingers four and five) in trypanosomes (Bercovich et al., 2009). 
The C-terminal arginine-aspartate-rich region (RD-rich) of the human protein that binds to U-rich 
RNA sequences is not present in the trypanosomatid protein but it contains an additional C3H1 
zinc finger (Kaufmann et al., 2004).  
All other identified proteins except for CstF64 display conserved domain architectures as well. 
CstF64 (sequence identity 4.9%) was only identified through a putative hinge domain present in 
both the trypanosomatid and human protein that was shown to interact with CstF77 and 
Symplekin in a mutual exclusive manner in humans (Takagaki & Manley, 2000, Ruepp et al., 
2011b). The N-terminal RRM binding the U-rich DSE and the highly conserved C-terminal 
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domain (CstF64-C) required for polyadenylation are absent in trypanosomes (MacDonald et al., 
1994, Gross & Moore, 2001, Qu et al., 2007).  
Both the T. brucei and the human CstF50 protein (sequence identity 17.2%) contain the WD40 
repeat domain, which functions as a binding platform for CstF77 interaction (Takagaki & Manley, 
2000). However, the N-terminal self-dimerization domain (CstF1-dd) of the human homolog is 
missing. 
Trypanosomatid CFIm25 (sequence identity 23.7%) and CFIIm (sequence identity 26.6 %) have 
the same domain structure as their respective human counterparts, of which the CFIm25 NUDIX 
hydrolase domain is of special interest, since it binds the USE and regulates poly(A) site 
selection in humans (Yang et al., 2010). 
Symplekin (sequence identity 12.6%) functions as a scaffold protein and the C-terminal domain 
(Symplekin-C) is conserved in trypanosomes as well, but the ARM repeats (armadillo-type fold) 
are missing. 
Take together our results suggest a general conservation of polyadenylation complex 








Figure 5.9 Domain conservation of polyadenylation factors.  
Schematics of human polyadenylation factors and the T. brucei homologs. Domains were identified by 
InterProScan 5 scanning and are depicted in scale as colored boxes. CPSF A, cleavage and 
polyadenylation specificity factor, A subunit, C-terminal domain; ß-lactamase, beta-lactamase domain; ß-
casp, beta-caspase domain; RMMBL, RNA metabolizing metallo beta lactamase domain (metal binding 
amino acid residues are colored in red); CPSF2-C, cleavage and polyadenylation specificity factor 2, C-
terminal domain; CPSF73-C, cleavage and polyadenylation specificity factor 3 C-terminal domain; ZnF 
C3H1-type, zinc finger C3H1-type; ZnF C2HC, zinc finger type C2HC; Fip1, pre-mRNA polyadenylation 
factor Fip1 domain; RD-rich, arginine-aspartate-rich region; H-rich, histidine-rich region; P-rich, proline-rich 
region; CstF1-dd, cleavage stimulation factor subunit 1, dimerization domain; RRM, RNA recognition 
motif; hinge domain; CstF64-C, cleavage stimulating factor C-terminal domain; WD40 repeat, tryptophan-
aspartate repeat; NUDIX, NUDIX hydrolase domain; MobB, MobB-type P-loop domain; Clp1, Pre-mRNA 
cleavage complex II cleavage and polyadenylation factor 1 domain; ARM repeat, armadillo-type fold; 
Symplekin-C, Symplekin C-terminal domain. 
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5.1.5 Characterization of the CPSF30 RNA-binding properties 
To further analyze a possible RNA-binding function of CPSF30, suggested by the conserved 
domain structure (see 5.1.4), a SELEX-seq experiment was performed to identify an in vitro 
binding motif. 
In brief: Recombinantly expressed and purified GST-CPSF30 and GST, as control, (Figure 5.10) 
was incubated with an in vitro T7 transcribed RNA, derived from a DNA oligonucleotide 
containing a random 20-mer sequence (Figure 5.11 A; page 80). Bound RNA was recovered, 
reverse-transcribed, PCR-amplified and used again for in vitro T7 transcription followed by 
another round of selection. Finally, libraries of all five rounds of selection (for GST, only round 
five) were prepared and subjected to high-throughput sequencing. We obtained between 0.55 
mio and 0.87 mio reads (0.86 mio for GST) containing a 18 to 20-mer sequence that were used 
for CPSF30 RNA-binding motif analysis.  
The representation of each of the possible tetramer (256) and hexamer (4096) motifs was 
determined after each SELEX cycle, and the enrichment of each tetramer and hexamer was 
evaluated by z-score values. Figure 5.11 B (page 80) shows heat maps for the top 20 and the 
bottom 10 tetramers (upper panel) and hexamers (lower panel) (ordered according to their z-
score after the fifth SELEX round with GST-CPSF30 protein), especially how the motifs were 
enriched over the five cycles (CPSF30 R1 to R5).The most enriched tetramers and hexamers 
were long poly(U) stretches, whereas GC-rich sequences were most depleted, arguing for a 
oligo(U) in vitro RNA-binding motif of trypanosomatid CPSF30.  
In addition, for further iCLIP-based in vivo analysis of CPSF30 RNA-binding a clonal procyclic 
cell line stably expressing a C-terminal PTP-tagged CPSF30 was generated (Figure 5.12; page 
80).  
 
Figure 5.10 Quantification of E. coli-expressed GST-CPSF30 and GST. 
Recombinant proteins were expressed in E.coli BL21 DE3 star cells, bound to glutathione sepharose and 
analyzed by SDS-PAGE and Coomassie staining. BSA standards (1-0.2 µg) were used for quantification. 
Protein size markers in kDa. 




Figure 5.11 Identification of the CPSF30 in vitro RNA-binding motif by SELEX-seq. 
(A) Schematic representation of the SELEX-seq procedure and data analysis. Using GST-CPSF30 (GST 
as control) and an N20 RNA pool, CPSF30 RNA-binding sequences were enriched through five SELEX 
rounds. After each selection round (CPSF30 R1-R5; GST control only R5), aliquots were taken for library 
preparation and high-throughput sequencing, followed by motif enrichment analysis (see panel B). 
(B) Motif enrichment analysis of CPSF30 RNA-binding. The upper and lower panel shows the enrichment 
of tetramers and hexamers during the five SELEX rounds with GST-CPSF30 (R1-R5) and GST control 
(R5), respectively. Only the top 20 and the bottom 10 tetramers and hexamers are represented as colour-
coded heat maps, showing z-scores of the motif frequencies for each round (ordered by z-score in R5 of 
GST-CPSF30).  
 
Figure 5.12 Validation of CPSF30-PTP expression. 
The expression of PTP-tagged CPSF30 [Tb927.11.12750] in T. brucei cells was detected by Western 
blotting, using polyclonal anti-protein A antibodies (lane PTP). As control, T. brucei 427 wildtype (lane WT) 
cells were included. Protein size markers in kDa.  
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5.1.6 Polyadenylation factors are required for both polyadenylation and trans splicing 
To assess the functional relevance of the proteins identified in the polyadenylation complex, we 
depleted each of them by inducible RNAi: Each of the individual knockdowns showed a severe 
growth defect in procyclic trypanosomes, with the exception of one of the two hypothetical 
proteins, Tb927.11.13860 (Figure 5.13; page 82). Following quality control of isolated total RNA 
by gel electrophoresis and silver staining, depletion of the individual factors was validated by 
semiquantitative RT-PCR (Figure 5.14 A and B; page 83). Afterwards the in vivo 
polyadenylation status was examined (Figure 5.15 A; page 84; for raw data, see Figure 5.16; 
page 85-86) as described for the two poly(A) polymerases (see 5.1.3).  
Knockdown of CPSF100, CPSF73, and CPSF30 strongly reduced the overall poly(A) tail 
lengths. In contrast, depletion of CPSF160 and Fip1 -as part of the CPSF complex- did not 
cause significant changes. CstF50 depletion strongly affected polyadenylation, in contrast to 
CstF64 depletion. Note that the putative CstF64 analyzed here exhibits only a very low 
sequence similarity to its mammalian counterpart (see 5.1.4); it may represent a truncated 
homolog functionally different from the mammalian factor or a trypanosomatid-specific factor. 
Depletion of the scaffold factor Symplekin resulted in a severe polyadenylation phenotype. In 
contrast, depletion of the two cleavage factors CFIm25 and CFIIm did not significantly affect 
poly(A) tail length. Finally, when analyzing the two unannotated proteins [Tb927.11.13860 and 
Tb927.8.4480], small, but significant inhibitory and stimulatory effects were observed, 
respectively.  
As several previous studies have indicated, both major pre-mRNA processing steps, trans 
splicing and polyadenylation, are interconnected. Therefore we also analyzed trans splicing 
activities to compare them directly with the corresponding polyadenylation effects. Both spliced-
leader (SL) RNA (Figure 5.15 B; page 84), which is known to accumulate upon inhibition of 
trans splicing (for example, see Tkacz et al., 2010), and a specific trans-spliced mRNA (PPIase) 
(Figure 5.15 C; page 84) were measured by quantitative RT-PCR after knockdown of the 
individual polyadenylation factors. Depletion of the CPSF complex subunits 160, 100, 73, and 30 
resulted in spliced-leader accumulation and severe splicing deficiencies. However, for Fip1 only 
blocking of splicing was observed, but no effect on SL RNA accumulation (Figure 5.15 C; page 
84). Knockdown of both CstF subunits 64 and 50, Symplekin, CFIIm, and the two hypothetical 
proteins Tb927.11.13860 and Tb927.8.4480 resulted in moderate effects on spliced-leader 
accumulation and in most cases also on inhibition of trans splicing. However, depletion of 
CFIm25 had neither an effect on SL RNA accumulation nor on trans splicing. These effects on 
PPIase trans splicing were largely confirmed with another gene, PRP8, analyzed by 
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semiquantitative RT-PCR (Figure 5.17; page 87). We conclude that the corresponding 
knockdown effects of most core polyadenylation factors on both polyadenylation and trans 
splicing, as well as splicing deficiencies after CPSF160 and Fip1 depletion, argue for a general 
coupling of these two major RNA processing steps. 
 
 
Figure 5.13 Growth curves of procyclic trypanosomes after RNAi depletion of polyadenylation 
complex constituents.  
Growth curves of representative cell lines, in which RNAi was induced by doxycycline (+Dox, lines with 
asterisks) and respective uninduced controls (-Dox, lines with triangles). The following factors were 
subjected to RNAi induction (TriTrypDB numbers in brackets): CPSF160 [Tb927.11.14560]; CPSF100 
[Tb927.11.230]; CPSF73 [Tb927.4.1340]; CPSF30 [Tb927.11.12750]; Fip1 [Tb927.5.4320]; CstF50 
[Tb927.6.1830]; CstF64 [Tb927.8.8210]; CFIm25 [Tb927.7.1620]; CFIIm [Tb927.6.3690]; Symplekin 
[Tb927.8.7490]; Tb927.11.13860; Tb927.8.4480. 
 




Figure 5.14 RNAi mediated knockdown of polyadenylation complex constituents. 
(A) RNA was isolated from uninduced (-) and RNAi induced cells (+), separated on a denaturing 10% 
polyacrylamide/urea gel and visualized by silver staining. The ribosomal sRNA1, sRNA2, 5.8S, sRNA4 
and 5S RNA as well as the tRNAs are indicated. The following factors were subjected to RNAi induction 
(TriTrypDB numbers in brackets): CPSF160 [Tb927.11.14560]; CPSF100 [Tb927.11.230]; CPSF73 
[Tb927.4.1340]; CPSF30 [Tb927.11.12750]; Fip1 [Tb927.5.4320]; CstF64 [Tb927.8.8210]; CstF50 
[Tb927.6.1830]; CFIm25 [Tb927.7.1620]; CFIIm [Tb927.6.3690]; Symplekin [Tb927.8.7490]; 
Tb927.11.13860; Tb927.8.4480.  
(B) mRNA levels were analyzed by semiquantitative RT-PCR from uninduced cells (-) and after 3 days of 
RNAi induction (+). As control, 7SL RNA from the same samples was analyzed. M, markers (200, 300, 
400, and 500 bp; for 7SL: 100 and 200 bp). 




Figure 5.15 Polyadenylation factors required for both polyadenylation and splicing in vivo. 
The following factors were subjected to RNAi knockdown (TriTrypDB numbers in brackets): CPSF160 
[Tb927.11.14560]; CPSF100 [Tb927.11.230]; CPSF73 [Tb927.4.1340]; CPSF30 [Tb927.11.12750]; Fip1 
[Tb927.5.4320]; CstF50 [Tb927.6.1830]; CstF64 [Tb927.8.8210]; CFIm25 [Tb927.7.1620]; CFIIm 
[Tb927.6.3690]; Symplekin [Tb927.8.7490]; Tb927.11.13860; Tb927.8.4480. Changes in the overall 
poly(A) tail length (A), in SL RNA accumulation (B), and in trans splicing of PPIase mRNA (C) upon 
depletion of individual polyadenylation factors are graphically shown. Poly(A) tail lengths were analyzed 
and quantitated by the “Riemann´s sum”, comparing induced and uninduced cells (for raw data, see 
Figure 5.15; page 86/87). SL RNA accumulation and trans-splicing activities were determined by RT-
qPCR on SL RNA and trans spliced PPIase mRNA, respectively, and normalized to U3 RNA. For both 
polyadenylation, SL RNA accumulation, and trans splicing, fold changes (in log2 values) of uninduced and 
induced levels were calculated, with standard deviations derived from three biological replicates (* for P 
values <0.05; ** for P values <0.01). 
 








Figure 5.16 Changes in the poly(A) tail length upon depletion of 12 individual trypanosomatid 
polyadenylation factors. 
(A and B; page 85-86) The following factors were subjected to RNAi induction (TriTrypDB numbers in 
brackets): CPSF160 [Tb927.11.14560]; CPSF100 [Tb927.11.230]; CPSF73 [Tb927.4.1340]; CPSF30 
[Tb927.11.12750]; Fip1 [Tb927.5.4320]; CstF50 [Tb927.6.1830]; CstF64 [Tb927.8.8210]; CFIm25 
[Tb927.7.1620]; CFIIm [Tb927.6.3690]; Symplekin [Tb927.8.7490]; Tb927.11.13860; Tb927.8.4480. 
(A) RNA from uninduced (- Dox) and RNAi induced (+ Dox) cells was splint-labeled, digested with RNases 
A/T1, followed by separation of the 
32P-labeled tails [poly(A)] on a denaturing 15% polyacrylamide/urea 
gel. 7SL RNA detected by RT-PCR served as loading control. Marker sizes are indicated in nucleotides.  
(B) The relative intensities of knockdown and uninduced control signals were measured with ImageJ and 
plotted. The tail length distributions in uninduced (blue lines) and induced cells (red lines) are represented. 
 
 




Figure 5.17 Changes in PRP8 mRNA trans splicing upon depletion of 12 individual trypanosomatid 
polyadenylation factors. 
The respective splicing activities were monitored in uninduced (-Dox) and induced (+Dox) cells by 
semiquantitative RT-PCR. To detect the trans spliced PRP8 mRNA, SL- and PRP8 exon-specific primer 
were used. The primer positions and orientations are schematically represented on the right side. As 
control 7SL RNA was analyzed. M, marker (100, 200, 300, 400, and 500 bp). TriTrypDB numbers in 
brackets: CPSF160 [Tb927.11.14560]; CPSF100 [Tb927.11.230]; CPSF73 [Tb927.4.1340]; CPSF30 
[Tb927.11.12750]; Fip1 [Tb927.5.4320]; CstF50 [Tb927.6.1830]; CstF64 [Tb927.8.8210]; CFIm25 
[Tb927.7.1620]; CFIIm [Tb927.6.3690]; Symplekin [Tb927.8.7490]; Tb927.11.13860; Tb927.8.4480. 
  
  5. Results 
88 
 
5.2 DRBD4-mediated regulation of mRNA polyadenylation in Trypanosoma 
brucei 
5.2.1 DRBD4 binds in vivo preferentially to gene UTRs 
To map DRBD4-RNA contacts at single-nucleotide resolution in procyclic T. brucei cells, we 
applied the iCLIP approach. Three individual experiments were performed, using a cell line 
expressing DRBD4 with a PTP tag (protein C epitope / TEV cleavage site / 2× protein A 
epitope), with wildtype T. brucei 427 (WT) cells as negative control. Trypanosomes were UV-
crosslinked, and DRBD4-RNA complexes were purified by tandem affinity purification (TAP), 
separated by SDS-PAGE, and blotted onto nitrocellulose membrane (Figure 5.18). 
Subsequently, bound RNA was eluted and used for library preparation, followed by high-
throughput sequencing.  
 
Figure 5.18 Representative DRBD4-PTP iCLIP experiment. 
Protein-RNA interactions were crosslinked by UV-irradiation of DRBD4-PTP-expressing cells or Tb427 
wildtype cells (WT; negative control), followed by lysate preparation, limited RNase digestion, 
immunoprecipitation of DRBD4-PTP RNA-protein (RNP) complexes, 3´ linker ligation, tobacco-etch-virus 
(TEV) protease cleavage and the second affinity step (anti-protein C immunoaffinity purification). 5′-
terminal 
32
P-labeled RNP-complexes were then gel-separated under denaturing conditions and visualized 
by autoradiography (left panel). In each case, RNase I amounts were titrated (as indicated). Boxed 
regions were cut out and subjected to RNA isolation and library preparation. Western blot analysis (right 
panel) of the same membrane was performed using anti-protein C antibodies including 2% input material. 
The gel positions of DRBD4 with the full PTP tag (PTP) and the remaining protein C epitope (P) after 
TEV-protease cleavage are indicated.  
 
Approximately 3.6 mio of the 9.5 mio total DRBD4-PTP iCLIP sequences could be uniquely 
mapped to the T. brucei genome (Figure 5.19; page 89). After random-barcode filtering, the 
387,577 crosslink tags from 255,063 crosslink sites were used for downstream analysis. Within 
the individual DRBD4 iCLIP crosslink tags, approximately 56% mapped to mRNAs, with a strong 
preference for the UTR regions (~42%, compared with ~14% in the coding regions). The large 
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proportion of not annotated iCLIP crosslink tags (~37%) can be most likely explained by the 
incomplete annotation of gene UTRs. In addition, the overall highly consistent distribution of 
iCLIP tags in the different RNA classes argues for the reproducibility of the individual 
experiments.  
 
Figure 5.19 Genome-wide mapping of DRBD4-RNA interactions in T. brucei by iCLIP-seq. 
Summary of sequenced/mapped iCLIP reads (upper panel) and the genomic distribution of barcode-
filtered tag counts (in percent; lower panel), based on three individual DRBD4-PTP experiments.  
 
In addition to the PTP-based iCLIP-approach (see above), a second iCLIP protocol using a YFP-
tag was established. A single experiment was performed with a procyclic DRBD4-YFP cell line 
and wildtype T. brucei 427 (WT) cells served as negative control. The experimental procedure is 
as described above, with the exception that only a one step immunoprecipitation using anti-GFP 
antibodies is applied.  
Approximately 1.1 mio of the 2.2 mio DRBD4-YFP iCLIP sequences were uniquely mapped to 
the T. brucei genome (Figure 5.20; page 90). After random-barcode filtering, the 954,953 
crosslink tags from 739,861 crosslink sites were used for downstream analysis. The majority of 
YFP-DRBD4 iCLIP tags mapped -similar to the DRBD4-PTP iCLIP (see above)- to mRNAs 
(68.1%), displaying again a preference for UTR regions (~40.2%, compared with ~27.9% in the 
coding regions). Moreover, a large proportion of not annotated iCLIP crosslink tags (~30.5%) 
was observed (see above). A general reproducibility between both protocols is reflected by the 
constant distribution of iCLIP tags in the different classes of RNAs in the PTP-based and YFP-
based experiments. However, the numbers of uniquely mapped reads, crosslink site counts and 
crosslink tag counts in the YFP-based experiment were strongly increased, when compared to 
  5. Results 
90 
 
individual DRBD-PTP experiments with a similar number of total sequenced reads (DRBD4-
PTP_1 and 3). This indicates that the YFP-library was more complex, compared to the individual 
DRDB4-PTP libraries, which can be most likely explained by a higher YFP-immunoprecipitation 
efficiency, since only a single-step method was used.  
 
Figure 5.20 DRBD4-YFP iCLIP experiment. 
(A) Protein-RNA interactions were crosslinked by UV-irradiation of DRBD4-YFP expressing cells or Tb427 
wildtype cells (WT; negative control), followed by lysate preparation, limited RNase digestion, 
immunoprecipitation of DRBD4-YFP RNA-protein (RNP) complexes and 3´ linker ligation. 5′-terminal 32P-
labeled RNP-complexes were then gel-separated under denaturing conditions and visualized by 
autoradiography (left panel). In each case, RNase I amounts were titrated (as indicated). Boxed regions 
were cut out and subjected to RNA isolation and library preparation. Western blot analysis (right panel) of 
the same membrane was performed using anti-protein GFP antibodies including 1.5% input material. The 
gel position of DRBD4-YFP is indicated.  
(B) Summary of sequenced/mapped iCLIP reads (upper panel) and the genomic distribution of barcode-
filtered tag counts (in percent; lower panel), in the DRBD4-YFP experiment.  
  5. Results 
91 
 
5.2.2 DRBD4 binds purine-rich sequences containing AUGA elements in vitro 
To further investigate the DRBD4 RNA-binding properties we next used a SELEX-seq approach 
to derive a minimal binding motif. Briefly, recombinant T. brucei GST-DRBD4 (with GST protein 
as negative control; Figure 5.21 A) was incubated with RNA T7-transcribed from a DNA 
oligonucleotide template containing a random 20-mer sequence (Figure 5.21 B). Bound RNA 
was recovered, reverse-transcribed, PCR-amplified, and used again for in vitro T7 transcription, 
followed by further rounds of selection. Finally, RNA-seq libraries were prepared from aliquots 
after each of the five selection rounds (for the GST control, only after the fifth round) and 
subjected to high-throughput sequencing.  
Between 0.45 and 0.67 mio sequence tags per SELEX cycle were obtained for GST-DRBD4 (for 
GST control: 2.02 mio after the fifth cycle), with 20-mer sequences that were analyzed for the in 
vitro RNA-binding motif of DRBD4.  
 
Figure 5.21 Identification of the RNA-binding motif of DRBD4 by SELEX-seq. 
(A) Quantification of E. coli-expressed GST-DRBD4 and GST. Recombinant proteins were expressed in 
E. coli BL21 DE3 star cells, bound to glutathione sepharose and analyzed by SDS-PAGE and Coomassie 
staining. BSA standards (1-0.2 µg) were used for quantification.  
(B) Schematic representation of the SELEX-seq procedure and data analysis. Using GST-DRBD4 (GST 
as control) and an N20 RNA pool, DRBD4 RNA-binding sequences were enriched through five SELEX 
rounds. After each selection round (DRBD4 R1-R5; GST control only R5), aliquots were taken for library 
preparation and high-throughput sequencing, followed by motif enrichment analysis (see Figure 5.22; 
page 93). 
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The representation of each of the possible tetramer (256) and hexamer (4096) motifs was 
determined after each cycle, and the enrichment of each tetramer and hexamer was evaluated 
by z-score values. Figure 5.22 (page 93) shows heat maps for the top 20 and the bottom 10 
tetramers (upper panel) and hexamers (middle panel) (ordered according to their z-score after 
the fifth SELEX round with GST-DRBD4 protein), especially how the motifs were enriched over 
the five cycles (DRBD4 R1 to R5). 
Interestingly, sequences containing purines -in particular adenosines- were highly enriched 
during the selection process, with the AUGA tetramer being most enriched. This was further 
underlined by the hexamer analysis, where also AUGA flanked by two A nucleotides was most 
enriched. In contrast, pyrimidine-rich stretches appear to be depleted in both the tetramer and 
hexamer analyses.  
Since a single RRM can recognize up to eight nucleotides and DRBD4 contains four RRMs, 
RNA binding of DRBD4 may be combinatorial and involve more than a single minimal motif. 
Therefore we also analyzed tetramer combinations: The eight most enriched tetramers from the 
final selection round with GST-DRBD4 were combined, allowing up to two nucleotides spacing 
between them, and ranked according to their representation in the SELEX-sequence tags. 
Figure 5.22 (lower panel; page 93) shows a heat map of the top 20 and bottom 10 most 
enriched double-tetramer combinations, ordered according to their motif frequency (sum of 
0/1/2-nts spacing). As the most enriched double-tetramer combinations AUGA-AUGA and 
GAAA-UGAA were identified, each without spacer (note that the latter one also contains an 
AUGA motif, with flanking adenosine nucleotides, as the most enriched hexamer).  




Figure 5.22 Motif enrichment analysis of DRBD4 RNA binding.  
The upper and middle panel shows the enrichment of tetramers and hexamers during the five SELEX 
rounds with GST-DRBD4 (R1-R5) and GST control (R5). Only the top 20 and the bottom 10 tetramers and 
hexamers are represented as colour-coded heat maps, showing z-scores of the motif frequencies for each 
round (ordered by z-score in R5 of GST-DRBD4). The lower panel shows the enrichment for combinations 
of the top eight tetramers from the upper panel (with 0/1/2 nts spacing). Only the top 20 and the bottom 10 
double-tetramers are displayed as colour-coded heat map, indicating motif frequencies in the R5 round of 
GST-DRBD4 (ordered by the sum of frequencies of 0/1/2 nts spacing). The motifs selected for 
experimental validation are highlighted in bold. 
 
To biochemically validate the binding motif, we assayed for in vitro binding of GST-DRBD4 to 
selected 32P-labeled RNA transcripts, using GST pulldown and analysis of associated RNAs by 
denaturing PAGE, followed by quantitation (Figure 5.23 A; page 95).  
Surprisingly, the most enriched hexamer (motif #1; in two copies with an eight-nucleotide spacer 
in between, see Figure 5.23 A for context; page 95) and the double-tetramer combination 
GAAA-UGAA (motif #3; in a single copy) did not significantly bind DRBD4 above GST control 
levels. In contrast, the transcript with the double-AUGA sequence (motif #2) efficiently bound 
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and appears to represent a minimal functional binding motif. To further analyze a possible 
spacing tolerance of this minimal motif, which was suggested by a high motif frequency with one 
or two spacing nucleotides (see Figure 5.22; lower panel; page 93), adenosine nucleotides 
(which were overrepresented in our SELEX-derived, DRBD4-binding sequences; Figure 5.22; 
page 93), were inserted between the two AUGA tetramers (motifs #6-8): Compared with the 
minimal double-tetramer (motif #2), the insertion of two adenosine (A2) nucleotides reduced, 
whereas four (A4) or eight (A8) adenosines enhanced binding. However, three adjacent AUGA 
motifs without spacing did not further increase the binding efficiency (motif #4). The specificity 
for and requirement of the AUGA unit was underlined by the strong effect of a single point 
mutation in the tetramer motif (AUGA to AUUA; compare motif #4 and #10). Moreover, another 
triple-tetramer combination (motif #5), with the high-affinity AUGA flanked by AAGA and AGAA, 
among the most enriched tetramers (see Figure 5.23 A; upper panel; page 95), bound almost 
as well as the triple-AUGA sequence. Surprisingly, even a simple oligo-adenosine stretch (A)12 
was bound with similar efficiency (motif #9). 
In addition, to test a polypyrimidine-rich DRBD4 binding motif as suggested in a previous study 
(Stern et al., 2009), we also assayed DRBD4 binding to four T. brucei polypyrimidine tracts 
(Figure 5.23 B; page 95). However, the relatively high DRBD4 binding affinities we observed 
were in all cases similar to the GST control, arguing for unspecific background binding probably 
based on the GST moiety. 
Taken together, our binding assays further confirmed and validated the SELEX-seq data: We 
conclude that DRBD4 binds in vitro RNA sequences that are purine-, in particular adenosine-
rich, often harboring AUGA elements.  
 
 




Figure 5.23 DRBD4 preferentially binds purine-rich sequences containing AUGA motifs.  
32
P labeled short RNA transcripts containing different (A) SELEX-derived binding motifs (#1-10) or (B) 
polypyrimidine tracts form T. brucei genes (#1: Tb927.1.2340; # 2, 3: Tb927.11.3630; #4: Tb927.6.510) 
were incubated with GST-DRBD4 or GST (negative control), immobilized on glutathione sepharose. 
Bound RNA was recovered and analyzed by denaturing polyacrylamide gel electrophoresis (marker sizes 
in nucleotides). For each pulldown assay, 10% of the input and the total recovered RNA were loaded. The 
respective pulldown efficiencies including standard deviations were calculated from three replicates.  
  5. Results 
96 
 
5.2.3 DRBD4 depletion affects polyadenylation site usage 
In addition to the reported functions of the trypanosome DRBD4 in mRNA stability and splicing 
(Stern et al., 2009), DRBD4 was identified in a targeted RNAi screen for genes that were 
necessary for the instability of developmentally regulated mRNAs. In the course of this work, it 
was found that RNAi depletion of DRBD4 resulted in an altered poly(A) site location in the GPI-
PLC (Tb927.2.6000) mRNA (see 5.2.4). As the human homolog PTB1 can also modulate 
polyadenylation efficiency (Castelo-Branco et al., 2004, Izquierdo et al., 2005, , Fred & Welsh, 
2009) we assayed for a regulatory role of DRBD4 in trypanosomatid 3´ end processing of 
mRNAs. In a procyclic T. brucei cell line expressing endogenous YFP-tagged DRBD4, depletion 
was initiated for three days by doxycycline-inducible RNAi and monitored through flow cytometry 
(Figure 5.24 A); the cells continued to proliferate throughout the time course (Figure 5.24 B). 
 
Figure 5.24 Validation of RNAi-mediated DRBD4 depletion. 
(A) Flow cytometry measurements of YPF in cell lines expressing tet repressor (pSPR2, gray) and an 
additional endogenous YFP-tagged DRBD4 allele (p3217, green). DRBD4-YFP levels were measured in a 
time course after 18, 42, 66 and 90 hours of DRBD4-RNAi (p4376) induction (blue; +Dox), and uninduced 
cells served as control (red; -Dox). FL1-H indicates the relative intensity of the YFP fluorescence. 
(B) Growth curve of the DRBD4-RNAi line (as in A), in which RNAi was induced by doxycycline (red line 
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Total RNA was isolated from cells after RNAi and from uninduced control, followed by poly(A)+ 
RNA selection, library preparation for 3´ end mapping and RNA-seq (Table 5.1). Based on 6.86 
mio and 10.48 mio total sequenced reads in control and knockdown cells, respectively, 
polyadenylation sites in both samples were mapped using the SLaP mapper tool: Based on 1.19 
mio (in control) and 1.70 mio poly(A)-site-spanning reads (in knockdown cells), we identified in 
total 152,628 (control) and 200,141 (knockdown) individual polyadenylation sites. First, poly(A) 
sites from the uninduced control cells were clustered (to give 8,962 poly(A) site clusters) and 
second, the poly(A)-site reads in each cluster were summarized and compared with those in 
DRBD4-knockdown cells: As a result, we identified 234 down- and 248 up-regulated poly(A) site 
clusters (Table 5.1). 
 
Table 5.1 DRBD-mediated poly(A) site choice. 
Summary of poly(A)-site-spanning reads, poly(A) sites, poly(A) site clusters, and up-/down-regulated 
clusters, based on RNA-seq analysis of DRBD4 knockdown (kd) and control (ctr) cells. 
 
5.2.4 DRBD4-regulated poly(A) site choice: integrating iCLIP and RNA-seq data 
Next, we combined our DRBD4-PTP iCLIP and RNA-seq datasets, with the aim to correlate in 
vivo RNA binding and DRBD4-dependent poly(A) site choice. Based on the 234 down- and 248 
up-regulated poly(A) site clusters, iCLIP crosslink tag counts in the region between -200 to +200 
nts of the regulated poly(A) site clusters were summarized. Likewise, non-regulated poly(A) site 
clusters with similar expression levels were selected as background group (see Materials and 
methods for details). Figure 5.25 (page 98, for DRBD4-YFP iCLIP see, Supplementary Figure 
8.2; page 130) shows the accumulated distribution of DRBD4-PTP iCLIP tag counts (as smooth 
line in 21-nts windows) around the regulated poly(A) sites; a poly(A) site was defined as the 
position with the highest number of poly(A) site tags within the cluster, with the background 
group (dashed line) plotted for comparison. As a result, we found an enrichment of DRBD4 
binding in the upstream region of regulated poly(A) sites (-20 to -140 nts for down-regulated, -
100 to -180 nts for up-regulated sites). 
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In sum, these data provide evidence for a correlation between DRBD4 in vivo binding and 
DRBD4-dependent changes in poly(A) site selection, arguing for a DRBD4-mediated regulation 
of this process.  
 
Figure 5.25 DRBD4 RNA binding around regulated poly(A) sites.  
Accumulated DRBD4-PTP iCLIP crosslink-tag counts were plotted in the region between -200 to +200 nts 
relative to the poly(A) site of the down- and up-regulated clusters (top: down-regulated n=234; background 
n=936; bottom: up-regulated n=248; background n=992) and are depicted as solid lines. As background 
control, unaffected polyadenylation sites were used (dashed lines). Crosslink-tag counts were plotted with 
fitted values (21-nts windows) on the Y-axis and positions on the X-axis. 
 
To validate individual cases of DRBD4-dependent poly(A) site choice, we analyzed by Northern 
blotting changes in transcript levels after DRBD4 knockdown (at 24, 48, and 72 hours; Figure 
5.26; page 100; for sequences and crosslink sites, see Figure 5.27; page 101). We initially 
tested two individual genes, Tb927.8.760 and Tb927.8.770, each containing a single poly(A) 
site, which is down-regulated after DRBD4 depletion (based on our RNA-seq read numbers: for 
Tb927.8.760, from 692 to 470 reads; for Tb927.8.770, from 223 to 128 reads) and Northern blot 
analysis confirmed lower transcript levels (Figure 5.26 A; top and middle; page 100).  
In contrast, Tb927.11.5440 is more complex since there are two reciprocally used poly(A) sites, 
separated by 350 nucleotides (tandem 3´ UTR APA; see 3.4): the distal one, which is down-
regulated after DRBD4 depletion (200 to 69 reads), and a proximal one, which is up-regulated 
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(46 to 177 reads), causing a shift from a long to a short isoform (Figure 5.26 A; bottom; page 
100). This shift in isoform levels, due to differential poly(A) site choice, could be nicely confirmed 
by Northern blotting, which showed after DRBD4 knockdown a decrease of the long and a 
parallel, approximately two-fold increase of the short isoform. Interestingly, in the bloodstream 
form, the opposite can be observed, that the short Tb927.11.5440 isoform is predominantly 
expressed (Figure 5.28; page 102).  
In addition, we tested two genes with DRBD4 crosslink sites upstream of a poly(A) site that was 
up-regulated after DRBD4 knockdown (Figure 5.26 B; page 100; for sequences and crosslink 
sites, see Figure 5.27; page 101): First, Tb927.6.1470 contains two poly(A) sites with a 960-
nucleotide distance (tandem 3´ UTR APA; see 3.4), of which the proximal site is up-regulated 
(62 to 270 reads) and the distal one down-regulated (52 to 32 reads). Northern blot analysis 
clearly confirmed this strong and reciprocal shift in poly(A) site use.  
In the second example, Tb927.2.6000 encoding a developmentally regulated 
glycosylphosphatidylinositol-phospholipase C (GPI-PLC), DRBD4 depletion activated a cryptic 
poly(A) site (proximal; 0 to 27 reads), whereas the distal polyadenylation site was not strongly 
affected (18 to 25 reads). The GPI-PLC mRNA is normally unstable in procyclic cells (Webb et 
al., 2005a) but the shortening of the 3´ UTR resulting from use of the cryptic polyadenylation 
sites removed the cis-elements necessary to most of the instability (Webb et al., 2005b). The 
activation of the cryptic poly(A) site results in the expression of a transcript shortened by 2.5 kb 
(Figure 5.26 B; page 100), as validated by Northern blotting, which showed the respective band 
only after knockdown for 48 and 72 hours. The long transcript [using the distal poly(A) site] 
appears in three closely spaced bands, most likely due to alternative trans splicing; in 
combination, these long isoforms did not change significantly over the knockdown time course.  
Taken together, our data clearly show that DRBD4 binds upstream of polyadenylation sites and 
is required for both their activation and repression. For the first time this provides evidence for a 
trans-acting RNA-binding protein regulating polyadenylation in trypanosomes. 
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Figure 5.26 DRBD4 binding modulates alternative poly(A) site usage. 
For each gene the DRBD4 iCLIP tag distribution, DRBD4-dependent alternative poly(A) site usage (based 
on RNA-seq read numbers), and validation by Northern blot analysis are shown together (page 100; panel 
A, three examples down-regulated after DRBD4 knockdown: Tb927.8.760; Tb927.8.770; Tb927.11.5440; 
panel B, two up-regulated examples: Tb927.6.1470; Tb927.2.6000).  
First, in each case the distribution of DRBD4 iCLIP tags within 200 nts upstream of the DRBD4-regulated 
poly(A) site [(A)n] is graphically represented, including the AG content of this region (in %). Gene bodies 
are marked as blue boxes, with distances between proximal (prox.) and distal (dist.) poly(A) sites 
indicated. Second, below the respective poly(A) sites the RNA-seq-based read counts are listed (DRBD4 
knockdown at 0 versus 72 h). Third, for RNA-seq validation, DRBD4-dependent poly(A) site choice was 
directly analyzed by Northern blotting, showing four time points of DRBD4 knockdown (0-72 h) and using 
18S rRNA as a loading control and for normalization. Below, the relative mRNA levels are listed. 
 
 
Figure 5.27 mRNA sequences upstream of regulated poly(A) sites. 
mRNA sequences with purine nucleotides (marked in grey) upstream of DRBD4-regulated poly(A) sites. 
The DRBD4 iCLIP crosslink sites are indicated as bold letters and the respective superscripts indicate the 
number of crosslink site counts. The number of crosslinked purine nucleotides (relative to the total 
crosslinks) in given in percent. 




Figure 5.28 Life-cycle dependent expression of Tb927.11.5440 isoforms. 
Expression levels of the long and short Tb927.11.5440 mRNA in wildtype bloodstream (BS) and procyclic 
(PC) trypanosomes after DRBD4 knockdown (0-72 hours). Transcript isoforms were detected by Northern 
blotting, and 18S rRNA served as loading control.  
5.2.5 DRDB4 is associated with polyadenylation complex constituents 
To get initial insights in the DRBD4-dependent regulation of polyadenylation we identified 
DRBD4-associated proteins. Two independent tandem affinity purifications (TAP) of DRBD4-
PTP were performed, and co-purified factors were analyzed by mass spectrometry (Figure 5.29; 
page 103). Among the approximately 200 factors (data not shown) with more than one unique 
peptide count (as sum of both experiments), we identified five proteins of the T. brucei 
polyadenylation complex, which were also purified by CPSF160-PTP TAP (see 5.1.4): Three 
subunits of the CPSF complex (CPSF160, CPSF100 and CPSF73), one constituent of the CstF 
(CstF50) and the scaffold protein Symplekin. In addition, we also co-purified the polyadenylation 
factor PABP2, the homolog of the human PABPN1 protein, which displayed in comparison to the 
polyadenylation complex constituents a high number of unique peptides. Interestingly, also the 
functional poly(A) polymerase [Tb927.7.3780], which was not purified by TAP of CPSF160-PTP, 
was associated with DRBD4. However, in contrast to the polyadenylation complex (see 5.1.4), 
DRBD4 does not form large, stable protein complexes, as indicated by a high number of co-
purified proteins with a very low unique peptide count. In sum, these data of DRDB4-associated 
polyadenylation factors provides further evidence for a DRBD4-dependent regulation of 
polyadenylation in trypanosomes.  




Figure 5.29 Identification of DRBD4-associated proteins by mass spectrometry. 
Extracts were prepared from T. brucei cell lines that stably express tagged DRBD4 (in two biological 
replicates; exp 1/2), followed by TAP-tag affinity purification. Proteins after the second purification step 
(protein C elution) were analyzed by SDS-PAGE, Coomassie staining and Western blotting using 
polyclonal anti-protein A antibodies (lanes prot C exp 1/2). Protein size markers in kDa (M). Protein 
constituents involved in polyadenylation as well as putative factors were identified by mass spectrometry. 
Each protein is described by name (factor), the TriTrypDB annotation number 
(http://tritrypdb.org/tritrypdb/), its molecular mass (in kDa), the number of exclusive unique peptide counts 









6.1 The poly(A) polymerase of T. brucei 
Two genes Tb927.3.3160 and Tb927.7.3780 code for putative poly(A) polymerases in T. brucei, 
the first of which is peculiar in that it containis an intron requiring additional cis splicing for mRNA 
maturation. Both proteins share strong similarities in their domain structure with other eukaryotic 
poly(A) polymerases (see 5.1.1): The tripartite domain architecture of classical poly(A) 
polymerases consisting of the N-terminal catalytic domain, the central domain (also referred as 
PAP domain), and the C-terminal RNA-binding domain, which is conserved in both 
trypanosomatid paralogs (Martin et al., 2000). Both Tb927.3.3160 and Tb927.7.3780 lack a 
clearly defined nuclear localization signal (NLS); however, some basic residues can be found 
near the C-terminus of the Tb927.7.3780 protein, which may act as an NLS (Supplementary 
Figure 8.1; page 128-129). Interestingly, only Tb927.7.3780 is located in the nucleus, whereas 
the putative poly(A) polymerase paralog Tb927.3.3160 has a cytoplasmic localization, 
specifically within distinct spots (see 5.1.1). Despite the fact that only the Tb927.7.3780 protein 
showed in vitro as well as in vivo polyadenylation activity, this argues for functions of the 
Tb927.3.3160 protein other than 3´ end processing of pre-mRNAs (see 5.1.2 and 5.1.3). 
However, due to our negative results in in vitro polyadenylation, we cannot rule out that 
Tb927.3.3160 may represent a functional poly(A) polymerase because additional factors might 
be required for activity even if Mg2+ is replaced by Mn2+ (Christofori & Keller, 1988). Moreover, 
we cannot exclude that Tb927.3.3160 has a limited, specialized set of targets, which our in vivo 
polyadenylation assay could not detect. For example, Tb927.3.3160 could function in 
cytoplasmic polyadenylation or uridylation regulating translation or mRNA stability (Norbury, 
2013). During cytoplasmic polyadenylation a poly(A) tail is re-added to a transcript, which was 
exported from the nucleus with a very short poly(A) tail preventing translation since PABP 
(poly(A)-binding protein) cannot bind. Cytoplasmic polyadenylation depends on two cis-acting 
elements, the PAS, which is bound by the CPSF complex, and a less conserved cytoplasmic 
polyadenylation element (CPE) with a UUUUUA1-3U motif, which is bound by the CPE-binding 
protein. As a result, re-addition of the poly(A) tail activates the transcript for translation by the 
ribosome. In contrast, cytoplasmic uridylation of polyadenylated mRNAs leads to decapping, 
transcriptional silencing and degradation of the mRNA.  
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6.2 Importance of cis splicing in trypanosomes 
An open question is the importance of cis splicing in trypanosomes, since only two genes 
contain a single intron with a highly conserved sequence in trypanosomes and require cis 
splicing for mRNA maturation (Tschudi & Ullu, 1990, Mair et al., 2000, Liang et al., 2003, 
Berriman et al., 2005, Kolev et al., 2010, Siegel et al., 2010): A putative poly(A) polymerase, 
Tb927.3.3160, which is currently classified as non-functional in 3´ end processing (see 5.1.2 and 
5.1.3) and an ATP-dependent DEAD box helicase Tb927.8.1510. However, RNAi-based 
depletion of Tb927.3.3160 (see 5.1.3) or Tb927.8.1510 had no effect on cell growth (Alsford et 
al., 2011). A recent study from our group supports the hypothesis that cis splicing may be an 
evolutionary relic (Preußer et al., 2014): Depletion of the U1 snRNP-specific U1C protein had no 
effect on cell growth and neither affected U1 snRNA levels nor the integrity of the U1 snRNP. 
U1C knockdown inhibited cis, but not trans splicing, which is in line with U1 snRNA binding at 
the 5´ cis splice site of both cis-spliced genes. Moreover, cis splicing was blocked with an 
antisense morpholino oligonucleotide that specifically binds the 5´ end of the U1 snRNA. After 
U1C depletion recovery from starvation stress was clearly impeded, indicating that cis splicing 
becomes essential only under stress conditions. Interestingly, Tb927.7.3780 is the major 
functional poly(A) polymerase in 3´ end processing, and for the intron-containing ATP-
dependent DEAD box helicase Tb927.8.1510 an intronless putative counterpart may exist 
(Tb927.10.6630). However, this does not exclude that the two introns may fulfill an important, 
still unknown function, especially since the sequence is highly conserved in trypanosomes.  
6.3 The trypanosomatid polyadenylation complex 
Our identification and initial characterization of the components of the trypanosomatid 
polyadenylation complex provides an important initial step in understanding the evolution of 
mRNA processing mechanisms. There are considerable differences in the cis-acting 
polyadenylation elements between trypanosomes, yeast, and mammals. The mammalian 
polyadenylation signal consists of three elements (see 3.3): First, the highly conserved AAUAAA 
hexanucleotide PAS typically located 15 to 30 nts upstream of the cleavage site, which is in 
most cases a CA dinucleotide (Sheets et al., 1990, Beaudoing et al., 2000, Hu et al., 2005); 
second, the GU- (YGUGUUYY; Y=pyrimidine) or U-rich (UUUU) DSE within 20 nts downstream 
of the cleavage site (Hart et al., 1985, McLauchlan et al., 1985, Gil & Proudfoot, 1987, 
MacDonald et al., 1994, Hu et al., 2005); and third, the USE with a UGUA sequence, which is 
positioned 40 to 100 nts upstream of the cleavage site (Hu et al., 2005).  
In contrast, the yeast signal is somewhat different in both its sequence and organization (Zhao 
et al., 1999, Mandel et al., 2008). It is less conserved and a minimum three elements are 
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needed. The UA-efficiency element (UAUAUA) is located at variable distances upstream of the 
cleavage site and is required for activation of the downstream positioning element. For 
functioning of the efficiency element, the first and the fifth U are most critical. However, this 
element only improves the efficiency of the cleavage reaction but is not essential. The A-rich 
positioning element is located approximately 20 nts upstream of the polyadenylation site and 
directs the cleavage site position. Mutations in this element disrupt only the position of the 
cleavage site, but not the efficiency of 3´ end processing, indicating that the function is less 
critical when compared to its mammalian PAS counterpart. Polyadenylation occurs in most 
cases at Y(A)n sequences (Y=pyrimidine) and the polyadenylation site is in comparison to 
humans less well defined, resulting in polyadenylation site clusters.  
In trypanosomes the only known cis-acting sequence element is the polypyrimidine tract 
upstream of a trans splice site, which affects polyadenylation of the upstream gene and trans 
splicing of the downstream gene (LeBowitz et al., 1993, Matthews et al., 1994, Benz et al., 
2005). The polyadenylation site is similar to yeast (see above) less well defined, resulting in 
polyadenylation site clusters as well (Siegel et al., 2011). These differences of cis-acting 
polyadenylation elements between trypanosomes, yeast, and mammals raised the question 
whether the protein factors involved in polyadenylation are correspondingly divergent in 
trypanosomes. For example, for some mammalian polyadenylation factors, such as CstF50, no 
counterpart could be identified in yeast (Takagaki & Manley, 1997).  
In trypanosomes, only Fip1 and CPSF30 had previously been identified and functionally 
described so far (Hendriks et al., 2003, Bercovich et al., 2009). Specifically, CPSF30 is required 
for polycistronic mRNA processing (Hendriks et al., 2003). In addition, the CPSF73 ortholog 
associates with the U1 snRNP specific U1A protein in trypanosomes (Tkacz et al., 2010). Here 
we identified eight additional factors as part of the trypanosomatid polyadenylation machinery, 
based on mass spectrometry and database search: CPSF160, CPSF100, CPSF73, CstF64, 
CstF50, Symplekin, Tb927.11.13860 and Tb927.8.4480 (see 5.1.4). However, the poly(A) 
polymerase was not co-purified, which is in line with previous observations, suggesting that the 
poly(A) polymerase is not tightly associated with other processing factors; instead, there may be 
a dynamic or transient association with the core polyadenylation complex (Shi et al., 2009). Even 
if the sequence similarity between these trypanosome polyadenylation factors and their human 
counterparts is low, they share for the most part their domain architectures. This becomes 
particularly obvious when comparing the conservation of the subunits of the CPSF complex (see 
5.1.4). For example, the CPSF73 subunit, which attracted special attention as the functional 
endonuclease in the mammalian polyadenylation reaction, shares specific, catalytically important 
residues with the trypanosome homolog: The zinc-binding residues (mainly histidines) are 
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conserved in the trypanosomatid CPSF73, indicating that CPSF73 likely also acts as the 
endonuclease during polyadenylation in trypanosomes (Mandel et al., 2006). Moreover, the 
domain structures of T. brucei CPSF30 and its mammalian homolog are strongly conserved, 
harboring five C3H1 zinc fingers and a C-terminal C2HC zinc finger. Human CPSF30 (together 
with WDR33) is required for PAS binding, and it was shown that CPSF30 binds poly(U) 
sequences in vitro (Barabino et al., 1997, Chan et al., 2014, Schönemann et al., 2014, Shimberg 
et al., 2016). These in vitro binding properties for poly(U) sequences were observed for 
trypanosomatid CPSF30 in our SELEX-seq experiment as well, arguing for similar RNA-binding 
properties of both proteins (see 5.1.5).  
Some of the new trypanosome factors display only low sequence conservation. The putative 
trypanosome CstF64 strikingly differs from the human counterpart (compare the molecular 
masses of 14 kDa vs. 64 kDa for the T. brucei and the human CstF64, respectively) and could 
only be identified through a putative hinge domain required for CstF64 interaction with CstF77 
and Symplekin (Takagaki & Manley, 2000, Ruepp et al., 2011b). The otherwise conserved N-
terminal RRM domain, however, is completely missing in trypanosomes. Therefore the 
trypanosomatid CstF64 may have retained only and function as a scaffolding protein required for 
the recruitment of other 3´ end processing factors. Moreover, we cannot exclude that the 
functions have been moved to another, still unknown factor or may be not essential in 
trypanosomes anymore.  
Finally, some known mammalian polyadenylation factors could be identified neither in our mass 
spectrometry approach nor through extensive database homology search: As an example, we 
did not find a trypanosome homolog of WDR33, a subunit of the CPSF complex. Independent 
studies had recently identified WDR33 as the factor that together with CPSF30 recognizes the 
AAUAAA polyadenylation signal (Chan et al., 2014, Schönemann et al., 2014, Shimberg et al., 
2016). Since trypanosomes lack the classical hexameric polyadenylation signal, this appears 
plausible. In sum, our results argue for a general conservation of polyadenylation factors among 
eukaryotes. 
6.4 Linkage of polyadenylation and trans splicing 
Depletion of the individual factors of the polyadenylation complex identified in our study showed 
severe growth defects and inhibition of polyadenylation in most cases (see 5.1.6). Interestingly, 
the two hypothetical proteins, Tb927.11.13860 and Tb927.8.4480, of which no known homolog 
or conserved domain structure could be identified, activate or repress polyadenylation, 
respectively. Such effects have been described in higher eukaryotes for factors that are not 
constituents of the core polyadenylation complex, but are required for regulation of 
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polyadenylation. As an example, 14-3-3ε interacts directly with the C-terminus of the poly(A) 
polymerase and inhibits the polyadenylation activity, whereas the transcription activator GAL4 
stimulates polyadenylation via an interaction with PAF1c (Kim et al., 2003, Nagaike et al., 2011). 
In addition, we observed trans splicing defects consistent with close coupling of both mRNA 
processing reactions in trypanosomes. Interestingly, we did not detect for all factors effects on 
polyadenylation and trans splicing: For example, knockdown of cleavage factor I m25 (CFIm25) 
neither affected poly(A) tail length nor splicing. In higher eukaryotes CFIm25 is involved in the 
regulation of alternative polyadenylation, especially in the repression of proximal polyadenylation 
sites leading to longer 3´ UTRs (Gruber et al., 2012). Since alternative polyadenylation is 
common in trypanosomes as well, CFIm25 identified here, which also contains a NUDIX domain 
required for USE binding in humans, is a potential regulator of this process (Kolev et al., 2010, 
Siegel et al., 2010, Yang et al., 2010).  
In other eukaryotes, a direct linkage between spliceosomal and 3´ end processing components 
had been demonstrated by several studies (Vagner et al., 2000, Kyburz et al., 2006, Millevoi et 
al., 2006). For example, U2AF65, which binds the polypyrimidine tract during splicing, interacts 
with CFIm59 (via an arginine-serine-rich region in both proteins) and stimulates 3´ end cleavage 
and polyadenylation. Moreover, the poly(A) polymerase interacts with U2AF65 and increases the 
binding affinity of the latter one to the polypyrimidine tract, which in turn enhances splicing. In 
addition, the U2 snRNP interacts via SF3b with the CPSF complex, and CPSF stimulates 
splicing, whereas the U2 snRNP activates mRNA cleavage. In trypanosomes, so far only the 
polypyrimidine tract is known to affect trans splicing and polyadenylation of two adjacent genes 
(LeBowitz et al., 1993, Matthews et al., 1994, Benz et al., 2005). Until recently no factor could be 
identified, which directly links the polyadenylation complex and the trans-spliceosome in 
trypanosomes. This is in line with our result that no known spliceosomal factor co-purified with 
CPSF160. However, a recent study provided first evidence that the polyadenylation factor 
CPSF73 copurifies with the U1A protein, a specific component of the spliceosomal U1 snRNP 
(Tkacz et al., 2010). The U1A protein was previously shown to autoregulate its own expression 
by binding of two U1A proteins to its own mRNA, regulating poly(A) polymerase activity in higher 
eukaryotes (Gunderson et al., 1994). In addition, the U1A protein interacts with CPSF160 and 
can generally stimulate polyadenylation (Lutz et al., 1996). Moreover, the whole U1 snRNP can 
inhibit polyadenylation due to an interaction between U1-70K and the poly(A) polymerase and is 
also involved in blocking cryptic polyadenylation signals in introns, thereby preventing premature 
cleavage and polyadenylation (Gunderson et al., 1998, Kaida et al., 2010, Berg et al., 2012). 
Note that the spliceosomal U1 snRNP was thought to be required only for cis splicing, not for 
trans splicing in trypanosomes. However, we recently reported that the U1 snRNP may also 
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associate with the trans-spliceosome, indicating a physical linkage between cis- and trans-
splicing (Preußer et al., 2014). Taken together this suggests that the U1 snRNP functions in both 
splicing and polyadenylation in trypanosomes, likely linking both processes as described for 
other eukaryotes before.  
6.5 Characterization of the DRBD4 RNA binding motif 
We initially characterized in vivo RNA binding of DRBD4 by iCLIP, which demonstrated a strong 
preference for UTR regions (see 5.2.1). Earlier studies had mapped DRBD3, a close paralog of 
DRBD4, in 3´ UTR regions, underlining the important regulatory role of gene UTRs (Das et al., 
2015). The DRBD4 RNA-binding motif was further evaluated by in vitro SELEX-seq, followed by 
GST pulldown assays of short transcripts for validation: The DRBD4 RNA-binding motif is 
purine-, especially adenosine-rich, containing AUGA elements (see 5.2.2). In contrast, 
polypyrimidine stretches were depleted during the SELEX rounds of selection.  
This was surprising, because human PTB binds, as indicated by the name, polypyrimidine 
stretches: First, two studies identified UCUUC and CUCUCU RNA-binding motifs, and second, 
follow-up experiments identified the RNA-binding motif of each RRM with four different 
consensus motifs (RRM1: YCU; RRM2: CU(N)N, RRM3: YCUNN, RRM4: YCN (1995, Perez et 
al., 1997, Oberstrass et al., 2005, Reid et al., 2009). Third, in vivo CLIP delineated a UYUYU 
consensus motif for PTB (Xue et al., 2009). In addition, a PTB-like, pyrimidine-rich binding motif 
had been identified for the second PTB homolog in trypanosomes, DRBD3 (Das et al., 2015). 
However, one has to consider that the sequence homology between DRBD4 and PTB is low and 
subtle changes in amino acids involved in RNA binding may change specificity (Maris et al., 
2005) 
6.6 DRBD4-dependent poly(A) site choice 
In trypanosomes gene expression is controlled mainly by post-transcriptional mechanisms 
(Clayton, 2014). Recent genome-wide approaches showed that most genes contain several 
trans splice and polyadenylation sites, indicating that the regulation of both processes provides 
another, still not very well explored level of post-transcriptional gene regulation in trypanosomes 
(Kolev et al., 2010, Nilsson et al., 2010, Siegel et al., 2010, Veitch et al., 2010).  
We focussed on DRBD4 binding upstream of activated and repressed polyadenylation sites, as 
an attempt to derive a predictive map for this factor. Our results provide evidence for a 
regulatory role of DRBD4 in poly(A) site choice in T. brucei (see 5.2.3 and 5.2.4), although we 
cannot recognize distinct features of DRBD4 binding sites or positioning that would associate 
with poly(A) site activation versus repression. Position-dependent effects on alternative splicing 
have been described for splicing regulators in humans (Rossbach et al., 2014): hnRNP L binds 
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at repressed exons preferential upstream of the 3´ splice site (peak at position -40), whereas 
hnRNP L activates exon splicing when bound in the intron further downstream of the 5´ splice 
site (positions +25 to +200). In sum, it was proposed that hnRNP L represses 3´ splice sites by 
blocking the recognition of the polypyrimidine tract and 3´ splice site region, and activates 5´ 
splice sites from downstream intronic positions. 
However, in case of DRBD4-regulated polyadenylation additional protein factors may be 
required, or there are distinctive changes in the sequence elements involved. Interestingly, 
among the DRBD4-associated proteins we found several constituents of the trypanosomatid 
polyadenylation complex (CPSF160, CPSF100, CPSF73, CstF50 and Symplekin) including the 
functional poly(A) polymerase [Tb927.7.3780] (see 5.2.5). Moreover, trypanosomatid PABP2 the 
homolog of human PABPN1, which stimulates the poly(A) polymerase for efficient 
polyadenylation and also regulates APA, was co-purified (Wahle, 1991a, Bienroth et al., 1993, 
Wahle, 1995b, Janal et al., 2012). The association of DRBD4 and PABP2 may provide a first 
protein factor that could be involved in a combinatorial regulation of polyadenylation as observed 
for human PTB (see below).  
However, further analyses are required to characterize the biochemical mechanisms and protein 
interactions involved in DRBD4-dependent regulation of polyadenylation. The repression of a 
polyadenylation site, as observed for a cryptic site in the 3´ UTR of Tb927.2.6000 (see 5.2.4) 
can be mediated in principle by blocking the assembly of single or multiple constituents of the 
polyadenylation complex. As an example, PTB and CstF64 can compete for binding to the 
downstream GU/U-rich sequence element (Castelo-Branco et al., 2004). In addition, it was 
reported that the U1 snRNP can block cryptic polyadenylation signals in introns, thereby 
preventing premature cleavage and polyadenylation (Kaida et al., 2010, Berg et al., 2012). 
Stimulatory effects on polyadenylation site choice, as observed in case of the gene 
Tb927.11.5440 (see 5.2.4), may be caused by recruitment of polyadenylation complex 
constituents like CstF or the poly(A) polymerase or by directly stimulating poly(A) polymerase 
activity as observed for PTB (Millevoi et al., 2009). 
6.7 Alternative polyadenylation in T. brucei 
In other eukaryotes, alternative polyadenylation is often associated with proliferation and cellular 
differentiation (Elkon et al., 2013). For example, activation of T-cell proliferation is linked to 
proximal poly(A) site usage as well as general shortening of 3´ UTRs in cancer cells (Sandberg 
et al., 2008, Mayr & Bartel, 2009, Lin et al., 2012, Morris et al., 2012). Most likely this correlates 
with the deletion of binding sites for miRNAs or trans-acting proteins that can negatively affect 
mRNA stability or translation efficiency. Moreover, many tissues show a specific bias in poly(A) 
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site choice, for instance a preference for distal poly(A) sites in brain and nervous system (Zhang 
et al., 2005). In procyclic trypanosomes, mainly the distal of the two polyadenylation sites in the 
transcript of Tb927.11.5440 (malic enzyme) is used, resulting in an almost exclusive expression 
of the long mRNA isoform: Upon DRBD4 depletion, the distal poly(A) site is down-regulated, 
whereas the proximal one is up-regulated, causing a shift to the short isoform (see 5.2.4). 
Interestingly, in the bloodstream form, the opposite can be observed, that the short 
Tb927.11.5440 isoform is predominantly expressed (see 5.2.4). In addition, a previous study 
showed that expression of Tb927.11.5440 is developmentally regulated, with malic enzyme 
levels higher in the procyclic than the bloodstream form (Leroux et al., 2011). Therefore the 
DRBD4-dependent poly(A) site choice and isoform expression in procyclic cells may be directly 
linked to differential regulation of developmental genes in the trypanosomatid life-cycle. 
 
6.8 Further perspectives 
Here we initially identified the functional poly(A) polymerase (see 5.1.1, 5.1.2 and 5.1.3) and the 
constituents of the polyadenylation complex in T. brucei (see 5.1.4). Moreover, we could show 
that depletion of most polyadenylation factors impaired both polyadenylation and trans splicing 
in vivo, arguing for close coupling of these processes (see 5.1.6).  
However, further work is required to study the polyadenylation complex in trypanosomes in more 
details. For example, RNA binding of the complex remains still elusive, since the canonical cis-
acting elements (PAS and DSE) and the WDR33 protein, which directly binds the PAS, are 
missing in trypanosomes (Proudfoot, 2011, Chan et al., 2014, Schönemann et al., 2014). 
Moreover, trypanosomatid CstF64 lacks the N-terminal RRM required for DSE recognition and 
was only identified through a putative hinge domain (see 5.1.4) (Takagaki et al., 1992, 
MacDonald et al., 1994, Takagaki & Manley, 1997, Perez Canadillas & Varani, 2003). Most likely 
the best candidate to analyze RNA binding of the T. brucei polyadenylation complex is CPSF30, 
since the mammalian protein is involved in PAS binding and the domain structure is highly 
conserved between the human and the trypanosomatid proteins (Chan et al., 2014, 
Schönemann et al., 2014, Shimberg et al., 2016). We initially identified a poly(U) in vitro binding 
motif for T. brucei CPSF30 in our SELEX-seq experiment, which was also observed for the 
mammalian protein (Barabino et al., 1997). However, this motif needs to be further analyzed 
biochemically by GST pulldown experiments of various RNA transcripts. To generally investigate 
in vivo RNA binding of the polyadenylation complex, CPSF30 iCLIP experiments can be used, 
and correlated with poly(A) sites identified in various RNA-seq datasets.  
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CPSF73 is the endonuclease in the cleavage and polyadenylation reaction and the domain 
structures of both the human and the trypanosomatid proteins are highly conserved, including 
the zinc-binding residues (mainly histidines), which are required for cleavage activity (Mandel et 
al., 2006). To assay the trypanosomatid protein for cleavage activity, CPSF73 can be 
recombinantly expressed, purified and tested for in vitro cleavage. In addition, the conserved 
residues for zinc-binding can be mutated to further analyze the catalytic mechanism.  
Moreover, the protein-protein interactions between the identified factors of the T. brucei 
polyadenylation complex remain elusive, but they have been well characterized for the 
mammalian system (see 3.3) (Chan et al., 2011, Xiang et al., 2014). Since the domain structures 
of most mammalian and trypanosomatid proteins are highly conserved (see 5.1.4) it appears 
likely that the interaction between the proteins is conserved as well. Indeed, the interaction 
between Fip1 and CPSF30 has been described in both trypanosomes and mammals (Bercovich 
et al., 2009, Kaufmann et al., 2004). To further identify the protein-protein interactions in the 
trypanosomatid polyadenylation complex, the factors can be recombinantly expressed, purified 
and tested for in vitro binding in pulldown experiments.  
Furthermore, we identified the trypanosomatid PTB homolog DRBD4 as first trans-acting 
regulator of polyadenylation. DRBD4 binds upstream of regulated polyadenylation sites, has a 
purine, in particular adenosine, -rich binding motif and is required for both activation and 
repression of polyadenylation sites affecting general transcript and isoform expression levels 
(see 5.2.1, 5.2.2, 5.2.3 and 5.2.4).  
To further analyze the DRBD4 RNA-binding motif and address the influence of single RRMs, 
truncated versions of the protein lacking individual RRMs can be recombinantly expressed and 
used in both SELEX-seq and pulldown assays.  
We analyzed the DRBD4-dependent poly(A) site choice only in procyclic trypanosomes and 
have evidence for a life-cycle-dependent regulation, as observed for the differential isoform 
expression of Tb927.11.5440 (malic enzyme). For further characterization of a life-cycle-
dependent regulation, DRBD4 binding sites need to be identified in the bloodstream form by 
iCLIP and correlated with poly(A) site choice after DRBD4 depletion or overexpression.  
Another putative regulator of polya(A) site choice is the trypanosomatid CFIm25 homolog, since 
the mammalian protein is involved in the repression of proximal polyadenylation sites leading to 
longer 3´ UTRs (Gruber et al., 2012). To assess CFIm25-dependent poly(A) site choice in T. 
brucei, the same combinatorial iCLIP/RNA-seq strategy as applied here can be used.  
The cross-regulation between trans splicing and polyadenylation is still an open question in 
trypanosomes. To analyze a trans splice-dependent polyadenylation site choice, splicing can be 
blocked by various methods (knockdown of splicing factors, antisense morpholino 
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oligonucleotides for against specific snRNAs and Sinefungin treatment) and poly(A) site usage 
can be assayed by RNA-seq.  
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8 Supplementary Information 
8.1 Figures and Tables 
A   
 
                            ~~~~~~~~~~~~~~~~~NPPPPPPPPPPPPQMMMMMMMMMN       PPPPPPPPPPP 
Tb927.3.3160 ---------------MEWMYGPTKPLEVPRPQDHDYDESEMLYGVLAECPSISPNP-------VLTLVESMALR  52 
PAPOLA       MPFPVTTQGSQQTQPPQKHYGITSPISLAAPKETDCVLTQKLIETLKPFGVFEEEEELQRRILILGKLNNLVKE  74 
                         :  ** *.*:.:. *:: *   :: *  .*     :. :        :*  ::.:. . 
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~NPPPPPPPPPPPPPPQMMMMMMNPPPPPPPPPPPPPPPPPPP 
 
             PPPPPQMM       MMMMMMSRRRTMNPPQMMMMMMMMSRRRRRRRTMMMMNQMMMNPP   PPPQMMMMMSR 
Tb927.3.3160 IVQRHSQN-------TQEQWARAYPFGSCGLSASVAESDLDVALICPSVLTTDIFFDEFP---RLLYNSVGPVS 116 
PAPOLA       WIREISESKNLPQSVIENVGGKIFTFGSYRLGVHTKGADIDALCVAPRHVDRSDFFTSFYDKLKLQEEVKDLRA 148 
              ::. *:.        ::  .: :.***  *.. .  :*:*.  :.*  :  . ** .*    :*  :  .  : 
             PPPPPPPPQMMMNPPQMMMMMSRRRTMNPPQMMMMMMMMSRRRRRRRTMMMNPQMMMNPPPPPQMMMSRT——SR 
 
             TMMMMMMSRRRRTMMSRRRRRRRRTMMMMMMMMMMMMMMNQMMMMMNQMMMNPPPPPPPPPPQMMMMMMMNPPP 
Tb927.3.3160 VVAARVPVVKFEYRGTAVDVVFVSVGLPQPPTEEQMLDDSFLLKVARETRPSANGIRFTFEIKRRLPVPYDVFT 190 
PAPOLA       VEEAFVPVIKLCFDGIEIDILFARLALQTIPEDLDLRDDSLLKNLDIRCIRSLNGCRVTDEILHLVPN-IDNFR 221 
             *  * ***:*: : *  :*::*. :.*   * : :: ***:* ::  .   * ** *.* ** : :*   * *   
             TMMMMMMSRRRRRTMSRRRRRRRRTMMMMMMMMMMMMMMNQMMMMMNPPPPPPPPPPPPPPPPQMMMM NPPPP 
 
             PPPPPPPPPPPQMMMMMMMMMMMMNPPPPPPPPPPPPQMMMMMNPPPPPPPPPPQMMMMMMMMMMMMMMMMMMM 
Tb927.3.3160 AVLKTVKLWAMRRMVYGNVYTYPNGAVLAIMVARVCQVLPSSHPSTLLRFFFLFYTQWMSRHDRISPVYLTATL 264 
PAPOLA       LTLRAIKLWAKRHNIYSNILGFLGGVSWAMLVARTCQLYPNAIASTLVHKFFLVFSKWEWPN----PVLLKQPE 291 
              .*:::**** *: :*.*:  : .*.  *::***.**: *.: .***:: ***.:::*   :    ** *. .   
             PPPPPPPPPPPQMMMMMMMMMMMMNPPPPPPPPPPPPQMMMMMNPPPPPPPPPPPPQMMMMM    MMMMMMMM  
 
             MMMMMMMMMMMMMMMMMMMMMMMMMMSRTMMMMMSRTMMMMMNPPPPPPPPPPPPPPPPPPPPPQ  MMMNPPQ 
Tb927.3.3160 EGRGRIPGLPDSWKPSKDKICCDLFPVISPAYPYVNDASSVGRCGLEALYSEITRVQCILTEART--LPLEEMW 336 
PAPOLA       ECNLNLPVWDPRVNPSDR---YHLMPIITPAYPQQNSTYNVSVSTRMVMVEEFKQGLAITDEILLSKAEWSKLF 362 
             *  ..:*      :**.     .*:*:*:****  *.: .*. .   .: .*:.:  .*  *        .:::  
             MMMMMMMMMMMMMMMNPQ   MMMMMSRTMMMMMSRTMMMMMNPPPPPPPPPPPPPPPPPPPPPQMMMMMNQMM 
 
             MMMMMMMMMMSRRRRRRRTMM 
Tb927.3.3160 EPYRIEEEYSTFLVVGVSCAG----------------------------------------------------- 357 
PAPOLA       EAPNFFQKYKHYIVLLASAPTEKQRLEWVGLVESKIRILVGSLEKNEFITLAHVNPQSFPAPKENPDKEEFRTM 436 
             *. .: ::*. ::*: .*..                               
             MMMMMMMMSRRRRRRRRRTMMNPPPPPPPPPPPPPPPPPPPPPQMMMSRRRRRRTMMMSRTMMMMMMMMMSRRR 
 
                                          NPPPPPPPPPPPPPPPPPPPPQMMMMMMSRTMMMSRTMMMMMMM 
Tb927.3.3160 ------------------------HSMAETEQALSVWSSYVASRLRILIYSIERHAQARPCPRKIRPKKDNHVG 407 
PAPOLA       WVIGLVFKKTENSENLSVDLTYDIQSFTDTVYRQAINSKMFEVDMKIAAMHVKRKQLHQLLPNHVLQKKKKHST 510 
                                     :*:::*   ::  *. .   ::*    ::*:   :  *.::  **.:*    
             RRRRRRTMMMMMMMMMMMMMNPPPPPPPPPPPPPPPQ-MMMMMMMSRRRRRRRTMMMMMMM~~~~~~~~~~~~~ 
 
                  SRRR   RRRRTMMMMMMMMMMMMMMNPPPPPPPPPPPPPPPQ 
Tb927.3.3160 GSSCFLSVN---FLIGVKAKEGGPTPQPSLFTEACGEFHHAVKEGCNN-------------------------- 452 
PAPOLA       EGVKLTALNDSSLDLSMDSDNSMSVPSPTSATKTSPLNSSGSSQGRNSPAPAVTAASVTNIQATEVSVPQVNSS 584 
              .  : ::*   : :.:.:.:. ..*.*:  *::.     . .:* *.                                                
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
                     MMMMMMMMM                
Tb927.3.3160 --------DSIPWSFQR--------------------------------------------------------- 461 
PAPOLA       ESSGGTSSESIPQTATQPAISPPPKPTVSRVVSSTRLVNPPPRSSGNAATSGNAATKIPTPIVGVKRTSSPHKE 658 
                     :*** :  :                                                    
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
                      SRRRRRTMNPPPQ~~~~~~~~~~~~~ 
Tb927.3.3160 ---------NDRAMHWPRVKFLEVHQVLHLLQDLK--------------------------------------- 487 
PAPOLA       ESPKKTKTEEDETSEDANCLALSGHDKTEAKEQLDTETSTTQSETIQTAASLLASQKTSSTDLSDIPALPANPI 732 
                      :*.: . ..   *. *:  .  ::*. 
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
             ~~~~~~~~~~~~~ 
Tb927.3.3160 ------------- 
PAPOLA       PVIKNSIKLRLNR 745 
             ~~~~~~~~~~~~~ 
 





             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~NPPPPPPPPPPPPQMMMMMMMMMNPPPPPPPPPPPPPPPPPP 
Tb927.7.3780 ------------MSRTDKSFLAKKIISSDGPSPAEEDHNVPLVEWCAAG--IEPEEEANRRRSVLEHINCIVRA  60 
PAPOLA       MPFPVTTQGSQQTQPPQKHYGITSPISLAAPKETDCVLTQKLIETLKPFGVFEEEEELQRRILILGKLNNLVKE  74 
                          . .:* :  .. **  .*. ::   .  *:*   .   :* *** :**  :* ::* :*: 
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~NPPPPPPPPPPPPPPQMMMMMMNPPPPPPPPPPPPPPPPPPP 
 
             PPPPPPPPQMMMMMNPPPPQMMMSRRRTMNPPQMMMMMMMMSRRRRRRRTMMMNPPQMMMNPPPPPQMMSRRRR 
Tb927.7.3780 WIRSTMIAEFRMPAEAAAQVEGRIFATGSYRYNVHGSGSDIDIVLIAPNRITREHFFNTLAPRLSHESRITELH 134 
PAPOLA       WIR-EISESKNLPQSVIENVGGKIFTFGSYRLGVHTKGADIDALCVAPRHVDRSDFFTSFYDKLKLQEEVKDLR 147 
             ***  :  . .:* ..  :* *:**: **** .** .*:*** : :**.:: *..**.::  :*. :..:.:* 
             PPP PPPPQMMMMNPPQMMMMMSRRRTMNPPQMMMMMMMMSRRRRRRRTMMMNPQMMMNPPPPPQMMMSRT——S 
 
             RTMMMMMMSRRRRRTMMMSRRRRRRTMMMMMMMMMM   NQMMMMMMNPPPPPPPPPPPPPPPPQMMMMNPPPP 
Tb927.7.3780 CIRDARVPLIAMVADGIDIDLSFGSIRQDRVPEVIT---DDLLQGLDDQSVLSCNAVRVAHNIMDLVPHKASFR 205 
PAPOLA       AVEEAFVPVIKLCFDGIEIDILFARLALQTIPEDLDLRDDSLLKNLDIRCIRSLNGCRVTDEILHLVPNIDNFR 221 
             .:.:* **:* :  ***:**: *. :  : :** :    *.**:.** :.: * *. **:.:*:.***:  .** 
             RTMMMMMMSRRRRRTMSRRRRRRRRTMMMMMMMMMMMMMMNQMMMMMNPPPPPPPPPPPPPPPPQMMMMNPPPP 
 
             PPPPPPPPPPPPQMMMMM-MMMMMNPPPPPPPPPPPPQMMMMMNPPPPPPPPPPPPQMMMMMMMMMSRTMMMSR 
Tb927.7.3780 QALRFIKAWGKARGIYSNTFGFPSGIGWAILVAFVCQCHPNQNAAGMVVRFFRIYHTWFSPNPHGSGRENRAIY 279 
PAPOLA       LTLRAIKLWAKRHNIYSNILGFLGGVSWAMLVARTCQLYPNAIASTLVHKFFLVFSKWEWPNP---------VL 286 
              :** ** *.* :.**** :** .*:.**:*** .** :**  *: :* :** :: .*  ***         : 
             PPPPPPPPPPPPQMMMMMMMMMMMNPPPPPPPPPPPPQMMMMMNPPPPPPPPPPPPQMMMMMM         MM  
 
             TMMMMMMMMMMMMMMMMMMMNPPQMMMMMSRTMMMMMSRTMMMMMNPPPPPPPPPPPPPPPPPPPPQMMMMSRR 
Tb927.7.3780 YLTETMRVKTNLGRGWDPRESKSDALALFPVLTPAVPYGNACYNVTMTNLRQLCDEFARGHEICSSYIGMGVEE 353 
PAPOLA       LLKQPEECNLNLP-VWDPRVNPSDRYHLMPIITPAYPQQNSTYNVSVSTRMVMVEEFKQGLAITDEILLS---- 355 
              *.:. . : **   **** . **   *:*::*** *  *: ***:::.   : :** :*  * .  . : 
             MMMMMMMMMMMMM MMMMMMMMNPQMMMMMSRTMMMMMSRTMMMMMNPPPPPPPPPPPPPPPPPPPPPQMMMMM 
 
             TMMMMSRTMMNPQMMMMMMMMMMSRRRRRRRRRRTNPPPPPPPPPPPPPPPPPPQMMMMMMMMMMMMMMSRRRR 
Tb927.7.3780 TKMKLGPHGIWSKILEPVKFFGEYKYYLHVQVTCTDAEAYQGYVDAVESKIRFLWAGTAESRAQSLESFPHVRL 427 
PAPOLA       -------KAEWSKLFEAPNFFQKYKHYIVLLASAPTEKQRLEWVGLVESKIRILVGSLEKN---EFITLAHVNP 419 
                    :. ***::*. :** :**:*: : .:..  :    :*. ******:* ..  :.   .: ::.**.  
                    MMMMNQMMMMMMMMMMMSRRRRRRRRTMMNPPPPPPPPPPPPPPPPPPPPPQMM   MSRRRRRRTM 
 
             RTMMMMMSRRRTMMN      PPPPPPPPQMMMMMMMMMMMMMMMMMMMMSRTMMM   MMMMMMMMMMSRRRR 
Tb927.7.3780 RLNPKGYEAPEEVEAR-----SRLLKKAPRGGGIPESGAQGRAGASSNGNSSSVSS---AVGGGSAGTAVKSFS 493 
PAPOLA       QSFPAPKENPDKEEFRTMWVIGLVFKKTENSENLSVDLTYDIQSFTDTVYRQAINSKMFEVDMKIAAMHVKRKQ 493 
             :  *   * *:: * *     . ::**: .. .:. . : .  . :..   .::.*    *.   *.  **  .                    
             MMSRTMMMMMMMMMSRRRRRRRRRRTMMMMMMMMMMMMNPPPPPPPPPPPPPPPQMMMMMMMMSRRRRRRRTMM 
 
             RRRRRR                   RRRTMMMMMMMMMMNPPPPPPPPQMMMMMMMMMMMMM     MMSRRRR 
Tb927.7.3780 RHYYFG-------------------MSVDSKAASMKVDLAPSIRSFHNIVRQLRQYRDGVTR-----LPVITVE 543 
PAPOLA       LHQLLPNHVLQKKKKHSTEGVKLTALNDSSLDLSMDSDNSMSVPSPTSATKTSPLNSSGSSQGRNSPAPAVTAA 567 
              *  :                    :. .*   **. * : *: *  . .:      .* ::      *.:*.              
             MMMMMM~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
             RRT                        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Tb927.7.3780 DMT------------------------KIPAFVKAAAGYKDPVSTTESDAGSGRACTPSEADTATSSNGAAAAT 593 
PAPOLA       SVTNIQATEVSVPQVNSSESSGGTSSESIPQTATQPAISPPPKPTVSRVVSSTRLVNPPPRSSGNAATSGNAAT 641               
             .:*                        .**  .. .*    * .*..  ..* *  .*.  .:..::... ***  
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Tb927.7.3780 AGASEAADKSEGAPSAETAGVKRHRGEDDENDAAA--------MKVVAKDSVNSAIADHAGPKLGKGSAEGGGA 659 
PAPOLA       KIPTPIVGVKRTSSPHKEESPKKTKTEEDETSEDANCLALSGHDKTEAKEQLDTETSTTQSETIQTAASLLASQ 715 
               .:  .. .. :.. :  . *: : *:**..  *         *. **:.:::  :   . .: ..::  ..  
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Tb927.7.3780 RRDNSTGHSKVSQDDDEELGLEQALGLGF-- 688 
PAPOLA       KTSSTDLSDIPALPANPIPVIKNSIKLRLNR 745 
             : ..:   .  :   :    ::::: * :   
             ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 
Supplementary Figure 8.1 Alignment of the human poly(A) polymerase (PAPOLA) to the two 
putative T. brucei poly(A) polymerases, (A) Tb927.3.3160, and (B) Tb927.7.3780.  
Residues (page 128-129) that are conserved or have a similar physicochemical character in more than 
50% of sequences are highlighted in black and gray, respectively. The predicted secondary structures of 
PAP from T. brucei and H. sapiens are shown above and below the alignments, respectively. α-helices 
are represented as tubes, and β-strands as arrows, while disordered regions are shown as “~”.  
 




Figure 8.2 DRBD4 RNA binding around regulated poly(A) sites.  
Accumulated DRBD4-YFP iCLIP crosslink-tag counts were plotted in the region between -200 to +200 nts 
relative to the poly(A) site of the down- and up-regulated clusters (top: down-regulated n=234; background 
n=936; bottom: up-regulated n=248; background n=992) and are depicted as solid lines. As background 
control, unaffected polyadenylation sites were used (dashed lines). Crosslink-tag counts were plotted with 
fitted values (21-nts windows) on the Y-axis and positions on the X-axis. 
 
 
     8. Supplement 
131 
 
Supplementary Table 8.1 CPSF160-associated proteins identified by mass spectrometry after tandem affinity purification. 
Extracts were prepared from T. brucei cell lines that stably express tagged CPSF160 (in two biological replicates; experiment 1/2), followed by TAP-
tag affinity purification. Proteins after the second purification step (protein C elution) were identified by mass spectrometry. Each protein is described 
by name (factor), the TriTrypDB annotation number (http://tritrypdb.org/tritrypdb/), its molecular mass (in kDa), the number of exclusive unique peptide 




Database Name: the T_brucei database
Version: unknown
Taxonomy: All Entries
Number of Proteins: 38057




Fragment Tolerance: 0,60 Da (Monoisotopic)
Parent Tolerance: 10,0 PPM (Monoisotopic)
Fixed Modifications: 
Variable Modifications: +16 on M (Oxidation), +57 on C (Carbamidomethyl)
Database: the T_brucei database (unknown version, 38057 entries)
Digestion Enzyme: Trypsin
Max Missed Cleavages: 2
Scaffold: Version: Scaffold_4.4.1.1
Modification Metadata Set: 1541 modifications
Comment: 
Protein Grouping Strategy: Experiment-wide grouping with binary peptide-protein weights
Peptide Thresholds: 95,0% minimum 
Protein Thresholds: 95,0% minimum and 3 peptides minimum
Peptide FDR: 0,7% (Prophet)
Protein FDR: 0,0% (Prophet)





Displaying: Exclusive Unique Peptide Count
# Identified Proteins (51) Accession Number
Molecular 
mass (kDa)










1 cleavage and polyadenylation specificity factor-like protein Tb927.11.14560 159 0 83 84 CPSF160
2 hypothetical protein Tb927.8.7490 158 0 79 76 Symplekin
3 cleavage and polyadenylation specificity factor, putative Tb927.11.230 91 0 45 42 CPSF100
4 cleavage and polyadenylation specificity factor subunit, putative Tb927.4.1340 85 0 37 33 CstF50
5 hypothetical protein Tb927.6.1830 50 0 23 25 CPSF73
6 beta tubulin Tb927.1.2330 50 10 23 23
7 alpha tubulin Tb927.1.2340 50 9 20 20
8 heat shock protein 70 Tb927.11.11330 71 2 16 19
9 hypothetical protein Tb927.11.13860 30 0 15 17 hyp. protein
10 cleavage and polyadenylation specificity factor 30 kDa subunit Tb927.11.12750 32 0 15 12 CPSF30
11 hypothetical protein Tb927.8.4480 29 0 15 18 hyp. protein
12 elongation factor 1-alpha, EF-1-alpha (TEF1) Tb927.10.2100 49 2 13 9
13 hypothetical protein, conserved Tb927.5.4320 31 0 9 9 Fip1
14 unspecified product Tb927.9.5750 22 1 5 3
15 chaperonin Hsp60, mitochondrial precursor Tb927.10.6400 60 1 4 5
16 hypothetical protein Tb927.8.7490 158 0 3 3
17 heat shock protein 83, putative Tb927.10.10890 81 0 3 8
18 heat shock 70 kDa protein, putative Tb927.7.710 70 0 3 6
19 60S acidic ribosomal subunit protein, putative Tb927.11.2050 35 0 3 2
20 heat shock 70 kDa protein, mitochondrial precursor, putative Tb927.6.3740 72 1 2 7
21 hypothetical protein, conserved Tb927.8 .8210 15 0 2 5 CstF64 
22 actin A Tb927.9.8850 45 0 2 4
23 peroxidoxin (TRYP2) Tb927.8.1990 26 0 2 4
24 chaperone protein DnaJ, putative Tb927.2.5160 45 0 2 3
25 GTP-binding nuclear protein rtb2, putative Tb927.3.1120 24 0 2 3
26 glutamine synthetase, putative Tb927.7.4970 47 0 1 12
27 40S ribosomal protein S3, putative Tb927.9.6070 30 0 1 3
28 40S ribosomal protein S4, putative Tb927.11.3590 31 0 1 3
29 t-complex protein 1 gamma subunit, putative Tb927.8.3150 61 0 1 3
30 elongation factor 2 Tb10.70.2650 94 2 0 9
31 glutamate dehydrogenase (GDH) Tb927.9.5900 112 0 0 10
32 succinyl-CoA ligase [GDP-forming] beta-chain,putative Tb927.9.5900 55 2 0 7
33 enolase Tb927.10.2890 47 0 0 10
34 T-complex protein 1, alpha subunit, putative (TCP-1-alpha) Tb927.11.16760 53 0 0 4
35 retrotransposon hot spot protein 5 (RHS5), putative Tb927.2.240 95 0 0 3
36 ATP-dependent DEAD box  helicase, putative, eukaryotic initiation factor 4a, putative Tb927.9.4680 45 0 0 4




37 2-amino-3-ketobutyrate coenzyme A ligase,putative Tb927.8.6060 44 0 0 5
38 DHH1 Tb927.10.3990 46 0 0 4
39 hypothetical protein, conserved Tb927.4.1300 42 0 0 5
40 phosphoglycerate kinase Tb927.1.710 45 0 0 5
41 delta-1-pyrroline-5-carboxylate dehydrogenase,putative Tb927.10.3210 62 0 0 4
42 T-complex protein 1, beta subunit, putative Tb927.11.1900 58 0 0 3
43 unspecified product Tb927.9.6230 42 0 0 4
44 T-complex protein 1, zeta subunit, putative Tb927.11.3240 60 0 0 3
45 ATP-dependent DEAD/H RNA helicase, putative Tb927.10.540 49 0 0 4
46 cystathionine beta-synthase, putative Tb11.02.5400 39 0 0 4
47 chain A, s-adenosyl homocysteine hydrolase (Sahh) Tb927.11.9590 48 0 0 3
48 ADP-ribosylation factor-like protein 3A, putative Tb927.3.3450 20 0 0 3
49 prostaglandin f synthase Tb927.11.4700 32 0 0 3
50 L-threonine 3-dehydrogenase, putative Tb927.6.2790 37 0 0 3
51 malic enzyme Tb927.11.5440 62 0 0 3
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8.2  Abbreviations and Symbols 
~   approximately  
<   less than  
>   more than  
+  plus 
-  minus 
%  percent 
×  times 
× g   times gravity  
°C   degree Celsius  
μ   micro  
2´   bonds to the C-2 carbon of ribose in nucleic acids  
3´   directionality in nucleic acids: in the direction of the C-3 ribose carbon  
5´   directionality in nucleic acids: in the direction of the C-5 ribose carbon  
α   alpha 
β   beta 
ε  eplison 
γ   gamma 
Δ   delta, without / lacking 
A   adenosine  
aa   amino acids  
AcTEV  tobacco etch virus protease 
APA  alternative polyadenylation 
APS   ammonium persulfate  
ARM    armadillo-type fold 
As  anti-sense 
ATP   adenosine triphosphate  
ß-casp  beta-caspase domain 
Bdf3  bomodomain factor 3 protein 
bp   base pairs  
BP   branch point  
BSA   bovine serum albumin  
C   cytidine  
cDNA   complementary DNA  
CF  cleavage factor 
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Ci  Curie 
CLIP   cross-linking and immunoprecipitation  
CPSF  cleavage and polyadenylation specificity factor 
CstF  cleavage stimulation factor 
CstF1-dd cleavage stimulation factor subunit 1, dimerization domain 
CstF64-C cleavage stimulating factor C-terminal domain  
CT   cycle of threshold  
CTD   carboxyl-terminal domain of RNA polymerase II 
C-terminal  carboxyl-terminal 
CTP  cytidine triphosphate 
ctr   control 
DAPI   4´,6-diamidino-2-phenylindole 
dCTP  deoxycytidine triphosphate 
DIG  digoxigenin 
DMPC  dimethyl pyrocarbonate 
DMSO  dimethyl sulfoxide 
DNA   deoxyribonucleic acid 
dNTP   deoxynucleoside triphosphate 
Dox  doxycyclin 
DRBD  double-stranded RNA-binding domain 
DSE  downstream sequence element 
dT  deoxythymidine triphosphate  
DTT   dithiothreitol 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetic acid 
e.g.   exempli gratia (for the sake of example) 
EGTA  ethyleneglycoltetraacetic acid 
et al.   et alii (and others) 
f  femto 
FBS  fetal bovine serum 
fw.   forward (primer) 
g   gram 
G   guanosine 
GST   glutathione S-transferase 
GTP   guanosine triphosphate 
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h   hour(s) 
HEPES N-2-hydroxyethylpiperazine 
His   polyhistidine-tag 
hnRNP heterogeneous ribonucleoprotein particle 
hPAPOLA  human poly(A) polymerase alpha 
HPLC  high-performance liquid chromatography 
H. sapiens Homo sapiens 
iCLIP   individual-nucleotide resolution cross-linking and immunoprecipitation 
IgG  immunoglobulin G 
IPTG  isopropyl-β-D-thiogalactopyranosid 
k   kilo 
kb   kilobases 
kd   knockdown 
kDa   kilodalton 
l   liter 
L-  L-confirmation 
LB  Luria/Miller 
LC-MS/MS  liquid chromatography-tandem mass spectrometry 
M   marker 
m   milli 
M   molar 
mA   milliampere 
min   minute(s) 
miRNA  micro RNA 
mRNA  messenger RNA 
MS  mass spectrometry 
(n)  poly 
n   nano 
N   random / any nucleotide 
NCBI   National center for biotechnology information 
NLS  nuclear localization signal 
NP-40   Nonidet P-40 
nPTB  neuronal polypyrimidine tract binding protein  
N-terminal  amino-terminal 
nts   nucleotides 
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NUDIX  NUDIX hydrolase domain 
OH   hydroxyl (-group) 
ORF  open reading frame 
p   pico 
P, p   phosphate 
PABPN1 nuclear poly(A)-binding protein 1 
PAGE   polyacrylamide gel electrophoresis 
PAP   poly(A) polymerase 
PAS  polyadenylation signal  
PBS  phosphate-buffered saline 
PCR   polymerase chain reaction 
PK  proteinase K 
PNK   polynucleotide kinase 
Pol II  DNA-dependent RNA-polymerases II 
PPIase prolyl isomerase 
PPT  polypyrimidine tract 
PRP8  pre-mRNA processing factor 8 
PTB   polypyrimidine tract binding protein  
PTP  protein C epitope / TEV cleavage site / 2× protein A epitope 
PTU  polycistronic transcription unit 
PVA  polyvinyl alcohol 
®  registered trade mark 
RNA   ribonucleic acid 
RNAi  RNA interference 
RNP   ribonucleoprotein (-particle) 
RRM  RNA recognition motif 
rRNA  ribosomal RNA 
RT   reverse transcription 
RT-qPCR  quantitative RT-PCR  
Rv.   reverse (primer) 
S   Svedberg; sedimentation coefficient 
SAP   shrimp alkaline phosphatase 
SDS   sodium dodecyl sulfate 
sec  second 
SELEX-seq  systematic evolution of ligands by exponential enrichment-sequencing 
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seq   sequencing 
SL  spliced-leader 
snRNA  small nuclear RNA 
snRNP  small nuclear ribonucleoprotein (-particle)  
ss   splice site 
SSR  strand switch region 
T   thymidine 
t   time point 
T4   enterobacteria phage T4 
T7   bacteriophage T7 
TAP  tandem affinity purification 
TBE   Tris-Borate-EDTA 
T. brucei Trypanosoma brucei 
TEMED  N,N,N´,N´-tetramethylenediamine  
TM  Trade Mark 
Tris   Tris-hydroxymethylaminomethane 
tRNA   transfer RNA 
TSS  transcription start site 
TTS  transcription termination site 
Tween 20 Polyoxyethylene (20) sorbitan monolaurate 
U   uridine 
U  unit 
USE  upstream sequence element 
UTP  uridine triphosphate 
UTR   untranslated region 
UV   ultraviolet 
V   volt 
V  A, G or C 
W   watt 
WD40 repeat tryptophan-aspartate repeat 
WT   wildtype 
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